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Within the field of mental health, the issues of quality of life, language production, social
adjustment, neurocognitive functioning, and symptom presentation are considered
important components in the assessment and treatment of psychiatric patients,
especially those with the diagnosis of schizophrenia. These individual domains of
functioning are critical to understanding the unique functioning of a person with
schizophrenia. A primary focus of mental health services is the general ability of a
person with schizophrenia to function adequately within the community. Domains such
as those tapped by the variables in the present study impact the ability of a person to
interact and relate to other people. In addition, these are areas that can be informally
assessed after brief contact with another person, and they may provide information
regarding effective interventions for the individual.
The present study assessed the variables of symptom presentation, subjective and
objective quality of life, social adjustment, communication failures, as manifested in
unclear references, and neurocognitive abilities. Results demonstrated that participants
were exhibiting relatively few psychiatric symptoms and were functioning adequately in
their social adjustment, although they evidenced some impairment in measures of
neurocognitive abilities. Specific relationships among variables of interest are described.
Overall, despite having a diagnosis of a severe and persistent mental illness, the
majority of the participants reported that they were generally satisfied with their lives.
The most important finding of this study is that quality of life can be best predicted by the
absence of high levels of depressive symptomatology, better overall social functioning,
and by observations of language production to identify the frequency with which persons
with schizophrenia use words in such a way that the intended meaning is not clear;
surprisingly, ambiguous word references are associated with higher quality of life. The
ultimate goal for working with persons with schizophrenia should be to increase the
individual’s overall ability to function adequately within the community in the hopes of
improving their global life satisfaction. Several potential strategies for intervention are
discussed.
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Functioning in Schizophrenia 1
Functioning in Schizophrenia and Schizoaffective Disorder:
Quality of Life, Symptom Presentation, Language Production,
and Neurocognitive Abilities
Within the field of mental health, the issues of quality of life and social adjustment,
language production, neurocognitive functioning, and symptom presentation are considered
important components in the assessment and treatment of psychiatric patients, especially those
with the diagnosis of schizophrenia. This is especially evident in the outpatient treatment that
many people with schizophrenia now receive and within the context of a move towards managed
care and a greater emphasis on accountability. A primary focus of case managers and other
outpatient treatment professionals is the general ability of the person with schizophrenia to
function adequately within the community. Domains such as those noted above impact the ability
of a person to interact with and relate to other individuals in the community.
Quality of life refers to the well-being of an individual in relation to objective factors, such
as type of living situation, income, and number of social contacts, and also subjective evaluations
of personal satisfaction with those factors; it is a positive indicator of well-being, as opposed to
only measuring the absence of debilitating or unpleasant symptoms (Frisch, 1994; Lehman,
1996). Language production refers to the manner in which an individual communicates with
others, and it often focuses on errors that result in a decrease in effective communication that are
associated with psychopathology (Andreasen, 1979a, 1979b). Neurocognitive ability refers to the
manner in which the brain functions and how this functioning is exhibited behaviorally, often
through performance on cognitive assessments (Lezak, 1995). Social adjustment describes the
functioning of an individual in social situations and within his or her community (Weissman, 1975).
Evaluation of symptom presentation is important in the understanding of an individual's
experiences, especially in light of the fact that psychiatric symptoms can impact overall
functioning, as well as performance in areas such as neurocognitive abilities and language
production.
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This study examined variables that are relevant to both researchers as well as to
professionals and caseworkers who interact with persons with schizophrenia and related
disorders on a regular basis. The variables are ones that other individuals, such as clinicians and
caseworkers, are able to assess informally and have been demonstrated to be areas of great
importance for functioning within the community. The present study evaluated variables of
symptom presentation, quality of life (both subjective and objective), social adjustment, language
production (specifically communication disturbances manifested through unclear references), and
neurocognitive functioning (evaluated in the domains of attention/concentration, verbal memory,
verbal fluency, higher cognitive functioning, and general mental abilities), to determine
relationships among these domains of variables and to discover patterns predictive of outcome, ft
is apparent that the manner in which an individual functions, whether exhibited through symptoms,
language, or neurocognitive abilities, can greatly impact his or her interactions with others,
general social adjustment, and overall quality of life. Thus, it is important to understand the
relationships among these variables in order better to understand the disease process, to provide
adequate care to individuals with schizophrenia, and to assist in the improvement of their life
situations.
This paper initially discusses issues related to the disorder of schizophrenia, including
history of the illness, diagnostic and classification issues, common symptoms and their
presentation, course, and outcome. The variables of interest for this study are then described in
more detail. Quality of life, both in its current and its historical use, as well as relevant research, is
explained. Social adjustment and its similarity to quality of life are described. Aspects of language
production commonly seen in patients with schizophrenia are discussed in terms of common
errors, theoretical underpinnings of these deviances, and strategies to measure such errors.
Common patterns in the neurocognitive functioning of persons with schizophrenia are explored,
while their relations to long-term outcome and specific tests for measuring performance are
explained. Literature related to these different domains individually and relationships between

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 3
them is explored, after which the hypotheses, methods, and results for the present study are
presented and discussed.
Introduction to Schizophrenia
Schizophrenia is a disorder involving disorganization of thought, serious difficulty
distinguishing reality from fantasy, frequent delusions and hallucinations, and abnormalities in
emotional expression, interpersonal relationships, attention, motivation, and drive (Andreasen,
Arndt, Alliger, Miller, & Flaum, 1995). It is characterized by psychotic symptoms, such as
hallucinations and delusions, as well as disorder of thought, as the defining features. It is also
considered to be a heterogeneous disorder with an often-changing presentation, causing
researchers to have trouble determining etiology, treatment, and even classification for individual
patients (Andreasen & Carpenter, 1993; Malla, 1995a; 1995b). Schizophrenia is regarded by
many to be a chronic, recurring disorder that is likely to affect multiple systems in the brain
(Andreasen, et al., 1995; Malla, 1995a; Schultz & Andreasen, 1999).
The Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision
(DSM-IV-TR-, American Psychiatric Association, 2000) presents diagnostic criteria for
schizophrenia requiring that two or more active characteristic symptoms be present for at least
one month, and signs of the disorder to be present for at least six months. The characteristic
symptoms consist of delusions, hallucinations, disorganized speech, grossly disorganized or
catatonic behavior, and negative symptoms. In addition, there needs to be a decreased level of
functioning in one or more major life areas, such as employment, education, interpersonal
relations, or self-care. There is general agreement that a diagnosis of schizophrenia can only be
given to an individual who has at least several of the diagnostically relevant symptoms (DSM-IVTR, 2000; Strauss, Carpenter, & Bartko, 1974). However, this allows for a variety of presentations
within the disorder of schizophrenia and has resulted in an acceptance of the idea that
schizophrenia probably involves multiple dysfunctions rather than one unitary process.
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A disorder that is related to schizophrenia is schizoaffective disorder, in which a individual
experiences an uninterrupted period of illness during which he or she also experiences a major
depressive, manic, or mixed episode concurrent with the symptoms of schizophrenia (DSM-IVTR, 2000). Specifically, the individual must experience one of a number of the symptoms of
schizophrenia for the majority of the time during a one-month period. These symptoms are
delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and
negative symptoms. In addition, during the same period of illness, delusions or hallucinations must
have been present for at least two weeks in the absence of an affective disturbance.
The diagnosis of schizoaffective disorder is commonly given to those patients who have
both affective and schizophrenic symptoms, but who do not clearly fit into the diagnostic
categories of schizophrenia or bipolar disorder (Lapens6e, 1992). After a review of the literature,
Lapens6e concluded that schizoaffective disorder appears to be a heterogeneous construct,
which includes patients with a variety of presentations and predispositions to the disorder. It
seems that schizoaffective disorder may be more similar to schizophrenia with a depressive
component, although the debate is far from over, and this may depend to a great extent on the
criteria used to define the disorder.
The diagnosis of schizophrenia is made in approximately .5 to 1.5% of the population in
the United States, which has one of the highest reported rates for schizophrenia in the world
(DSM-IV-TR, 2000). Explanations for the cross-national differences in prevalence of
schizophrenia vary, but issues such as industrialization, life expectancies, or diagnostic practices
and customs, which differ from other countries, may play a part (Torrey, 1987). The breadth of the
prevalence range for schizophrenia is most often accounted for in terms of the variety of
methodology (e.g., specific operational definitions, rural vs. urban populations, community vs.
hospitalized populations) employed in different research that has studied prevalence rates of
schizophrenia.
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The onset for the disorder usually occurs in early adulthood, but it can develop at any
age, and it has been seen in children as young as five years old. Males tend to develop
schizophrenia earlier than females, often between the ages of 18 and 24 years, whereas females
generally develop this disorder after age 25 (Larsen, McGlashan, & Moe, 1996; Moriarty, et al.,
2001). A variety of factors have been associated with the development of schizophrenia, such as
genetic vulnerability, season of birth effects, and, pregnancy and birth complications, although
research has been inconclusive and none of these factors have been unequivocally demonstrated
to be causal (Eaton, 1991; HSfner & an der Heiden, 1997). Specific information about the
prevalence of schizoaffective disorder is not available, even after a review of the literature, but it
appears that this diagnosis is made less frequently than that of schizophrenia (DSM-IV-TR, 2000),
which appears to be, in part, due to the diagnostic systems and criteria that are used to define the
disorder (Lapens6e, 1992).
Once diagnosed with schizophrenia, patients are further classified into subtypes based
upon the predominant symptomatology at the time of the current evaluation. According to the
DSM-IV-TR (2000), a specific exclusion order should be followed to determine an individual
patient’s subtype. Catatonic subtype is assigned if prominent catatonic symptoms are present,
regardless of the presence of other symptoms. Disorganized subtype is assigned if disorganized
speech and behavior and flat or inappropriate affect are present, unless catatonic features are
also present, which then indicates the catatonic subtype. Next, the paranoid type is considered if
delusions or hallucinations are prevalent and if the catatonic and disorganized subtypes have
been eliminated as alternatives. The subtype of undifferentiated schizophrenia is assigned if the
patient shows signs and symptoms of schizophrenia but does not meet the criteria for the other
subtypes. Finally, a patient is categorized as residual type if s/he presents with continuing
evidence of the disturbance, but no longer meets criteria for active-phase symptoms. Although a
common practice in some research, an analysis of the subtypes of schizophrenia was not
undertaken as part of the current research.
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These subtypes are supposed to have high predictive validity, help therapists select
specific treatment and predict individual outcome, and provide researchers with homogeneous
groups. However, the utility of these subtypes has been questioned by many professionals due to
the heterogeneity of the disorder (Fenton, 1996). Some researchers have presented a variety of
alternative conceptualizations for subtypes or syndromes of schizophrenia. These are discussed
in the next section.
Symptom Classifications
An awareness of the importance of symptoms has been present in the study of
schizophrenia since Kraepelin first defined Dementia Praecox in 1898. Kraepelin focused on the
description of symptomatology and acknowledged that symptoms related to a “weakness-state"
illness existed. As early as 1914, Berze (Sass, 1989) recognized two broad types of symptoms in
schizophrenia, which included those that were excesses or distortions in functioning and those
that were deficits or decreases in functioning. A similar distinction was later conceptualized based
on a typology of neurological symptoms specifically described by J. Hughlings-Jackson in 1889
(Sass). Hughlings-Jackson referred to a “double condition” in insanity, which included both
positive and negative components. Using epilepsy as his model, he referred to the negative
components as a “loss of control permitting" the body to do something, and the positive
components as “increased automatic action” resulting from activity in the lower portions of the
nervous system which arise as involuntary behavior. Translating this to present work within
psychiatry, these are commonly known as negative and positive symptoms, respectively, and are
considered to represent independent dimensions of pathology. The distinction between positive
and negative aspects of any condition in general, which are independent of each other, dates
back to J. R. Reynolds in 1858, although in relation to schizophrenia this distinction is generally
attributed to Hughlings-Jackson (Berrios, 1985).
Positive symptoms consist of hallucinations, delusions, formal thought disorder, and
bizarre or disorganized behavior, all representing functions that are in excess of the reality and
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behaviors of most people. Negative symptoms consist of alogia, affective flattening or
inappropriate affect, anhedonia, asociality, avolition, apathy, and attentional impairment
(Andreasen, et al., 1995; Andreasen & Olsen 1982; Malla, 1995b), although others have found
through factor analysis that inappropriate affect does not correlate highly with other negative
symptoms and have concluded that it should not be included in the construct (e.g., Kibel, Laffont,
& Liddle, 1993; Peralta & Cuesta, 1995; Schuldberg, Quinlan, Morgenstem & Glazer, 1990).
Care needs to be taken when considering the cause of negative symptoms, and if they
are actually a result of schizophrenia. The appearance of negative symptoms could be due to
depression or dysphoria, from which many schizophrenia patients may suffer, and should be
differentiated from true negative symptoms (DSM-IV-TR, 2000; Kibel, Laffont, & Liddle, 1993;
Malla 1995a, 1995b), or as a result of an impoverished environment and a lack of social
stimulation, especially when the patient is hospitalized or extremely withdrawn (Owens &
Johnstone, 1980). There is also the suggestion that negative symptoms may be sequelae of
neurological insult. Additional discussion of depressive symptoms can be found in the affective
disturbances portion under the heading “clinical findings in schizophrenia" in this paper.
This dichotomy of symptoms has been utilized to subtype patients into classes of positive
and negative schizophrenias (Andreasen, Flaum, Swayze, Tyrrell, & Amdt, 1990; Andreasen 8i
Olsen 1982; Malla, 1995a; Rosen, et al., 1984). This can be useful for description and to provide
information about individual patients for clinicians. Patients diagnosed with positive, or Type I
(Crow, 1987), schizophrenia are generally characterized by prominent positive symptoms, normal
brain structure, relatively good response to neuroleptic medications, fairly good premorbid
adjustment, and an underlying neurochemical mechanism for the disorder probably related to the
dopamine system (see also Crow, Johnstone, Longden, & Owen, 1978). Those patients
characterized by negative, or Type II, schizophrenia usually present with prominent negative
symptoms, structural brain abnormalities, impaired cognitive functioning, poor response to
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treatment and poor premorbid adjustment. Crow also indicated that the two classifications
represent overlapping syndromes and not discrete illnesses.
It was originally thought that positive and negative symptoms were inversely related
(Andreasen & Olsen, 1982), but it has been shown that this is not always the case, as symptoms
on the two dimensions can co-occur (Liddle & Barnes, 1990; Liddle, Barnes, Morris, & Haque,
1989). Ratings of the two types of symptoms are not always negatively correlated. In some
patients, both positive and negative symptoms are present, causing the subtype of ‘‘mixed”
schizophrenia to be assigned. In a portion of these patients, as positive symptoms increase over
time, negative symptoms also tend to increase, although there is no relation between the number
of positive symptoms and the severity of the negative symptoms. This has been especially evident
in the most severely disturbed of individuals with schizophrenia (Rosen, et al., 1984). Instead of
meeting criteria for both positive and negative symptoms, some patients who do not meet criteria
for either positive or negative schizophrenia are also given the subtype of mixed schizophrenia
according to this classification system (Andreasen & Olsen; Malla 1995a). This latter classification
is not considered useful or informative to clinicians.
Alternatives to the positive and negative schizophrenia classification system have been
introduced by a number of authors. An early enhancement of the positive-negative symptom
classification was presented by Strauss, Carpenter and Bartko (1974), who suggested that three
categories of symptoms be considered in the process of schizophrenia rather than the previous
two. These three categories are positive symptoms (disorders of content of thought and
perception, types of form of thought such as distractibility, and behaviors such as catatonic motor
disorders), negative symptoms (blunting of affect, apathy, and types of formal thought disorder
such as blocking), and disordered personal relationships. The authors posited that the separation
of symptoms into these three categories lends support to a multiprocess conception of
schizophrenia in which more than one symptom process may be present in the presentation of the
disorder.
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Another variation has been proposed by some current researchers who have suggested
that again three syndromes of schizophrenia be considered (Liddle & Bames, 1990; Liddle,
Bames, Moms & Haque, 1989; Malla, 1995a, 1995b). These are not to be thought of as subtypes,
but instead are hypothesized to be different sets of symptoms that may or may not coexist in the
same patients, with these sets potentially having different responses to specific interventions,
such as different types of neuroleptic medications. These dimensions are reality distortion or
psychoticism (delusions and hallucinations are prominent), psychomotor poverty (deficits such as
poverty of speech, decrease in spontaneous movements, and blunted affect) and disorganization
(poverty of content, inappropriate affect, and formal thought disorder). Symptoms within each
dimension have been found to vary in severity together, and symptoms across dimensions show
lesser congruent variation. In creating these dimensions, the positive symptoms were split into two
separate syndromes, reality distortion and disorganization, while negative symptoms were
maintained, except for the transfer of inappropriate affect to the disorganized dimension. Similar
results have been found by other groups who classify the symptoms of schizophrenia into the
categories of psychotic symptoms, disorganization (together make up the positive symptom
dimension) and negative symptoms (Andreasen, et al., 1995). Overtime, these three symptom
categories have been found to change along with one another, however in a completely
independent manner from the others (Arndt, Andreasen, Flaum, Miller, & Nopoulos, 1995).
Typically, the two positive symptom dimensions, psychoticism and disorganization, tended to
improve much more over time, while the negative symptoms tended to improve much less or even
worsen over time, although this is now controversial as some studies suggest that negative
symptoms do improve over time (Quinlan, Schuldberg, Morgenstem & Glazer, 1995) or at least
remain relatively constant (Herbener & Harrow, 2001). Interestingly, changes in the dimensions of
psychoticism and disorganization are also not correlated with one another, indicating that these
two dimensions are separate and independent from one another (Arndt, et al.)
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Additional research has indicated that four or more distinct types of symptoms may be
present in schizophrenia. The analysis of one research group (Schuldberg, et al., 1990) revealed
symptom factors of positive symptoms, negative symptoms, attentional impairment, and formal
thought disorder. Two additional factors, bizarreness and avolition-apathy, emerged as possibly
separate symptom categories as well. An item-level factor analysis of individual items on two
symptom measures in another study (Toomey et al., 1997) resulted in two negative symptom
factors of diminished expression and disordered relating, two positive symptom factors of bizarre
delusions and auditory hallucinations, and a disorganization factor. This different research
indicates that additional attention should be given to more detailed classifications of symptoms
and the variety of syndromes they reveal.
The issue of symptom presentation and the positive-negative distinction was included in
this project by studying both total symptom presentation (by using the Brief Psychiatric Rating
Scale; BPRS; Overall & Gorham, 1962) and by discriminating those symptoms that load most
predominantly on the positive symptom dimension from those that load most predominantly on the
negative symptom dimension, as identified by Ventura, Nuechterlein, Subotnik, Gutkind, and
Gilbert (2000). In addition, factors such as manic and depressive affect were also considered.
These factors will be addressed in more detail in the methods section of this paper.
Clinical Findings in Schizophrenia
Perceptual and cognitive disturbances. As noted above, disturbances in thinking and
language are usually considered the primary pathognomic feature of schizophrenia (see also
Bleuler, 1950; Meehl, 1989). Problems in the form of thought are referred to as “thought disorder"
or “formal thought disorder.” This is differentiated from problems involving the content of thought,
which include delusions and possibly hallucinations. Thought disorder is usually inferred from the
patient’s language production, for it is assumed that disorganized thought, if severe enough, will
substantially impair effective communication. The term “thought disorder” is used somewhat
loosely to refer to both disturbances of language and communication. Andreasen (1979a) defined
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a set of specific terms for disturbances in language behavior and production - based on a number
of clinical descriptions in the literature - that are still applicable today and include both deficits and
excesses in communicative behaviors. These categories are discussed in greater detail in the
language section.
Language disturbances can be very pervasive and affect a wide range of types of
communication, although patients with schizophrenia are often not aware that their language
production is abnormal and may become frustrated when trying to communicate with others who
do not understand them (Amador & David, 1998). Other persons with schizophrenia sometimes
seem oblivious or “not to care" about being hard to understand. In general, subjects with
schizophrenia may have little insight into their disturbance. Language and communication
disturbances are discussed in greater detail in the language section of this paper, and form the
basis of one of the predominant areas of research in this study.
Psychotic symptoms of hallucinations and delusions are also symptomatic of
schizophrenia, even though they may also occur as part of other disorders. Hallucinations are
perceptions that are experienced as originating in the outside world or within one’s own body, yet
do not involve an external stimulus to any of the sense organs. These experiences nevertheless
seem to the patient to be true perceptions and are experienced by a reported 70% of persons with
schizophrenia (Mueser, Bellack, & Brady, 1990).
Delusions involve disturbances in the end products of logical thinking rather than in
perception or the formal processes of thinking themselves. Delusions are firmly held ideas, with
no plausible reason for the beliefs that are untrue and often bizarre, yet are maintained by the
patient. The “untrueness” or “bizarreness” of the belief must be judged by the clinician or
researcher based upon the patient's educational and cultural background. A delusion is
considered to be bizarre if it is clearly implausible, not understandable, or not deriving from normal
life experiences (DSM-IV-TR, 2000; Spitzer, First, Kendler, & Stein, 1993). Bizarre delusions have

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 12
been estimated to occur in as many as 79% of persons with schizophrenia (Goldman, Hien, Haas,
Sweeney, & Frances, 1992).
A final cognitive disturbance common in patients with schizophrenia is a lack of insight,
mentioned above. As many as 97% of schizophrenia patients may believe that they are not ill or
abnormal, and their hallucinations and delusions are perceived as actual and not imagined
experiences (Sartorius, Shapiro, & Jablensky, 1974). This lack of insight is found more commonly
in patients with schizophrenia than with other psychiatric condition, such as bipolar affective
disorder or schizoaffective disorder (Amador, et al., 1994). As noted above, a lack of insight can
cause significant difficulties in communication with others for the individual with schizophrenia
(Amador & David, 1998). These patients usually have normal orientation and memory, although
they may experience some age disorientation, evidenced by difficulty in providing their own age.
This lack of insight with intact orientation and memory makes patients with schizophrenia
extremely difficult to treat, especially because rates of treatment compliance are greatly
decreased when the patient does not believe s/he is ill (Black & Andreasen, 1994).
Behavioral and motor disturbances. Some people with schizophrenia exhibit both
behavioral and motor disturbances throughout the course of the illness. At times it is difficult,
however, to separate true behavior disturbance in schizophrenia from effects of medications
provided to the individual, and possibly from the effects of chronicity or institutionalization. A
deterioration in social behavior can also be observed as the individual neglects him/herself and
his/her surroundings. Social withdrawal and isolation also become prominent for these individuals
and they may experience a lack of motivation and exhibit a disinterest in planning for the future
{DSM-IV-TR, 2000; Black & Andreasen, 1994) which result in a paucity of motor behaviors. Such
disturbances are most often seen in the Disorganized and occasionally in the Residual Types of
schizophrenia.
A variety of motor disturbances are sometimes seen in persons with schizophrenia. They
may exhibit uncontrolled and aimless motor activity (excitement) including repeated but non-goal
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directed movement, such as rocking (stereotypy), or regular goal-directed activities appearing to
have social significance but which are out of context and odd in appearance (mannerisms).
Catatonic motor behavior may be exhibited, such as extremely decreased reactivity to the
environment (stupor), allowing one’s body to be posed by another person (waxy flexibility),
maintaining a rigid posture over an extended period of time (rigidity), or posing in an inappropriate
and bizarre posture (posturing) while resisting attempts to be moved (negativism). This is most
often seen in persons given the subtype of Catatonic Schizophrenia or in those with negative
symptoms (Chandrasena, 1986; DSM-IV-TR, 2000; Gelenberg, 1976).
Impulse control is another behavioral problem exhibited by patients with schizophrenia.
Some individuals may become quite agitated and exhibit a decrease in judgment and impulse
control when experiencing active-phase symptoms which increases their risk of suicide or other
self-harm and demonstrating violent behaviors towards others. Although violence may occur,
knowing that a patient has schizophrenia does not generally predict violence or dangerousness
(Swanson, 1994). However, recent research has shown that violence in persons with
schizophrenia is related to clinical variables, especially an increase in positive symptoms (Arango,
Barba, Gonzalez-Salvador, & Ordoftez, 1999; Krakowski, Czobor, & Chou, 1999). When a person
with schizophrenia is violent, the victims are usually family members or friends of the patient.
These violent behaviors seem to be in response to delusions and hallucinations, or are traceable
to incorrect dosages of medications (Gottesman, 1991; Junginger, 1996), and violent behavior
also seems to be associated with a poor prognosis (Karson, & Bigelow, 1987), as patients with a
history of violence evidenced a greater number of previous hospitalizations.
Affective disturbances. Alterations or decreases in affect can be seen in some individuals
with schizophrenia, such as those diagnosed with Disorganized or Residual Types, or in patients
exhibiting negative symptoms. People with affective disturbances tend to exhibit indicators of
blunted affect, such as indifferent and apathetic responses to others, a lack of empathy,
decreased intensity of emotional expression, unchanging facial expressions, and poor eye
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contact. A more extreme form of reduced emotion, anhedonia, in which the patient is unable to
experience or even imagine any form of pleasure, is also seen in some people with schizophrenia.
Research has revealed that persons with schizophrenia report significantly greater physical and
social anhedonia, less positive affect, and more negative affect than control subjects, and these
phenomena have all been found to be stable over time (Blanchard, Mueser, & Bellack, 1998).
Inappropriate expressions of affect are also common, such as exhibiting a profound silliness or
discussing a sad or morbid topic with a smile and cheerful manner, and are most often seen in the
Disorganized subtype. It has been noted that patients with schizophrenia may actually experience
appropriate emotions despite their outward appearance (Black & Andreasen, 1994). The
discrepancy, in part, seems to arise from their difficulties in communication and reduced
expression of affect.
Due to affective disturbances, approximately 60% of schizophrenia patients appear as
though they have significant depressive symptoms as well (Escamilla, 2001; Kibel, Laffont, &
Liddle, 1993; Sands & Harrow, 1999; Siris 1991,2000;Taylor, 1992). The separate diagnosis of a
mood disorder is difficult to make, because the symptoms (e.g., of anhedonia and depression)
greatly overlap, and because antipsychotic medications can cause what seems to be depression
(drug-induced akinesia). Care must be taken to determine if a depressive disorder should be
diagnosed in addition to schizophrenia, or if the depressive symptoms are just manifested through
other symptoms of schizophrenia. Alternatively, the diagnosis of schizoaffective disorder
(discussed previously) needs to be considered when a patient presents with both the symptoms of
schizophrenia and affective disturbance, especially when the mood disorder appears to be an
episode of major depression or a mixed episode.
Course and Outcome
The paths that patients with schizophrenia patients follow throughout their illness are
heterogeneous; there is no way to predict the exact course of an individual person with
schizophrenia, for it varies from patient to patient (McGlashan, 1988; Strauss & Carpenter, 1972).
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However, there are some general patterns observed that are used to describe the course of
schizophrenia. There are three stages of schizophrenia which patients cycle through (Black &
Andreasen, 1994). The prodromal stage precedes the active phase of the illness, sometimes by
many years. It is characterized by a general decline and deterioration in behavior and emotional
responsiveness. The active phase is when psychotic symptoms, often delusions and
hallucinations, are predominant. During this phase the patient’s behavior is florid and alarming to
others and often leads to hospitalization. The residual phase is similar to the prodromal phase and
equivalent to the experience of the patient subtyped with residual schizophrenia, where activephase symptoms are no longer present, but there is still evidence of a disturbance.
As noted, the course of schizophrenia is variable, and it generally follows one of four
patterns (Black & Andreasen, 1994; DSM-IV-TR, 2000). The first is of an illness that resolves
completely with or without treatment and the patient remains stable over time. The second is an
illness that recurs repeatedly, with a full recovery every time. Each of these patterns is seen very
infrequently among schizophrenia patients. The third pattern is of an illness that recurs repeatedly,
but without full recovery, causing a persistent deficit state to develop. The last is of an illness with
progressive worsening from the onset of the disorder. These last two patterns are most commonly
found among patients with schizophrenia. The classic course of schizophrenia is one of repeated
exacerbations and remissions, with a lack of return to baseline functioning following the active
phase. Research has found that after the first exacerbation of psychotic symptoms, the course of
schizophrenia tends to remain fairly stable, with the most activity and severity of symptoms early
on in the illness (Mason, Harrison, Glazebrook, Medley, & Croudace, 1996).
In relation to the positive (Type I) and negative (Type II) syndromes of schizophrenia,
Crow (1987) noted that although either syndrome may be present at any time during the course of
the illness, the negative syndrome tends to be identified in the patients with more chronic states,
may be associated with some level of irreversibility, and indicates a limited prospect of
improvement. Additional research has shown that schizophrenia characterized by primarily
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negative symptoms is associated with a progressive course that often results in permanent
disability, whereas schizophrenia characterized by primarily positive symptoms are associated
with a better prognosis (Fenton & McGlashan, 1991; see also Breier, Schreiber, Dyer, & Pickar,
1991). Arndt et al. (1995) found that negative symptoms tended to remain fairly constant over
time, whereas positive symptoms were less stable and fluctuated over the course of the illness
(see also Davidson & McGlashan, 1997)
Some patients experience what is commonly referred to as the “revolving door
phenomenon.” This is a function of both clinical course, and treatment and clinical management
practices. These patients have a high frequency of hospital readmissions and discharges,
commonly thought to be caused by inadequate rehabilitation facilities and a lack of utilization of
after-care services. These patients also have a tendency towards noncompliance with their
treatment regimens and also possibly a history of substance abuse, which increases their
chances of rehospitalization. This revolving door phenomenon previously was thought to be due in
part to the use of psychiatric hospitals for non-psychiatric purposes, such as holding facilities for
individuals with a lack of money, no housing, or family problems. This phenomenon is now
considered to be caused by more frequent exacerbations of the illness influenced by various
factors described above (Haywood, Kravitz, Grossman, Cavanaugh, Davis, & Lewis, 1995;
Prendergast, 1995). Patients in circumstances such as these may have a lower quality of life due
to their numerous hospitalizations and the disruption this occurs in their lives, their refusal of case
management and other community services, or the lack of available community resources (Geller,
1986).
The symptoms of schizophrenia may change over the course of the illness, but this idea
is controversial within the literature. Some sources (Black & Andreasen, 1994; DSM-IV-TR, 2000)
indicate a symptom course of negative symptoms being seen early in the illness, especially during
the prodromal phase, and positive symptoms being prevalent primarily during the active phase.
Overall, this can result in a progressive downward course of the disorder. Such a
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conceptualization has been refuted by some authors, who adhere to the more “classic course” of
schizophrenia evidencing more negative symptoms over time, or that in general a more variable
development and course of symptoms may be present in people with schizophrenia (Davidson &
McGlashan, 1997; Liddle, et al., 1989; Quinlan, et al., 1995). Others have noted that the severity
of symptoms appear to stabilize after five to ten years of active symptoms (McGlashan, 1988).
The expected outcome or prognosis for persons with schizophrenia today is more
optimistic than in the past, due in a large part to the development of a variety of antipsychotic
medications. After a first hospitalization, approximately one-quarter of patients are expected to
have a good outcome with no subsequent hospitalizations. Another one-fourth is expected to have
a severe and chronic outcome with continued hospitalization, intellectual and/or social impairment.
Approximately one-half of persons with schizophrenia are found to have a moderately good
outcome, with some subsequent hospitalizations and social impairment, but able to function fairly
well otherwise (Marengo, 1994; see also Mason, et al., 1996). Alternatively, one can consider
outcome groups in slightly larger categories. Clinical lore asserts that persons with schizophrenia
fall into three categories, approximately one-third of whom have a good outcome, one-third a poor
outcome, and one-third experience a moderately good outcome. A more optimistic report has
supported the considerable heterogeneity in the long-term outcome of individuals with
schizophrenia, and present that approximately one-half to two-thirds of persons with
schizophrenia significantly improve or recover from the disorder (Harding, Zubin, & Strauss,
1987).
Indicators of a good prognosis for patients with schizophrenia include an acute onset at a
later age, having a family history of mood disorder rather than schizophrenia, exhibiting good
premorbid adjustment and interepisode functioning with minimal residual symptoms, the
presentation of brief active-phase symptoms with few or no negative symptoms, and having
normal neurological functioning indicating an absence of brain abnormalities (Davidson &
McGlashan, 1997; Hdfner, et al., 1998). In addition, increasing evidence has indicated that long-
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term prognosis is greatly improved through early detection of symptoms and intervention with
medication(s) to relieve the symptoms and assist in the prevention of relapse (Kasper, 1999;
Robinson, et al., 1999). This apparently tends to curtail the progression of the disorder and
facilitates better overall functioning.
The present study considered the issue of quality of life (to be discussed below) as an
outcome measure to be compared to variables of language production, social adjustment,
symptom presentation, global assessment of functioning, and neurocognitive functioning in order
to determine predictive patterns and relationships among the variables.
Quality of Life
Quality of life and schizophrenia. As noted above, the outcome for patients with
schizophrenia is greatly varied. Lehman (1996) stated that one of the various challenges in
evaluating services for persons with schizophrenia is the development of adequate outcome
measures that consider a broad range of issues faced by the patients. Many different areas of
functioning and/or disease aspects can be considered when evaluating the outcome of patients
with schizophrenia. A construct that includes a number of these areas is Quality of Life, which is
generally considered to be composed of functional status, burden on family and community,
access to resources and opportunities, and subjective sense of well-being (Attkisson, et al.,
1991). A more detailed discussion of the construct and history of quality of life, approaches, and
measurement, will follow.
Although some measures of quality of life assess functioning from the “outside” in an
objective manner, a current focus in mental health has been to include the patient's perspective in
determining relevant outcomes. This has resulted in the growth of the construct of subjective
quality of life (Awad & Voruganti, 2000; Diener, 1984). Frisch (1994) describes subjective quality
of life as composed of two parts, a component involving positive affect, and a cognitive
component in which an individual judges whether needs and wishes have been fulfilled, and
relates this to personal satisfaction.
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When assessing a patient’s functioning, as done by a medical doctor, issues related only
to physical health are considered and those concerns related to satisfaction or subjective quality
of life are often ignored. Quality of life assessments are helpful to the field of mental health (as
well as to medicine in general) because they contribute information about how patients are
functioning in various domains of their lives, which, although beyond issues of medicine
specifically, are still affected by and can impact the individual’s physical health (Lehman, Ward, &
Linn, 1982). This approach to measuring outcomes through quality of life also allows the
professional to have a broader focus and directs additional attention to positive or adaptive areas
of functioning when determining the status of the individual patient (Lehman, 1996).
Measures of quality of life are also important because some of the information gathered
comes from the patient’s own point of view. This is especially relevant in the study of
schizophrenia, because the disorder inherently affects the overall functioning of the patient. As a
result, it is imperative to research the patient’s subjective evaluation of his or her own life and
experiences. Also, in asking the patient directly, the professional is showing a respect and
understanding that the patient does not often experience, especially when receiving medical or
mental health services (Awad & Voruganti, 2000).
Some clinicians may express discomfort with the process of asking patients directly about
their quality of life, because it is assumed that psychopathology would confound and interfere with
the patient’s responses. This is especially relevant in the study of schizophrenia, where patients
often exhibit a variety of neurocognitive deficits as well as disturbed thinking and communication
which many clinicians assume result in unreliable reports. However, this appears to not be a
concern for most domains assessed by quality of life measures. Lehman (1983) determined that
psychopathology does not bias overall quality of life findings. He found that the structure of the
assessment results was not significantly changed due to the removal of the effects of
psychopathology in the analysis of overall quality of life ratings. Instead, the only influence of
mental health effects was found in the assessment of patients’ self-rated (perceived) health,
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utilization of health services, and satisfaction with health care, all of which are part of only one of
the nine subjective areas of quality of life that Lehman considers. This, as the author notes, is not
surprising in light of the fact that the general notion of health involves both mental and physical
health. Voruganti, Heslegrave, Awad and Seeman (1998) reported similar results and found that
patient’s self-reports were consistent over time and evidenced significant correlations with
objective measures completed by clinicians. This group of authors also determined that although
patients' reports of subjective quality of life were impacted by symptom severity, side effects,
neurocognitive functioning, clinical interventions, and medication levels, the reliability of the
reports were not affected by these factors.
It has also been argued that professionals already make informal quality of life
assessments during the process of “getting to know” a patient and understanding his or her
experiences. But even such a practice is not specific enough to truly assess the patient’s quality
of life, and formal assessments are needed. A number of domains of quality of life can be
considered, which may include the patient’s health care, safety, security, housing, food,
occupation, social contacts, finances, and education (Frisch, 1994; Packer, Husted, Cohen &
Tomlinson, 1997; Skantze, Malm, Dencker, May & Corrigan, 1992). The third group of authors
explained that quality of life is not the same concept as standard of living, which is only an
objective assessment of the previously listed areas. Also considering the patient’s satisfaction with
these domains constitutes quality of life. At the least, the concept of quality of life should
emphasize the patient’s perspective on his or her sense of well-being and consider issues such
as how the patient feels that he or she is doing, how the patient feels about what he or she has,
and how the patient feels about his or her life situation (Frisch, 1994; Lehman, 1996). This is
considered the patient’s subjective quality of life. In addition, researchers often do consider more
objective areas of quality of life, including the patient’s functional status and access to resources
and opportunities, in order to add to the patient’s own perspective. It appears that using a
multidimensional approach to quality of life assessment rather than a global self-report rating may
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yield more reliable information. To a great extent, the concept of quality of life has come to
represent the ultimate outcome of the interaction between the patient and the illness, its treatment,
its psychological impact, as well as social contributions and consequences (Awad & Voruganti,

2000).
History of quality of life assessments. The precise origins of the concept of quality of life
are largely undetermined, but it appears that the idea developed after World War II when many of
the population of Western societies were experiencing an increased standard of living which
followed the economic prosperity of the times. This led to people’s expectations of greater
satisfaction, fulfillment, and well being in their lives. This concept of satisfaction with domains of
life was readily applied by society to areas such as physical health and job satisfaction. The term
quality of life appears to have been first introduced to the general population by President
Johnson in 1964 during his address on “the Great Society” (Awad & Voruganti, 2000). The 1960’s
saw an increased focus and concern with the concept of quality of life in psychiatric patients due
to the deinstitutionalization movement. Many chronically mentally ill patients, especially those with
schizophrenia, were released from facilities without the necessary abilities to live independently
and in a time in which the community was not prepared to cope with their needs. The subsequent
deterioration of the patients' living conditions, personal safety, income, and social support resulted
in an inferior quality of life that soon came to the notice of mental health professionals.
Thus, evaluating and improving quality of life became an emphasis in the study of
discharged psychiatric patients. Initially, the focus was placed upon identifying patients’ needs in
the community and drew considerable attention to the situation of the chronically mentally ill in the
community. This attention was not maintained, however, through the late 1970’s and early 1980’s
when the concept of quality of life was essentially discounted and ignored. It appears that the
disinterest resulted primarily from a lack of agreement on a consistent definition of the term
“quality of life,” a lack of adequate conceptual models pertaining to the concept, questions
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regarding the reliability of self-report measures, and a lack of standardized measures appropriate
for patients with specific disorders, such as schizophrenia (Awad, 1997).
In the last decade, there has been a revival of interest in the concept of quality of life for
psychiatric patients. Many factors are potentially involved in this change, one of which is the issue
of cost of care and services for psychiatric patients in a time when resources are limited (Awad,
1997; Frisch, 1994). Professionals are now being pressed to consider alternative outcome
measures when evaluating services and treatments. This is as prevalent in the field of physical
health as it is in the field of mental health. In addition, the pharmaceutical industry, while
introducing and promoting new medications, has stressed quality of life as a significant marketing
tool to underline differences between various medications and to emphasize a favorable health
economic status (Awad & Voruganti, 2000).
In the age of consumerism, people are motivated to consider more personal outcomes,
one of which has been quality of life, and cause professionals to do the same. This focus on
quality of life has also been utilized to address the costs and benefits of various types of
treatment. Unfortunately, most of the recent focus has been directed towards the application and
measurement of quality of life, and little research has been completed on determining a globally
accepted definition for quality of life, the boundaries of the concept, determinants of quality of life,
and discovering relevant clinical correlates. It is clear that research in these areas must be
undertaken before further advancement can be made with the issue of quality of life for the
chronically mentally ill (Awad, 1997). Indeed, it may be that multiple definitions of the term quality
of life are needed depending on the population under study, the progression of the illness and its
treatment, as well as societal expectations at the particular point in time of a research study
(Awad & Voruganti, 2000).
Quality of life and schizophrenia research. Recent studies have shown that patients with
schizophrenia report a decreased satisfaction in particular areas of their lives such as mental
health, inner experiences (i.e., self-fulfillment, self-reliance, freedom, joy, love), social contacts,
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and, employment (Skantze et al., 1992), as well as income level, knowledge base, education,
general opportunities and leisure activities (Grawe & Lovaas, 1994). This has been found even in
situations where the patient was enjoying a relatively adequate standard of living and having all
basic needs met. Similar findings were reported in a study that compared individuals with
schizophrenia in the United States and Italy (Warner, de Girolamo, Belelli, Bologna, Fioritti, &
Rosini, 1998). These studies determined that the subjective quality of life reported by these
patients was not just the absence of acute suffering and/or symptoms, nor just having some
income and a place to live. Instead, it appears that subjective quality of life for these patients
involved dynamics of their inner world and overall satisfaction with their experiences. This
supports the idea that subjective quality of life is not the same as objective assessments of life
domains.
Other research has found that seriously mentally ill patients who lived with family
members in a very poor and rural area but reported high support from those same family
members expressed significantly less dissatisfaction in all life domains except finances/income
(Sullivan, Wells & Leake, 1991). It was presumed that the positive and supportive relationship with
family members increased patient life satisfaction, even when the subject was living in adverse
conditions. Results such as these are in direct contrast to other findings which indicate that family
interactions can be experienced by persons with schizophrenia in very negative and critical ways
(Hooley, 1998). Such interactions are high in expressed emotion, which is a measure of criticism,
hostility and emotional overinvolvement within the family. Similar contrasts again support the
notion that patient perspective is crucial in considering quality of life.
Involvement in educational groups which address issues related to schizophrenia and the
course of the disorder was found to be related to significant gains in quality of life, even when no
specific skills training was provided to these patients (Atkinson, Coia, Gilmour & Harper, 1996).
Thus it appears that education, understanding, and overall insight into the disorder of
schizophrenia provides the patient with an increased satisfaction with his or her own life. Other
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researchers have found opposite results, in that no increase in quality of life was found as the
patient gained insight into the disorder of schizophrenia (Browne, Garavan, Gervin, Roe, Larkin &
O’Callaghan, 1998). However, these authors do state that their population under investigation
already maintained high levels of insight into the disorder, and a ceiling effect in gaining insight
may have occurred.
Some researchers have undertaken to compare patient reports of quality of life with
overall psychopathology, as well as the difference between negative and positive symptoms, and
have found some significant results (Packer et al., 1997). The findings of this research indicate
that level of psychopathology, as measured by the Brief Psychiatric Rating Scale total score for in
patient schizophrenia patients, was negatively correlated with global life satisfaction and
subjective quality of various life domains (see also Heslegrave, Awad & Voruganti, 1997; Kaiser et
al., 1997), although not with objective evaluations of the same domains. In addition, negative
symptoms were found to have a greater negative correlation on subjective measures of quality of
life than positive symptoms. The impact of psychopathology on ratings of physical health, which
are a component of quality of life, may again be implicated here. An explanation was provided for
the finding that negative symptoms were more related to quality of life; the negative symptoms
appear to exert a large impact on the patient and his or her experiences in part because they are
often seen as not Treatable” and imply a more pejorative attitude towards the patient because the
negative symptoms could be seen in some way as able to be altered. Negative symptoms also
interfere more with basic aspects of functioning and thus potentially with satisfaction of one's life.
An extension to the concept of negative symptom presentation is that of the deficit
symptoms or deficit syndrome which involves impairment in intrapsychic, interpersonal, and
instrumental functioning. The deficit syndrome has been related to quality of life and is assessed
in measures such as The Quality of Life Scale (Heinrichs, Hanlon, & Carpenter, 1984). This
particular measure rates the person with schizophrenia on a variety of domains (i.e., sense of
purpose, emotional interaction, social experiences, occupational role, possession of common
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objects) providing a score which reflects the individual's functioning, ranging from normal or
unimpaired functioning to severe impairment on each of the domains in question. These authors
assert a conceptual link between quality of life and the deficit syndrome, that they are inversely
related. This measure is intended to be used by the clinician to make judgments about deficit
symptoms, to register levels of change, and to describe the course of illness for the individual.
An important consideration regarding the impact of symptoms, especially the florid and
unusual positive symptoms, on the life of a person with schizophrenia are the attributions a
spouse makes about the etiology of the behaviors (Hooley, Richters, Weintraub, & Neale, 1987).
When a spouse attributes the deviant behaviors as unintentional and involuntary aspects of a
genuine illness, he or she is less likely to blame the patient for any difficulties in the relationship
and this attribution will contribute to the marriage remaining intact. Thus it appears that not all
symptoms are as salient or problematic for the families of individuals with schizophrenia as many
professionals would believe.
Related to the impact of negative symptoms of the patient’s functioning and perception of
his or her life is the effect of neuroleptic medications. Many patients report that a negative
response to medications and a resulting “zombie-like” state leads to a perception of an inferior
quality of life (Browne, et al., 1998), although the authors do caution that the patient's perceived
response to the medications may actually instead be negative symptoms of schizophrenia.
In addition to the effects of psychopathology, the relationships between neurocognitive
deficits and quality of life have been examined. Researchers have found that patients with
schizophrenia perform poorly on tests of iconic memory via a backward-masking task, and frontal
functioning, measured via the Wisconsin Card Sorting Task (Heslegrave, Awad & Voruganti,
1997). These same patients reported a compromised quality of life. Although both neurocognitive
deficits and decreased quality of life were found, correlations between the two were nonsignificant
or very weak. This led the researchers to conclude that quality of life is not related to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 26
neurocognitive deficits unless in extreme instances when the deficits are in basic rather than in
higher cognitive functioning.
Issues such as symptom presentation and neurocognitive functioning appear to be
important factors in the study of quality of life. These areas are domains of functioning that can
often be readily assessed by clinicians and are relevant to successful community functioning. The
present study examined these and other variables to better understand their impact on the quality
of life of the person with schizophrenia.
Significant differences have also been found between inpatients and those living in the
community in several areas. Patients living in the community consistently reported greater
satisfaction in domains of general well-being, living situation, safety, mental health, and work, than
patients who were hospitalized (Kaiser, et al., 1997). Contradictory results have been found in
other research which determined that there were no differences in global assessments of the
quality of life reported by these two groups, but that some differences on specific life domains
were present (Grawe & Lovaas, 1994). These authors stated that outpatients more often report
greatest dissatisfaction with their inner experiences and overall mental health. Inpatients tend to
express the greatest dissatisfaction with their financial situation, low level of social contacts, and
overall mental health. It is not surprising that both groups express dissatisfaction with their mental
health, as this is the determining factor in much of their daily functioning and ongoing limitations.
When considering the issue of multiple respondents in the assessment of patient quality
of life, it was found that different reports are provided by mental health professionals than those
from patients with schizophrenia for particular life domains (Sainfort, Becker & Diamond, 1996).
The two groups evidenced much agreement on areas of functioning, symptoms experienced by
the patient, and overall physical health. Reports differed when considering social support and
occupation. Providers rated the quality of each area as lower than the patients did themselves. In
fact, the patients evaluated each of these areas as adequate in their own lives. This result raises
the interesting question of whose point of view to consider when making these types of
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evaluations. It appears that either source will provide accurate judgments of the quality of clinical
aspects of the patient’s life, but that the patient him or herself should be questioned regarding
social aspects of their perceived quality of life. It was unclear to these authors why such a
discrepancy would arise, although they did present some possibilities, including a greater patient
knowledge of relevant factors, provider emphasis on clinical aspects of patient’s experiences, and
patient focus on the social aspects of his or her own experiences. This relates to validity issues of
both self-report, observer, and informant data which are always of concern in any assessment
measure, especially those related to quality of life. This issue was addressed in the present study
by using a measure that relies on patient report, of primary significant to ratings of satisfaction,
and corroboration of more objective reports through an interview with a “current informant.” In
addition, this study included the use of a “reliability” checklist for interview measures to indicate if
particular responses were of questionable reliability.
A review of the literature has revealed that factors such as gender (Kaiser, et al., 1997;
Lehman, Slaughter, & Myers, 1992) and levels of neuroleptic medication for those on medication
(Kaiser, et al., 1997) apparently have no direct impact on the reported quality of life of an
individual with schizophrenia. As noted previously, it does appear that a negative (dysphoric)
subjective response to neuroleptic medication, rather than the actual level of the medication, is
associated with diminished quality of life for persons with schizophrenia (Browne, et al., 1998).
Selection of quality of life assessments. Many different quality of life measures have been
developed over the years, each with a particular focus and application to research and practice. A
number of issues related to the selection of a specific quality of life assessment for research have
been addressed by Lehman (1996). These are as follows:
1.

The investigator must determine his or her particular purpose and needs before selecting a
specific measure; this includes an operational definition of quality of life, means to measure
the domains under consideration, ability to make comparisons to other relevant populations
(other psychiatrically impaired, physically disabled, general population, economically
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disadvantaged, etc.), selection of a time frame (longitudinal or not) to study quality of life, and,
the ability to apply quality of life results to interventions and evaluations with patients
2.

The measure chosen should assess both subjective and objective domains of life

3.

The assessment should be based upon a comprehensive quality of life model

4.

The measure should be developed for or applicable to the population of interest

5.

Training of administrators and time involved in the assessment must be considered

6.

Consideration of the psychometric properties of the measure (e.g., reliability, validity, etc.) is
important.
Another area of concern noted by the author includes the possibility of encountering floor

effects with patients with schizophrenia, especially in role functioning domains such as spouse,
parent, and employment roles. Researchers are also warned about the limited task perseverance
and comprehension of psychiatric patients, recommending an interview format rather than penciland-paper measures to gather information.
Additional concerns regarding selection of a quality of life measure should also consider
whether or not responses may be biased by patient psychopathology, whether it validly
differentiates patients with different severity of illness (e.g., inpatient versus community living) and
housing status (homeless versus domiciled), and whether the measure assesses symptoms that
are nonredundant with the anhedonia common to depression (Russo et al., 1997). It was
recommended by the authors (Lehman, 1996; Russo) that a researcher carefully select a quality
of life assessment based upon the needs of the study and the specific characteristics of the
measure.
Quality of life and the present study. The issue of quality of life has been demonstrated to
be an important component in the assessment and treatment of psychiatric patients and it forms a
central focus of the current research. This importance is especially evident in the outpatient
treatment that many people with schizophrenia now receive and within the context of a move
towards managed care and a greater emphasis on accountability of treatment organizations and
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agencies. With the rising cost of chronic illnesses such as schizophrenia, emphasis has shifted
from merely prolonging life to actually enhancing the patient’s quality of life. The focus has also
moved away from mere alleviation of symptoms. A primary emphasis of case managers and other
outpatient treatment professionals is the quality of life of the patient and his or her ability to
function adequately within the community. Through clinical management, quality of life
assessments can theoretically provide information regarding a needs assessment, gaps in
services, implementation and effectiveness of corrective measures, and focus on the patient’s
potential return to a somewhat productive role in society (Awad & Voruganti, 2000).
Due to the importance of this potential clinical management, accompanied by the relative
lack of comprehensive research involving quality of life assessments and their integration into
clinical psychiatric care, quality of life has been a focus of this study. A number of other variables
(communication, social adjustment, neurocognitive functioning, and symptom presentation) have
been assessed to determine their relationships to both the subjective and objective quality of life
reported by persons with schizophrenia.
The quality of life measure that was selected for inclusion in the present study is the
Quality of Life Interview - Brief Version (QOLI; Lehman, 1988; 1996). This measure is intended to
be used with the chronically mentally ill and assesses general quality of life rather than health
related quality of life. The QOLI is focused predominantly on current levels of satisfaction, recent
functional status, and access to resources. The main purpose of the QOLI is to assess life
circumstances of patient populations both in terms of what the individuals actually do and their
feelings about those situations. Thus it involves both an objective and a subjective assessment of
quality of life. For the subjective assessment, patients are requested to utilize a life satisfaction
rating scale consisting of ratings 1 = terrible through 7 = delighted. The Objective Subscales
assess areas of living situation, daily activities, family relationships, social relations, finances,
work-school issues, legal-safety issues, and health issues. The Subjective Subscales assess
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satisfaction with the same areas excluding daily activities, and instead include ratings of
satisfaction with leisure activities and overall quality of life.
The effects of psychopathology and its biasing effects of self-report measures have been
mentioned previously in this review. Conclusions have been drawn which implicate the role of
symptom presentation and general health concerns much more than satisfaction ratings involved
in quality of life (Lehman, 1983). In addition, Lehman’s research with the QOLI has concluded
psychopathology does not impact quality of life ratings on this particular measure.
Initial studies on the QOLI were completed with patients in board and care homes,
supervised community residences, and psychiatric hospitals. Research with the QOLI has shown
differences between various groups and their quality of life. When considering community
residents versus hospitalized patients, it was found that regardless of length of stay in the
particular placement (community or hospital) the community residents more favorably rated their
living conditions, had access to more financial resources, and were less likely to be assaulted in
the past year then the hospitalized patients (Lehman, Possidente, & Hawker, 1986.) Factors that
best predicted the quality of life of individuals with chronic psychiatric illness attending a day
treatment program were found to be the number of admissions to the hospital in the past year,
frequency of family contacts, satisfaction with social life, psychiatric health, and adult education
(Levitt, Hogan, & Bucosky, 1990). In addition, of the patients in day treatment, those not of
Caucasian race, and/or those with higher levels of anxiety and depression (as measured by the
BPRS) rated their quality of life as significantly lower than other participants. A study discussed
previously involving the QOLI indicated that seriously mentally ill patients who lived with family
members in a very poor and rural area expressed significantly less dissatisfaction in all life
domains except finances/income when they perceived high support from those family members
(Sullivan, et al., 1991). Additional research involving the QOLI has determined that, with the
possible exception of social relationships, there are no differences in the patient reports of quality
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of life between men and women with schizophrenia, and that this finding has proved true for
populations in the United States, Canada, and Cuba (Vandiver, 1998).
A recent study involving the QOLI found that this measure of quality of life was less
sensitive to change and treatment effect than other measures in patients with schizophrenia
(Cramer, et al., 2000). The authors concluded that this could be a result of the highly symptomatic
population under investigation and the tendency for these patients to experience extreme
deprivation that results in a minimization of differences over time. They point out that patient
responses to subjective questions on the QOLI might correlate poorly with rater assessments on
other measures, which corresponds with arguments described previously made by Lehman about
measurements of quality of life made by various sources. However, this study did determine that
the QOLI question on global health-related quality of life was moderately to highly correlated with
most other subjective scales, which indicates that this simple scale may be an accurate indicator
of overall subjective quality of life. The authors concluded that the QOLI would be an appropriate
measure for documenting either patient-rated status or objective manifestations of change in
experiences, although it may be less likely to show significant change over time.
An alternative quality of life measure is the Quality of Life Inventory (Frisch, 1994), which
includes a descriptive discussion of the construct of quality of life. This inventory is modeled after
the Quality of Life Theory, which involves life satisfaction and subjective well-being and the
integration of these factors into a theory of depression and other disorders. This self-report
measure elicits responses from the individual regarding his or her satisfaction in sixteen areas of
life, including love, work, and health. This measure was not chosen for inclusion in the present
study because it does not involve both subjective and objective ratings of quality of life, the impact
of psychopathology was unknown for this measure, and it is intended to be used more in
evaluations of outcome and treatment response, which is not the focus of this research.
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Social Adjustment
Social adjustment and schizophrenia. Related to the interest in a patient’s quality of life is
evaluation of the social and community functioning of that individual. Social adjustment is
generally accepted to be the interactions between the person and his or her social environment
and performance in social roles (Weissman, 1975). Like quality of life, the evaluation of social
adjustment in mental health patients has developed in response to the number of patients now
living in the community and the increased interest in the experiences and abilities of those
individuals (Weissman, Sholomskas, & John, 1981). The consideration of social adjustment in the
lives of patients with schizophrenia is especially relevant due to the oftentimes profound impact
that the disease has on the social functioning of those individuals, even when they are relatively
asymptomatic and medicated (Glazer, Aronson, Prusoff, & Williams, 1980). These individuals may
experience difficulties with activities of daily living, social relationships, use of leisure time,
occupational performance, and even the ability to make use of therapy and other interventions. In
general, poor social functioning contributes to the social isolation, poor performance in social
roles, and dissatisfaction with social interactions of individuals with schizophrenia.
Research has determined that individuals with schizophrenia are able to report their social
adjustment accurately, as significant agreement has been found between the reports of patients
and those of their significant others (Glazer, Sholomskas, Williams, & Weissman, 1982).
Gender differences have also consistently been reported in relation to social adjustment.
Females tend to exhibit better premorbid social functioning and tend to survive longer in the
community without additional relapse of symptoms. In addition, the social adjustment of males
appears to deteriorate at a faster rate than that of females after the onset of schizophrenia
(HSfner, et al., 1998; Moriarty, et al., 2001).
Social adjustment can be seen as measuring similar constructs to those tapped by quality
of life measures when one considers factors such as social and family relationships, occupational
functioning, and leisure activities. However, quality of life looks at broader areas of functioning
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than just social interactions and often includes the individual’s satisfaction with these numerous
areas.
There has been much speculation about the interaction between symptomatology and
social adjustment, as many have presumed that social functioning was a reflection of current
psychopathology, especially those categorized as negative or deficit symptoms. However,
research has revealed that social functioning is independent of severity of overall psychotic
symptoms (Halford & Hayes, 1995) and that individuals with schizophrenia experience fairly
significant social impairment regardless of their level of negative symptoms (Bellack, Morrison,
Wixted & Mueser, 1990).
Social adjustment and the present study. Assessments of social adjustment are regularly
made as part of providing services to patients with schizophrenia and is also a significant interest
in the research of psychotic disorders. Because a measure of social adjustment was available for
this project, social adjustment had been added as another variable of interest.
The Social Adjustment Scale II (SAS-II; Schooler, Hogarty, & Weissman, 1979) is a scale
that was designed specifically to assess the social adjustment of patients with schizophrenia. The
SAS-II was modified from the SAS-I (Paykel, Weissman, Prusoff, & Tonks, 1971), a scale that
assessed the social functioning of depressed individuals, but did not take into consideration
important concerns of those persons with schizophrenia, such as unemployment, lack of spouse
and children, special living arrangements, and impaired skills of daily living. The time period of
interest in assessment with this measure is the preceding two months. The SAS-II consists of 52
questions that are asked within the context of a semi-structured interview by a trained rater. This
measure takes 45 minutes to one hour to complete.
The SAS-II assesses the areas of work role, relationship with a principal (primary)
household member, conjugal and nonconjugal sexual adjustment, romantic involvement, parental
role, extended family relationships, social leisure activities, and personal well-being. Each area of
interest includes ratings of performance at expected tasks, interpersonal relations, friction, and
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satisfaction in the roles. Ratings for these items are made on a 5-point scale, with higher numbers
indicating greater impairment in the area being assessed. Five global ratings are also completed,
to assess areas of work and daily responsibilities, relationship with primary household member,
relationship with external family, social leisure activities, and general adjustment. Ratings of most
specific items were based upon the reports of the study participants and their descriptions of their
social roles and interactions with others. Interviewers are instructed to focus their ratings on the
global items by comparing the participant to the adjustment of a “normal” person (i.e., one without
mental illness) within the community and considering community norms and standards rather than
knowledge of the individual’s adjustment or comparisons to other patients. For the purposes of
this research study, only the global ratings will be examined.
Language Production
Language production and schizophrenia. Language errors and deviances are common in
the speech of individuals with schizophrenia. The concept of thought disorder in schizophrenia
was emphasized by Kraepelin’s (1919,1971) descriptions of abnormal communication, and in
Bleuler’s (1911,1950) conceptualization of schizophrenia with his identification of “associative
loosening” as the characteristic symptom of the disorder. Although thought disorder has continued
to be considered pathognomic of schizophrenia, Bleuler's vague description of associative
loosening and the more recent finding that thought disorder is present in disorders other than
schizophrenia (Andreasen, 1979b; Harrow, Silverstein, & Marengo, 1983), has changed the
course of research on the topic.
Some past researchers postulated that there was a “schizophrenic language” common to
all patients, and that if one could learn this language, one would be able to communicate with
persons with schizophrenia. This has been disputed by studies that have shown that persons with
schizophrenia tend to respond to associations in fairly idiosyncratic ways, and that there is very
little commonality in associations among persons with schizophrenia (Sommer, Dewar, &
Osmond, 1960)
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A significant amount of past research has focused on the attempt to identify a
fundamental and underlying deficit for language disturbances, and when assuming that language
reflects underlying thought patterns, for thought disturbances (Maher, 1972; McGrath, 1991).
Thus, studies have focused on specific aspects of thinking disturbances, such as concreteness
and overinclusion in concept formation, idiosyncratic thinking and looseness of associations in
cognitive focusing, and, overgeneralization and circumstantiality in reasoning (Johnston &
Holzman, 1979; Maher, 1972; Pavy, 1968). However, it has become more evident over time that
thought disorder varies across a continuum ranging from slight slippage, as sometimes seen in
normal speech, to extremely deviant verbalizations, and that any given individual may exhibit
varying degrees of thought disorder over time (Andreasen, 1979a; Chapman, Chapman, & Miller,
1964)
The DSM-IV-TR (2000) characterizes the speech of patients with schizophrenia as
disorganized via speech behavior such as frequent derailment (ideas “slip off the track” onto one
another and appear to be unrelated or only vaguely related) or incoherence (speech that is
incomprehensible or seemingly random). Most clinicians will agree that the communication
disturbances observed in the speech of these individuals are an integral component in the
identification and diagnosis of schizophrenia.
As discussed earlier, the concept of thought disorder is related to language and
communication in schizophrenia. The idea of thought disorder has been plagued in the past with
the absence of any agreement as to its definition, although the concept has been present in the
literature for an extended period of time. Different conceptualizations of thought disorder have
involved reasoning, concept formation, set maintenance, and abstraction of thought. This has
shifted with the conceptualization of thought disorder as being composed of or at least manifested
as an observable language disturbance that could involve any of eighteen different language
behaviors considered to be subtypes of thought disorder (Andreasen, 1979a). These behaviors
are poverty of speech, poverty of content of speech, pressure of speech, distractible speech,
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tangentiality, derailment, incoherence, illogicality, clanging, neologisms, word approximations,
circumstantiality, loss of goal, perseveration, echolalia, blocking, stilted speech, self-reference,
and paraphasias (use of wrong words or using words in wrong or senseless combinations), both
phonemic and semantic.
A number of researchers (Barch & Berenbaum, 1996; Docherty, Hawkins, et al., 1996)
state that multiple language production processes are associated with thought disorder and
communication disturbances in schizophrenia. These processes include discourse planning,
encoding of information, monitoring speech, editing own speech for errors, and articulating ones
own speech. Barch and Berenbaum (1996) studied a variety of language production tasks and
found that common errors in schizophrenic speech were associated with specific processes.
Increased referential errors (vague or unclear references) were associated with impaired
discourse planning on a story-telling task. Greater word approximations (use of an existing word in
a new and unconventional way or development of a new word used in an understandable way)
and neologisms (creation of a completely new word with no understandable derivation) were
associated with decreased grammatical and phonological encoding on a speech error induction
task. What these authors termed derailment-non sequiturs (ideas within spontaneous speech that
are obliquely related or completely unrelated) were associated with decreased performance on a
reality monitoring task.
The authors concluded that thought disorder is multidimensional and that the variety of
tasks used measured different aspects of language production because they were associated with
different speech errors. Factors such as general verbal intelligence and medication effects were
explored and were not related to the results. The authors clarified that theirs was only a
correlational study and did not conclude that language production deficits cause thought disorder.
An alternative theory of the communication disturbances evidenced by patients with
schizophrenia is that the patients exhibit deficits in general cognitive processes of working
memory and sustained attention rather than thought disorder or specific language production
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difficulties (Docherty, Hawkins, et al., 1996; see also Saykin, et al., 1994). Results supporting this
theory have been seen in the performance of patients with schizophrenia when compared with
those with bipolar and nonpsychiatric control subjects (Docherty, Hawkins, et al.). Tests of verbal
fluency, concept formation, working memory, and attention were completed by these subjects.
Results revealed that the persons with schizophrenia performed significantly worse than the
control subjects. The mania group was no different from either the schizophrenia or the control
groups. Specifically, reference performance was associated with general working memory and
sustained attention, but not with concept formation or verbal fluency. Opposite results were found
for the bipolar and normal control groups, in other words that verbal fluency and concept formation
were associated with reference errors. Severity of illness was examined and was not related to
the results. These researchers conclude that errors for the patients with schizophrenia are caused
by general cognitive processes rather than specific language production processes.
The debate whether language errors are due to cognitive processes or specific language
production processes is ongoing in the literature. It is unclear at this time which theory is correct,
or whether both have an impact on language errors. This study will assess communication
disturbances (which are related to discourse structure, linguistics, and specific language
processes) and neurocognitive functioning in hopes of shedding additional light on this topic.
Language errors exhibited by patients with schizophrenia are common in the area of
general verbal fluency, involving both letters and words, or categories. Kuperberg, McGuire and
David (1998) presented patients with schizophrenia having thought disorder, those without
thought disorder, and normal subjects with verbal fluency tasks to produce words beginning with a
specific letter or to provide examples of specific categories. The results of a portion of the study
revealed that patients with schizophrenia performed significantly worse than the normal subjects,
and within the schizophrenia group those having thought disorder were more impaired than those
not having thought disorder. Common errors were production of an alternative form of the same
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word, repetitions, perseverations, neologisms, and associations to other stimuli. It was noted that
these are common errors produced by patients with schizophrenia in less formal tasks as well.
A concerted effort has been maintained in the literature to differentiate schizophrenia from
aphasia, because at times the language productions of individuals in both groups are similar. One
study examined both patients with schizophrenia having a formal thought disorder and those with
aphasia (Faber, et al., 1983). The results revealed that the two groups were essentially the same
in the frequency of neologisms and paraphasias (mispronunciation of a word because sounds
have slipped out of sequence or substitution of an inappropriate word in an effort to say something
specific). The patients with aphasia evidenced significantly more poverty of speech content,
anomia (word finding problems), and decreased auditory comprehension. Those with
schizophrenia produced significantly more word approximations, derailment, and tangentiality
(response to a question in an oblique or even irrelevant manner). The authors reported that most
errors in classification arose in the misidentification of aphasia patients as having schizophrenia.
They concluded that a difference in verbal productions of individuals with schizophrenia and
aphasia can be seen, even though a large overlap exists between the two groups.
The speech of patients with schizophrenia has been found to differ from that of other
groups when considering syntactic properties of the speech (Fraser, King, Thomas & Kendell,
1986). individuals with schizophrenia were found to be significantly different than those with mania
as well as normals. The schizophrenia groups showed decreased complexity of speech,
decreased number of well-formed sentences, increased syntactic and semantic errors, and
increased dysfluencies. Steps were taken to control for medication effects within this study. These
authors concluded that the psychotic illness of schizophrenia is reflected in linguistic features
even if the disorder is not necessarily a primary language dysfunction.
Similar results were found when patients with schizophrenia are separated into those with
chronic and those with acute forms of the disorder (Thomas, King, Fraser, & Kendell, 1990).
Analysis of symptom measures revealed that positive symptoms predominated for patients with
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acute schizophrenia, while those in a more chronic state evidenced both positive and negative
symptoms. Analysis of syntactic properties of schizophrenic speech revealed that the language
productions of the chronic group were significantly worse than the other two groups, while the
acute patients evidenced performance between the chronic and the control groups. Overall,
individuals with chronic schizophrenia evidenced less fluency, more errors and less complexity in
their speech. When separating hospitalized and community patients in this study, it was found that
the performance of hospitalized patients was less complex and less fluent than those in the
community. Symptom severity had been controlled for, and it was determined that the poorer
performance of hospitalized patients was not due to severity of symptoms at the time of testing. A
three year follow up to this research project (King, Fraser, Thomas & Kendell, 1990) found that the
language of patients with schizophrenia had become more impoverished and degraded overtime
even though the patients' symptoms were in remission. Further study showed that this
degradation was not due to medication effects, a prolonged hospital stay, nor to patient relapse
because patients with schizophrenia still evidenced decreased complexity and fluency over time
when compared to previous ratings. This deterioration was not seen in persons with mania
because at follow up they appeared essentially normal in their language productions.
Language production and the present study. The preceding review has indicated that
language disturbances are common in persons with schizophrenia and are considered to be an
integral component in the identification and diagnosis of schizophrenia. These language
disturbances have included both clinical aspects of language, noted in the observations of
Kraepelin (1919,1971) and Bleuler (1911,1950), and more technically-defined and measured
linguistic aspects of language. Each area, clinical and linguistic, are relevant to the study and
understanding of schizophrenia. Due to the importance and prevalence of language disturbances
in people with schizophrenia, this construct has been included in the present study. Unclear
references, a subtype of language disturbance and one periodically seen in the speech of non-
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patients, was considered in conjunction with the variables of quality of life, social adjustment,
neurocognitive functioning, and general symptom presentation.
The concept of unclear references considers language disturbance with a more specific
and scientific focus and allows the researcher to tap into the linguistic components of natural
language within the context of the clinical aspects of the speech. The study of unclear references
has provided valuable information about the relationships of these language disturbances with the
other variables of interest of this study and contributed to a literature that contains relatively little
information relating unclear references to other domains of functioning.
The Communication Disturbances Index (CDI) was developed as a measure of natural
language that would specifically assess the level and type of communication disturbances
evidenced in the speech of psychotic patients, even with subtle instances of communication
failure (Docherty, DeRosa & Andreasen, 1996). The CDI focuses specifically on failures of
communication rather than on signs of underlying thought disorder or disturbances of language
structure. As such, it measures failures in the transmission of meaning from one person (the
speaker) to another (the listener). Thus, vague words or incorrect usage of words are not
measured unless they confuse or otherwise impede the meaning of the statement. The CDI
involves a wider and more inclusive index of communication disturbance than other commonly
used measures such as the Scale for the Assessment of Thought, Language, and Communication
(TLC; Andreasen, 1979a, 1986) which focuses on specific examples of language behaviors that
contribute to formal thought disorder. Docherty and her research group based the development of
the CDI on the theory that communication disturbance, or a failure in the transmission of meaning
from speaker to listener, is the hallmark of schizophrenia and other psychotic disorders. The idea
of communication disturbance implies that the patient speaks and uses words or phrases in such
a way that the meanings are not socially shared with the listener(s).
The CDI is focused on the concept of “the unclear reference” which refers to unclarity of
meanings in speech. These unclear references are: (1) vague references, (2) confused
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references, (3) missing information references, (4) ambiguous word meanings, (5) wrong word
references, and, (6) structural unclarities. The CDI is more inclusive than other scales because it
includes instances of very subtle unclear meanings, considers violations of “common knowledge”
as unclear references, takes into account unclear meanings of any word or phrase rather than
only nominals and pronominals (as seen in other scales), and includes instances of faulty word
usage or grammatical structure that precludes the clarity of speech meaning.
It is for these reasons that the CDI was selected for inclusion in the present study. The
unclear reference is a construct that is periodically seen in the speech of normal subjects and is
easily noticed by the listener in most situations. Thus, this measure tends to capture even low
levels of communication disturbance and provide more detailed analysis when applied to the other
variables of interest in this study (quality of life, social adjustment, neurocognitive, symptom, and
demographic). The unclear reference language disturbance is one which affects individuals with
schizophrenia in their daily interactions with others and can be applied through the interventions
that are done with persons with schizophrenia via managed care and case management. All six of
the communication failures were considered as part of the current study, specifically because
each type of failure exhibits a different sort of unclarity in speech. A Total Communication
Disturbance rating is also obtained by summing the six unclarities.
Initial research with the CDI has shown a number of differences between healthy persons
and patients with mania or schizophrenia (Docherty, DeRosa, et al., 1996). It was found that the
total number of words produced was greatest within the mania group, followed by the healthy
group, then the schizophrenia group. Overall, the two patient groups (mania and schizophrenia)
were equivalent and exhibited significantly more unclear references than the healthy persons in all
areas, although the group with schizophrenia did evidence a greater frequency of vague
references than the mania patients.
Three of the six types of disturbances (missing information references, ambiguous word
meanings, and structural unclarities) have shown to be more prevalent in the speech of relatives
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of patients with schizophrenia and may be potential indicators of genetic vulnerability to the
disorder (Docherty & Gottesman, 2000). In addition, these three communication disturbances
have also been found to occur even more frequently in the speech of the patients themselves than
in their relatives. Of these three disturbances, missing information references were found to be the
most “schizophrenic” in quality and are speculated to be associated with specific cognitive
weaknesses, although this connection is not well understood and needs to be studied in more
detail.
Exploration of these communication failures exhibited by patients with schizophrenia and
their potential cognitive origins has recently been completed. Initially, research indicated that
patients with schizophrenia exhibited significant numbers of communication failures and that these
were associated with both deficits in immediate auditory memory (as measured by a digit span
task) and distractibility (involving a distracter voice) on the same task (Docherty & Gordinier,
1999). Follow up research expanded on these results (Docherty, Hall, Gordinier, & Cutting, 2000)
when it was found that four of the communication failures (grammatical unclarities, confused
references, missing information references, and ambiguous word meanings) were significantly
related to conceptual sequencing as measured by a conceptualization test in which the subject is
required to analyze a series of items and add to the series with the next sequential item. In
addition, each of these four failures was also associated with a specific combination of other
cognitive abilities, sustained attention (as measured by a computerized visual continuous
performance task), immediate memory (as measured by a digit span test), and organization and
sequencing (as measured by a trail making test). Confused references were associated only with
deficits in immediate memory. Missing information references were associated with deficits in
sustained attention and organization/ sequencing. Ambiguous word meanings were associated
with deficits in sustained attention and organization/sequencing. Finally, grammatical unclarities
were associated with deficits in immediate memory and organization/sequencing. These results
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support the theory that communication disturbances do have some connections to specific
cognitive abilities, at least to some extent.
Additional research has been completed considering the impact of affectively positive and
negative topics on communication disturbances utilizing the CDI. Docherty and Hebert (1997)
found that CDI scores for patients with schizophrenia were significantly higher in the affectively
negative than in the positive condition. When specific communication disturbances were
considered, vague references, confused references, and ambiguous word meanings were found
to be most affected by the affectivity of the topic. When utilizing scores from the TLC to assess for
formal thought disorder, the authors found that there was a significant increase in positive thought
disorder ratings in the affectively negative condition but no change in negative thought disorder.
Patients with schizophrenia have been found to be reactive to affectively-laden material
(Docherty, Hall, & Gordinier, 1997). Although normals did exhibit some reactivity, patients with
schizophrenia were found to evidence much more disturbances in speech when discussing
negative topics.
Neurocognitive Functioning
Neuropsychology and schizophrenia. Neuropsychology is generally accepted to refer to
the study of the relation between brain function and behavior of the individual, with a specific focus
on the behavioral expression of brain dysfunction (Keefe, 1995; Lezak, 1995). In clinical practice,
neuropsychology has allowed professionals to determine the location of disease or damage to the
brain as well as the abilities of the individuals in treatment. The areas of functioning traditionally
assessed through neuropsychological assessment are: attention, higher cognitive and executive
functioning, motor and perceptual skills, spatial abilities, affect, language, memory, and intellectual
ability (Lezak). Such assessments are becoming much more common and this practice is no
longer reserved only for patients with brain injury.
Benefits of neuropsychological assessment with psychiatric patients are diverse (Keefe,
1995). An assessment can provide an objective indication or description of the patient’s mental
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functioning as well as his or her cognitive and behavioral abilities and weaknesses. The results of
an assessment can assist in predicting the course of the illness and potentially improve diagnostic
classification while contributing to the development of individual treatment strategies and
interventions. The author cautions that poor performance on a single test or measure does not
necessarily indicate a specific deficit because a number of other factors may be involved, such as
motivation, difficulty of the task, symptoms of the illness, impaired memory, and, medication
effects. Corroborating evidence should always be sought. One must also be aware that a specific
deficit does not necessarily indicate dysfunction in a specific brain region because the complexity
of the task and damage in other areas may affect the region of concern. In the study of
schizophrenia, considering alternative applications of neuropsychological assessment such as
those discussed above is especially important because a summary of previous research has
determined that there is no conclusive evidence for the presence of a specific lesion indicative of
schizophrenia (Levin, Yurgelun-Todd & Craft, 1989). In addition, a review of fifteen longitudinal
studies (with at least follow up at one year) found that neurocognitive functioning of patients with
schizophrenia did not decline over time (Rund, 1998).
As a result of the findings that cognitive functioning is stable over time, that no one
specific lesion is indicative of schizophrenia, and no typical deficits are to be expected with
schizophrenia, an understanding of the patient’s individual functioning is needed. Once this
individual pattern of neurocognitive functioning is established, it can be applied to other areas of
interest, such as those involved in this study (psychiatric symptoms, social adjustment,
communication disturbances, and quality of life) to see what relationships exist and to determine
patterns in outcome. Specific domains of neurocognitive interest for this research included
attention and concentration, verbal fluency, verbal memory, general mental, and higher cognitive
functioning. A review of each of these domains and research involving neurocognitive variables,
schizophrenia, and outcome follows.
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Neurocognitive functioning and schizophrenia research. Researchers are in agreement
that schizophrenia is associated with neurocognitive deficits in a number of areas of functioning. A
review of the research was provided in a meta-analysis of 204 studies involving 7420 patients with
schizophrenia assessing 22 neuropsychological test variables (Heinrichs & Zakzanis, 1998). The
goal of the research was to estimate the consistency, strength, and selectivity of neurocognitive
deficits in schizophrenia relating to most neurocognitive tasks in common use today. The authors
concluded that neurocognitive impairments are a reliable finding in schizophrenia but that no one
test and its indicated deficits are completely indicative of schizophrenia. The authors instead
argue that neurocognitive deficits are not defining characteristics nor central to the illness, but
rather secondary to other processes within the disease. Results are presented according to areas
of functioning.
The authors concluded that for memory, defective total verbal learning over trials is a
reliable finding in schizophrenia. Problems with verbal memory are related to a number of the
language disturbances discussed in the previous section. The finding of decreased verbal learning
was replicated with more specific indices of verbal memory such as rate of forgetting or savings
after a delay. Nonverbal memory evidenced the same conclusions, but with more heterogeneity in
the results. Executive functioning revealed a moderately large and reliable impairment. More
specifically, performance on the Wisconsin Card Sorting Test (WCST) was significantly
associated with IQ as measured by the Wechsler Adult Intelligence Scale, Revised (WAIS-R).
Within general intellectual ability, a greater sensitivity was found with the WAIS-R than other
measures of IQ. Impairments of intellectual functioning of patients with schizophrenia were large
and reliable when the WAIS-R was used. A modest discrimination was found between patients
with schizophrenia and normal controls on measures of attention. Tests such as ones like the
continuous performance test and Trail Making Test were equally sensitive. In addition, no
difference was found between the performance on Trails A and Trails B. Several of these domains
were studied in the present study and relationships between the different domains were
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examined. The domains of interest included verbal memory, verbal fluency, higher cognitive
functioning, general mental abilities, and attention.
A moderately large and reliable unilateral deficit was found with motor functioning. When
considering tactile transfer of information a large effect was found, but the results were very
heterogeneous across patients. A moderately large effect was found between the spatial ability of
individuals with schizophrenia and those without. These findings were presented with caution
because spatial ability is not often studied in schizophrenia research and only a few studies were
considered.
The assessment of language functioning through neurocognitive measures is important in
the understanding of how language deficits impact other neurocognitive abilities and functioning in
various areas of their life. At a gross level, language in the context of neuropsychology refers to
comprehension, fluency, repetition, and naming. Assessment of neurocognitive abilities in the
domain of language functioning allows the clinician to understand the individual’s brain functioning
as expressed by language behavior. Assessment of language functioning revealed that large
effects in the impairment of patients with schizophrenia are found in language, as measured by
the Controlled Oral Word Association Test, a test of verbal fluency, and the Token Test, a test
involving oral commands to the individual to manipulate ‘‘tokens'’ of various colors and sizes.
Moderate effects were found for a variation of vocabulary test, although there was no difference
between the WAIS-R Vocabulary subtest and other measures of vocabulary. Medication effects
were found with these results as a significantly larger impairment on verbal fluency is found in
those individuals who are taking greater doses of medications. These specific deficits in language
functioning can again be tied to the discussion in the preceding section about language
disturbances and the communication of persons with schizophrenia. This literature in some
aspects overlaps with that specific to language, but in no way replaces the research done
primarily in the domain of language disturbances. The domain of verbal fluency was also under
consideration as part of the present study.
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The authors assert between 61 and 78% of individuals with schizophrenia exhibit some
neurocognitive deficit(s). They related that the evidence shows a number of patients with
schizophrenia are neurocognitively normal, but that most have some deficit(s) and often they are
more impaired than some individuals with neurological disorders. The best indicators of
impairment in people with schizophrenia were determined to be the score of global verbal
memory, Performance IQ and Full Scale IQ on the WAIS-R, scores from the CPT, and word
fluency. The measures with the least ability to differentiate were the Block Design and Vocabulary
subtest from the WAIS-R, and IQ scores derived from non-WAIS-R measures. As previously
noted, the domains of verbal fluency and general mental ability were included in the present study.
Similar findings have been presented which reflect a generalized deficit in schizophrenia
(Dickerson, Boronow, Ringel, & Parente, 1996; Heaton et al., 1994; Jeste, et al., 1995; Perlick,
Mattis, Stastny, & Teresi, 1992). However, different conclusions have been drawn regarding
specific impairments in persons with schizophrenia. Specific selective deficits for both in-patients
and out-patients have been found to be in semantic memory, visual memory and verbal learning,
while little if any impairment has been found in abstraction/flexibility, verbal intelligence, attention
and motor skills (Saykin, et al., 1991). Other conclusions have indicated that out-patients with
schizophrenia evidence impairments on tasks of efficiency, attention, auditory discrimination,
learning, incidental memory, fine motor coordination, and sensory perceptual skill, while
performance equivalent to normal controls is seen on tasks of forgetting, aphasia screening,
spatial relations, and motor speed (Braff, et al., 1991).
A review of the literature that did not involve any quantitative meta-analysis of the findings
supports these findings (Levin, et al., 1989). In general, individuals with schizophrenia were found
to have significantly lower global performance scores than brain-damaged patients. No
comparisons to normal controls were provided. Overall, deficits in performance were seen more
with chronic schizophrenia than acute schizophrenia. Specific indications were provided for
several of the separate areas of functioning. Memory was found to be especially impaired in
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severely disturbed patients with schizophrenia. Attention was found to differ across classifications
of schizophrenia. When considering subtypes of the disorder, those with non-paranoid
schizophrenia evidenced greater impairments in attention than those diagnosed with paranoid
schizophrenia. Both of these areas, verbal memory and attention, are constructs of interest in the
present study. However, no analysis of subtypes was done for the current study. Symptomatology
also influenced attentional performance, in that patients with predominantly negative symptoms
were more impaired than those with predominantly positive symptoms (see also Lieh-Mak & Lee,
1997). Basic language functions such as naming and repetition were intact for patients, but
difficulties were found in language behaviors involving semantic content, discourse, and complex
language. This has been discussed in more detail in the language disturbances section above.
Visual and verbal affective processing were impaired in patients with schizophrenia and those with
predominantly negative symptoms exhibited specific deficits in conveying vocal affect to others.
Further evidence for the differentiation of neuropsychological performance in individuals
with schizophrenia based upon symptom classification has been presented (Green & Walker,
1985). Individuals with predominantly negative symptoms showed significant impairment on visual
motor and visual spatial tasks, such as the Block Design subtest of the WAIS-R. Those with
predominantly positive symptoms showed significant impairments on short-term verbal memory
recall tasks while their performance on recognition tasks was not impaired. Exploration of the
relationship between neurocognitive functioning and symptom presentation was undertaken as
part of the current study.
A comprehensive review of the literature has concluded that positive symptoms tend to be
associated with deficits in auditory information processing and self-monitoring, while negative
symptoms tend to be associated more with deficits in visual and motor skills (Strauss, 1993). The
author summarized recent reports that included recommendations that neurocognitive research
focus on the analysis of individual symptoms rather than symptom dimensions (e.g., positive and
negative symptoms). This is due to findings that individuals with hallucinations tend to have
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difficulty with discriminating the source of information and persons with delusions tend to have
difficulty with inferential thinking and dysfunction with perceptual processes.
Some confusion between older patients with schizophrenia and individuals with
Alzheimer's Disease (AD) arises due to impaired memory evidenced by each group. Relatively
little is known about the interaction between the disease process of schizophrenia and the effects
of aging. A question in the literature is whether schizophrenia continues later in development or if
diagnoses of late-onset schizophrenia should actually be AD. A hallmark of AD is the rapid
forgetting of recently learned information (Lezak, 1995), whereas in schizophrenia the memory
difficulties appear to stem from inefficient learning with intact remembering of what was learned.
Heaton, et al. (1994) engaged in a project to study memory performance in AD and
schizophrenia. Ail participants were individuals living in the community, and were classified into
groups as normal control, AD patients, or those diagnosed with schizophrenia. The patients with
schizophrenia were further classified as early onset-still young, early onset-older, or late onset.
Results indicated all patient groups (schizophrenia and AD) were within the normal range on Full
Scale IQ and the Average Impairment Rating on the Halstead-Reitan Neuropsychological Battery
(HRB), but were significantly lower than the normal controls. AD patients exhibited significantly
lower Global Deficit Scores on the HRB than the control group or the three schizophrenia groups.
The four patient groups performed worse than the control group on all measures except memory
which was calculated as percent retention of information learned. Individuals with schizophrenia
performed equally with the control group, while the AD group had a significantly greater learning
impairment. No significant differences were found on any measures across the three
schizophrenia groups. The authors conclude that neuropsychological impairment in schizophrenia
is unrelated to current age, age at onset, or duration of the illness. In addition, they state that late
onset schizophrenia is not just AD with psychotic features because the memory impairments
measured with rapid forgetting were seen only in the individuals with AD and the deficits
associated with schizophrenia were nonprogressive.
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Similar results have been found in other studies of late-onset schizophrenia (Jeste, et al.,
1995). Specifically, individuals with early and late-onset schizophrenia showed essentially equal
performance to each other and lower performance than the normal controls on most
neuropsychological tests. No differences were found between patients and the controls on
delayed recall or memory, perceptual motor tasks and sensory abilities. Persons with late-onset
schizophrenia did perform better than those with early-onset on the W CST and the California
Verbal Learning Test. The authors conclude their results support the diagnostic validity of
schizophrenia with onset after age 45.
Neurocognitive functioning and outcome in schizophrenia. Based upon the above
discussion, it appears no debate is necessary regarding whether people with schizophrenia suffer
from neuropsychological and cognitive impairments. The impact of these deficits on the daily lives
of the patients is less understood. A review of the literature relating neurocognitive measures to
functional outcome for individuals with schizophrenia has indicated several important
consistencies in research (Green, 1996). The goal of Green’s review was to determine which
neurocognitive impairments may restrict the functioning of patients with schizophrenia in the
community. Functional outcome is defined as the result of competence in a large number of tasks.
The domains of community outcome, social problem solving, and social skill acquisition are
considered.
Results of studying community outcome have been quite variable, but several findings
consistently emerge (Green, 1996). Secondary verbal memory and card sorting via the WCST
both emerged as predictors of community functioning, each of which were also examined as part
of the current project. Secondary verbal memory refers to memory for lists of words or stories and
is usually assessed after a delay. This is in contrast to immediate memory, which is equivalent to
short-term memory and is often assessed with measures such as the Digit Span. No relationship
was found between psychotic symptoms and community outcome. Social problem solving was
best predicted by secondary verbal memory and vigilance, measured by a continuous
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performance task. A relationship between negative, but not psychotic symptoms, and social
problem solving was found. Primary and secondary verbal memory as well as vigilance were
determined to be the most probable predictors of social skill acquisition. No relationship between
symptoms, negative or psychotic, was found with social problem solving.
The author concluded that the WCST performance and secondary verbal memory, as
measured by the Rey Auditory Verbal Learning Test (AVLT), a list learning task, or the Logical
Memory I and II subtests from the WMS-R, measuring memory for paragraph length material, are
the best predictors of functional outcome. Primary verbal memory and vigilance were determined
to be moderate predictors of overall outcome. The lack of a strong relationship between functional
outcome and symptoms was attributed to a number of potential influences. Symptoms may be
more informative across diagnostic classifications where more variability in both symptoms and
outcome are found rather than within the single diagnosis of schizophrenia. Not all symptoms are
equally disruptive to outcome and some may preclude individuals from community life in general.
A primary indicator of outcome is occupational status, and it is important to note that not all job
positions would be equally affected by symptoms and symptoms may be more tolerated in some
positions than others. Regardless of these considerations, the author points out that several
neurocognitive measures were consistently more associated with outcome than symptoms.
Outcome as assessed by social functioning has been examined in relation to
neurocognitive functioning. Results indicate that verbal memory, overall verbal ability, and
cognitive flexibility are associated with social problem solving (Addington & Addington, 1999;
Addington, McCleary, & Munroe-Blum, 1998) as measured by an individual’s ability to assess an
interpersonal social problem, then develop and implement a solution. These authors also
determined that neither social functioning in the community nor quality of life (both areas
considered in this study) were associated with neurocognitive performance. Similar results have
been found which revealed that deficits in higher cognitive functioning, although quite prevalent in
persons with schizophrenia, were not associated with reports quality of life (Heslegrave, et al.,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 52
1997). These authors did postulate that deficits in more basic areas of neurocognitive functioning
would be associated with decreased quality of life.
The study of the relationship between occupational functioning and WCST performance of
outpatients with schizophrenia has revealed that “task orientation” at work, better social skills, and
higher levels of occupational functioning were significantly related to WCST trials to first category
and total number correct (Lysaker, Bell, & Beam-Goulet, 1995). The authors present the idea that
the WCST should continue to be used in neuropsychological studies of schizophrenia and
focused attention should be placed upon the implications of results for vocational counselors and
neuropsychological professionals. Contrasting results have been presented which indicate that
the WCST was not helpful in predicting social or occupational functioning in outpatients, while
performance on aphasia, spatial organization and visual spatial tasks were correlated with social
functioning (Dickerson, et al., 1996).
Performance on WCST has also been associated with community tenure and avoiding
hospitalization for individuals with schizophrenia. Poorer performance on the WCST predicted
shorter duration of community life before a first rehospitalization better than did an individual's
history of hospitalization (Lysaker, Bell, Bioty, & Zito, 1996). An explanation for the result posits
that impairments in cognitive flexibility and reasoning are closely associated with difficulties in
community life and compromise the individual's ability to function which limits adaptation to social
situations and increases vulnerability to relapse.
Specific neuropsychological functions have been found to discriminate between
hospitalized patients and those individuals living in the community. Although all patients overall
evidenced mild to moderate impairment on all tasks, measures of motor coordination, initiation
and perseveration as measured by the Dementia Rating Scale (DRS), a measure used to assess
the changes that characterize senile dementia, and measures of memory and attention
significantly discriminated inpatients from outpatients (Perlick, et al., 1992). Measures of
conceptualization, language, somatosensory and oral association were not significant
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discriminators of hospitalization status. Most specifically, bilateral and nondominant hand Purdue
Pegboard performance were the most clear discriminators, followed by the DRS initiation and
perseveration scale and the DRS memory and attention scales.
Neurocognitive functioning and the present study. The previous section suggests that the
study of neuropsychological abilities in persons with schizophrenia is still warranted, especially in
considering factors such as functional outcome. The present study assessed a number of
neurocognitive domains (attention/concentration, verbal memory, verbal fluency, higher cognitive
functioning, and general mental ability) and examined their relationship with variables of quality of
life, social adjustment, language production, and general symptom presentation. The
neurocognitive domains examined by this study were ones in which individuals, such as case
workers, are able to assess informally and are areas relative to good functioning within the
community. This research explored the interactions between neurocognitive functioning and the
other variables in this study, providing knowledge that will be helpful in providing improved care for
persons with schizophrenia. Findings from recent research have revealed that neurocognitive
deficits are more closely associated with quality of life if the deficits are in basic functioning rather
than in higher cognitive functioning (Heslegrave, et al., 1997). A review of the literature has also
indicated that impairments in attention (Landre & Taylor, 1995; Nuechterlein, Edell, Norn's, &
Dawson, 1986) and reality-monitoring (Harvey & Serper, 1990) are associated with language
disturbances. Exploration of higher cognitive abilities and attentional skills was undertaken as part
of this study, and the relationships between neurocognitive abilities and indications of overall
functioning, as measured by social adjustment and quality of life, were completed.
The Present Study
The constructs of quality of life and social adjustment, language production,
neurocognitive functioning, and symptom presentation have been demonstrated to be important
components in the assessment and treatment of psychiatric patients, yet their inter-relationships
have not been studied extensively. A primary focus of mental health services and more
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specifically case management is the general ability of the person with schizophrenia to function
adequately within the community. Domains such as the variables of interest to the present study
relate to the ability of a person to interact and relate to other individuals in the community and
otherwise function adequately.
An understanding of an individual patient’s functioning is needed in order to predict his or
her ability to survive in the community and overall outcome. Very little research has been
completed which considers together any of the different areas of interest for the present study. In
particular, the study of quality of life has focused predominantly on outcome and symptom
presentation, with little emphasis on neurocognitive functioning and no focus on language
production. Findings from recent research have indicated that increased symptom presentation is
associated with diminished subjective quality of life (Lehman, 1983; Packer, et al., 1997), and
neurocognitive deficits are more closely associated with quality of life if the deficits are in basic
functioning rather than in higher cognitive functioning (Heslegrave, et al., 1997). Some research
has centered on the relationships between symptom presentation and neurocognitive functioning
which have found that neurocognitive deficits are related to negative symptom presentation
(Levin, et al., 1989; Lieh-Mak & Lee, 1997; Nuechterlein, et al., 1986). More specific evidence for
the relationship between neurocognitive performance and symptom presentation has determined
that negative symptoms are inversely related to visual-motor tasks, while positive symptoms are
inversely related to verbal memory performance (Green & Walker, 1985).
The present study assessed variables of symptom presentation, quality of life (both
subjective and objective), social adjustment, language production (specifically communication
disturbances manifested through unclear references), and neurocognitive functioning (evaluated
in the domains of attention/concentration, verbal memory, verbal fluency, higher cognitive
functioning, and general mental abilities), to determine existing relationships and to discover
patterns in outcome. The variables considered for this study are those which other individuals,
such as clinicians and case workers, are able to assess informally and have been demonstrated
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to be areas of great importance for functioning within the community. This research examined
relationships between each of the variables in this study which are relevant to both researchers as
well as to professionals and case workers who provide care and intervention in hopes of
improving community functioning for persons with schizophrenia.
Hypotheses
Based upon the research reviewed regarding each of the different variables of interest for
the study, a number of findings were predicted. In some cases these were only speculative, as a
number of these areas had not been studied specifically in relation to one another in the past, or
else research had addressed them only in an oblique manner. Several preliminary hypotheses
were omitted due to insufficient numbers of participants in some groups to make analyses. These
include exploration of the differences in functioning between males and females, exploring
differences between those who live in rural and urban areas, and comparisons between inpatients
and those persons living in the community. In addition, as the measure of social adjustment
became available for this research, global ratings of social adjustment were added as variables as
data collection was coming to an end. General hypotheses involving the social adjustment
variables were intended to be similar to those of the quality of life assessment, as they in some
ways measure similar constructs and can both be used as outcome measures. Social adjustment
was expected to correlate negatively with overall symptom presentation, correlate positively with
neurocognitive functioning, and correlate positively with ratings of quality of life.
The specific hypotheses for this study were as follows:
1. Overall symptom presentation would be negatively correlated with the measures of
quality of life (1a) and neurocognitive functioning (1b).
2. Overall symptom presentation would be positively correlated with communication
disturbances.
3. Negative symptoms would have a stronger negative correlation with quality of life (3a)
and neurocognitive functioning (3b) than positive symptoms.
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4. Quality of life (objective) would be positively correlated with measures of verbal
memory, attention, and higher cognitive functioning within the domain of neurocognitive abilities.
5. Participants would exhibit more ambiguous word meanings than other types of unclear
references within the area of communication disturbances. The second most common form of
communication disturbances will be missing information references.
6. Communication disturbances (unclear references) would be negatively correlated with
performance in the specific neurocognitive domains of memory, attention, and verbal fluency.
7. Participants would exhibit greater deficits in the areas of verbal memory, word fluency,
attention, and higher cognitive functioning than in general mental ability, the remaining domain of
neurocognitive functioning.
8. Individual scores on the QOLI could be predicted from the other variables of the study.

Method
Participants
Participants were 55 patients diagnosed with DSM-IV (American Psychiatric Association,
1994) schizophrenia or schizoaffective disorder. The patients were recruited from the Minneapolis
VA Medical Center (/? = 43), Hennepin County Mental Health Center (n = 5), or other programs
within the community (n = 7) such as the National Alliance for the Mentally III of Minnesota, or the
Tasks Unlimited program, which facilitates employment and provides other resources to persons
with mental illness. Potential participants were screened with a medical history questionnaire
either by review of their medical records or interview to exclude for the following: (a) current
alcohol abuse, (b) current or past substance dependence or current substance abuse, (c)
neurological illness or history of a medical condition with likely central nervous system effects, (d)
history of head injury with skull fracture or loss of consciousness of greater than 20 minutes, (e)
significant tardive dyskinesia (DISCUS score greater than 7), (f) history of Electro-Convulsive
Therapy, (g) adoption, (h) mental retardation or charted IQ of less than 70, (i) being a non-native
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English speaker, and (j) being younger than 18 or older than 60 years of age. See Appendix A for
Checklist for Exclusionary Criteria form that was used for the study’s initial chart reviews.
Most patients were medicated and had been receiving the same medications and
dosages for at least two months prior to entrance into the study. As previously noted, subtypes of
schizophrenia were not explored as part of this research study. Daily oral doses of antipsychotic
medications were converted to chlorpromazine equivalents according to guidelines suggested by
Bezchlibnyk-Butler and Jeffries (2001) for descriptive purposes. Depot doses were converted to
average daily dosages using similar guidelines set by the same authors.
Materials
Chart review. After receiving permission to access medical records, a chart review (see
Appendix B) was completed for each participant. The chart review included information about
medical and psychiatric conditions and treatments, current psychotropic medications and
compliance plus recent changes to medications, and current outpatient therapy. In addition, a
record of hospitalizations was generated which included information about length of stay, location
of hospitalizations, presenting issues, and discharge diagnosis.
Diagnostic Interview for Genetic Studies. To establish diagnosis, the Diagnostic Interview
for Genetic Studies (DIGS; Numberger, et al., 1994) was completed with each patient by a trained
rater at either a pre-doctoral or doctoral level. The DIGS is a semi-structured clinical interview that
was developed for the differential diagnosis of mood and psychotic disorders and related
“spectrum” disorders. The DIGS incorporates items which, when answered completely with
sufficient detail and examples, can provide diagnoses through a variety of diagnostic systems.
The individual items included on the DIGS were derived from other structured interviews in order
to be used with the various diagnostic systems. The authors have described a number of
additional key features of the DIGS, including the extensive coverage of the course, chronology of
symptoms, and comorbidity with other disorders, and algorithmic scoring capability of the
interview results. This interview collects self-reported psychiatric history data that may be
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supplemented with additional medical record and relative information prior to determining the
diagnosis. It is intended to be used by interviewers who employ significant clinical judgment, make
ratings on symptoms, and utilize a narrative format to indicate additional information. The DIGS is
designed for use in research settings that require a detailed and organized history of
symptomatology since it is an interview that is not easily administered by lay interviewers or in use
with cognitively disorganized individuals. As reported by the authors, reliabilities for the DIGS
using computer-generated diagnoses based on algorithms (item scores that are evaluated in pre
determined combinations to establish for which diagnoses criteria are met) were excellent,
ranging from .73 to .96, except for schizoaffective disorder, for which disagreement on duration of
mood vs. psychotic symptoms reduced reliability. See procedures section for a discussion of the
present study’s inter-rater reliability for the DIGS.
A procedure often used in conjunction with the DIGS interview involves the rating of a
series of 90 items that have been taken from the operational criteria for major clinical syndromes.
This procedure allows the precise recording of signs and symptoms as an accurate method to
establish a diagnosis. These rating are then entered into a computer scoring program that
provides a diagnosis based on computer-scored algorithms. This program, the Operational
Criteria Checklist (OPCRIT; McGuffin, Farmer, & Harvey, 1991) system, was developed to be
used after a comprehensive diagnostic interview was completed and detailed information was
obtained about the individual's psychiatric history. The OPCRIT has been found to provide
convenient, reliable, easy, and valid psychiatric diagnoses according to a variety of diagnostic
systems.
Diagnostic reliability between raters using the OPCRIT has been found to be very good,
with coefficients between .69 and .78 for DSM-III-R diagnoses, the most recent system when the
measure was first developed (McGuffin, et al., 1991). Item-by-item agreement, although less
good, still achieved reasonable reliability despite the problem of low base rates for some items,
with coefficients ranging from .34 to 1.0. A larger multicenter assessment found that the OPCRIT
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provided good reliability across a variety of geographical and theoretical backgrounds, with an
inter-rater reliability coefficient of .73 for DSM-III-R diagnoses (Williams, et al., 1996). Concurrent
validity was determined with comparisons between lifetime diagnoses generated by OPCRIT and
consensus best-estimate diagnoses, with coefficients exceeding .80 for DSM-III-R diagnoses
(Craddock, et al., 1996). Previous research on the OPCRIT has shown that independent
clinicians having extensive experience with both the DIGS and the OPCRIT can make reliable
diagnoses, providing a more structured procedure to establish best-estimate consensus
diagnoses. Agreements between clinicians’ diagnoses and consensus diagnosis produced were
excellent, with reliability coefficients ranging from 0.83 to 0.89 for DSM-III-R syndromes (Azevedo,
et al., 1999).
Brief Psychiatric Rating Scale. To assess current symptomatology, the Expanded Version
of the Brief Psychiatric Rating Scale (BPRS; Ventura, et al., 1993) was administered. This version
involves the original eighteen items relating to patient symptom presentation and experiences of
the BPRS (Overall & Gorham, 1962), plus an additional six items, all of which were rated for the
period of one month preceding the assessment. The BPRS can be easily scored based upon
interview information that can be gathered after engaging in any standard therapeutic session and
possibly some direct questioning about behavior that is not elicited in the session. The BPRS
takes only a few minutes to complete once familiarity with the items is established. Interrater
reliabilities for the BPRS, using Cronbach's alpha, are very satisfactory, with r = .87 for the BPRS
Total score (Bell, Milstein, Beam-Goulet, Lysaker, & Cicchetti, 1992). Specific factors for
consideration in this study incorporated the factor structure identified by Ventura, et al., (2000) for
the expanded BPRS. This structure incorporates symptom factors of Manic-Excitement, Negative
Symptoms, Positive Symptoms, and Depression-Anxiety.
Global Assessment of Functioning. A judgment of each participant’s overall level of
psychiatric functioning was made with the Global Assessment of Functioning (GAF) Scale as it is
used with DSM-IV (1994) diagnoses. The GAF involves a clinician’s judgment of a patient's
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psychological, social, and occupational functioning at the time of the assessment. Scores range
from 100 (superior functioning) to 1 (persistent danger of hurting self or others, inability to
maintain minimal hygiene, or serious suicidal acts). The GAF provides detailed descriptions for
each rating to assist in assigning a score for the individual. Reliability for the GAF has been found
to range from .72 to .76, and it has been determined to be valid in relation to other measures of
clinical need such as support time provided by staff and changes in neuroleptic medication
(Jones, Thomicroft, Coffey, & Dunn, 1995).
Quality of life. The quality of life measure that was selected for inclusion in the present
study is the Quality of Life Interview - Brief Version (QOLI; Lehman, 1988; 1996). This measure is
intended to be used with the chronically mentally ill and assesses general quality of life rather than
health related quality of life. The QOLI - Long Version is a highly structured interview of 143 items
that takes approximately 45 minutes to complete and can be administered by a trained nonclinical
interviewer. The Brief Version takes approximately 15 minutes to complete, allows for the
consideration of the same scales, and has psychometric properties comparable to the Long
Version and moderate to high correlations between similar scales on each version (Lehman,
Kernan, & Postrado, 1995). The Brief version was used in the present study. The scale is focused
predominantly on current levels of satisfaction, recent functional status, and access to resources.
The QOLI provides a general assessment of an individual’s life experiences in eight domains:
living situation, daily activities and functioning, family relations, social relations, finances, work and
school, legal and safety issues, and health. In addition, a global measure of life satisfaction is
obtained at both the beginning and completion of the interview.
The main purpose of the QOLI is to assess life circumstances of patient populations, both
in terms of what the individuals actually do and their feelings about those situations. Thus it
involves both a subjective and an objective assessment of quality of life. For items which apply to
the individual’s subjective quality of life, patients are asked to indicate their satisfaction using a life
satisfaction rating scale consisting, as previously described, of ratings 1 = terrible through 7 =
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delighted. The Delighted-Terrible scale is presented to the patients on a continuum, with each of
the ratings from one to seven accompanied by a computer-generated picture of a face with
varying degrees of a smile or frown corresponding to the particular rating. Anchor-point
descriptions for each of the ratings (1 through 7) are also provided.
Psychometric properties of the full version of the QOLI have been studied and are
determined to be quite satisfactory with only a few ranges including statistics lower than ideal
(Lehman, 1988). Internal consistency reliabilities reported by Cronbach's alpha range from .79 to
.88 for the life satisfaction scales and from .44 to .82 for the objective quality of life scales. Testretest reliabilities of one week have been found to range from .41 to .95 for the life satisfaction
scales and from .29 to .98 for the objective quality of life scales. Large variations in the ranges for
objective ratings may be a result of drastic changes in the individual’s life circumstances from one
test session to the next, and were attributable mostly to ‘‘cohesion” and “independence” within the
current living situation, specific areas that are assessed only by the full version of the QOLI.
Construct and predictive validity have been deemed good by a variety of methods. The QOLI
discriminates between patients with severe mental illness and persons in the general population,
as well as hospitalized patients and those living in supervised community settings. These findings
regarding the psychometric properties of the QOLI were replicated by other researchers studying
a total of 981 acutely ill psychiatric inpatients (Russo, et al., 1997). The psychometric qualities of
the brief version are comparable to the full version (Lehman, 1988).
Social adjustment The social adjustment measure that was available for this research
project was the Social Adjustment Scale-ll (SAS-II; Schooler, Hogarty, & Weissman, 1979). The
SAS-II is a semi-structured interview consisting of 52 items that takes approximately 45 minutes to
complete. It is focused predominantly on performance at relevant tasks, interpersonal relations,
friction with others, and satisfaction in the roles within the areas of work/daily responsibilities,
relationship with a principal (primary) household member, conjugal and nonconjugal sexual
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adjustment, romantic involvement, parental role, extended family relationships, social leisure
activities, and personal well-being.
The main purpose of the SAS-II is to assess the functioning of the individual within the
given areas for the preceding two month period. Ratings for most items are made on a 5-point
scale, with higher numbers indicating greater impairment in the area being assessed. Area means
can be calculated from the scores on sets of individual items within each section. Five global
ratings are also completed, to assess areas of work and daily responsibilities, relationship with
primary household member, relationship with external family members, social leisure activities,
and general social adjustment. Ratings on these global items are made on a 7-point scale, again
with higher numbers indicating greater impairment. Interviewers are instructed to make these
global ratings based upon comparison with persons generally found in the community in relation to
community norms and standards, without regard to knowledge of the patient's earlier adjustment
or expectations of mentally ill individuals.
Only the global ratings were used for the purposes of this study. The Work global rating
takes into consideration the consistency and effectiveness of the individual’s work performance
and completion of daily responsibilities in relation to his/her education, prior training, and
experience. The Household Member global rating examines the relationship with the patient's
primary contact within the household in terms of support, affection, and involvement with each
other. The External Family global rating considers the relationship with family members outside of
the home in terms of support, affection, and involvement with one another. The Social Leisure
global rating evaluates the level and quality of social activities, and meaningfulness of interactions
in social situations. The General Adjustment global rating takes into consideration the individual’s
overall functioning, while considering performance in each of the social roles (work, parental,
marital, etc.), interpersonal relationships, and personal comfort or well-being.
Psychometric properties of the SAS-II have been reported to be similar to those of the
SAS, for which Pearson correlations were quite high, with a mean correlation of .83 (Weissman,
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Paykel, & Prusoff, 1993). The SAS-II has been found to have high agreement between patients
and their significant others, as measured by a Spearman’s rank correlation coefficient of .98
(Glazer, et al., 1982).
Language production. Language disturbances of each participant were assessed with the
Communication Disturbances Index (CDI; Docherty, DeRosa, et al., 1996). This scale was
developed with consideration of the concept of “the unclear reference” which refers to unclarity of
meanings in speech. Definitions of each of the unclear references are provided within the scale
along with several examples (see Appendix C). The six types of unclear meanings included in the
CDI are Vague References, Confused References, Missing Information references, Ambiguous
Word Meanings, Wrong Word References, and Structural Unclarities.
Speech samples for the CDI are obtained via an audiotaped semistructured interview
lasting ten to fifteen minutes that is later transcribed for analysis. The topic(s) of this interview are
intended to be ones unrelated to the diagnosis or treatment of the patient, but rather outside
interests or hobbies of the individual. If a participant begins to talk about their diagnosis or
treatment, they are redirected to discuss more neutral topics. In addition, the interviewer is
instructed to speak as minimally as possible in order to obtain adequate speech samples from the
participant. To control for different production rates of speech among the different experimental
groups, the authors calculated the number of each type of communication disturbance per 100
words of speech. Total CDI communication disturbance scores are computed by summing the
numbers of each of the six subtypes per 100 words of speech. Thus each is a frequency rather
than absolute score.
Initial research involving the CDI revealed that the psychometric properties are quite
satisfactory (Docherty, Hawkins, et al., 1996). The inter-rater reliabilities for each of the six
subscales and for the overall total communication disturbances are as follows: Vague references
(.73), Confused references (.88), Missing information references (.89), Ambiguous word meanings
(.88), Wrong word references (.80), Structural unclarities (.93), and Total communication
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disturbances (.94). The CDI discriminates the language of persons with schizophrenia from
normal controls on all subtypes, and from the language of persons with mania, specifically on the
subtypes of vague references. Considering correlations between scores on the different subtypes,
it was found that most of the subtypes were moderately to highly correlated with each other.
Vague references were the least related to the other subtypes, but were still correlated r = .45
with the total communication disturbances score. When regarding the proportions of the six
subtypes in speech of the participants, those individuals with schizophrenia evidenced a higher
proportion of Missing Information references compared with other groups.
Neurocognitive functioning. A variety of neurocognitive measures was employed within
this study. These measures included: (1) Trail Making Test, parts A and B, (2) Controlled Oral
Word Association Test, (3) Wisconsin Card Sorting Task, (4) California Verbal Learning Test, (5)
WAIS-III Block Design, (6) WAIS-III Digit Symbol, (7) WAIS-III Digit Span, (8) WAIS-III
Vocabulary.
The Trail Making Test (Reitan & Wolfson, 1985) from the Halstead Reitan Battery,
employing standard scoring and norms (Heaton, Grant, & Mathews, 1991), was completed by
each subject. Participants on the Trail Making Test must first connect consecutively numbered
circles on a page (Part A), and then connect the same number of consecutively numbered and
lettered circles on another page by alternating between the numbers and letters (Part B). The Trail
Making Test is generally thought of as a measure of orientation and attention, while part A is often
considered a measure of visual sequencing and part B is considered to tap into set-shifting and
higher cognitive abilities. The reported reliability coefficients for the Trail Making Test vary
between .60 and .90, although a low reliability of r= .36 has been reported for patients with
schizophrenia on Part A (Lezak, 1995).
The Controlled Oral Word Association Test (COWAT; Benton & Hamsher, 1989) is
composed of three trials in which subjects are to orally produce words beginning with a
designated letter. The letters FAS were the first to be used with this measure. Additional word sets
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have included PRW and CFL, of which the latter was used in the present study. The COWAT is a
measure of verbal fluency and word production. Reliability of the COWAT is quite satisfactory,
with only the letter A (of the FAS set) having a reliability coefficient below .70, and then only for
elderly subjects (Lezak, 1995). Updated norms reflecting a more normally distributed range of
scores was used for this measure (Ruff, Light, Parker, & Levin, 1996).
The Wisconsin Card Sorting Test (WCST; Heaton, 1981; Heaton, Chelune, Talley, Kay, &
Curtiss, 1993) involves a pack of cards on which are printed one to four symbols, in the patterns
of triangle, star, cross, or circle. These symbols appear in one of four colors, red, green, yellow,
and blue. The subject’s task is to place them one by one under four stimulus cards (one red
triangle, two green stars, three yellow crosses, or four blue circles) according to a matching
principle that the subject must deduce from the pattern of the administrator’s responses to the
patient’s placement of item cards under the four stimulus cards. The subject is not provided with
any initial information about the assessment and just begins by placing cards and the
administrator states whether the placement is correct or not. After a series of ten correct
placements in a row, the examiner shifts the matching principle, indicating the shift to the subject
only by the altered pattern in correct and incorrect item card placements. The matching principle
starts with color, shifts to form, and then to number. The matching principles are then repeated for
a maximum total of six principles. The test is discontinued after placement of 128 cards or six
successful series of cards. Versions of the WCST are available which involve computer
administration. The reliabilities of this procedure are comparable to the card administration. The
WCST measures higher cognitive functioning, specifically concept formation and reasoning
abilities. Satisfactory interrater reliabilities have been reported for the WCST; however, reliability
coefficients are not available since success on the test depends upon discovery of the set
principle and once determined most subjects are unlikely to exhibit impaired performance on
future administrations of the WCST (Heaton, 1981; Lezak, 1995).
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Specific scores provided by the WCST can be evaluated in order to better understand the
individual’s performance on the test. A Failure to Maintain Set occurs when the individual achieves
five or more consecutive correct responses and then makes an error before eventually completing
ten consecutive correct responses for that category. A Perseverative Error occurs after the
individual has obtained ten consecutive correct responses and the examiner then changes the
sorting principle without informing the individual, yet the individual continues to match on the
previous sorting principle and does not incorporate feedback that these responses are now
incorrect and instead persists with the previous sorting principle. The Number of Categories
Completed refers to the number of categories (sequences often consecutive correct responses)
that the individual successfully completed during the test. This value can range from zero to a total
of six categories.
The California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987) is a
measure of immediate word list recall. The administrator reads a list (A) of 16 words at the rate of
one word per second. The subject is then asked to recall as many words from the list as possible
while the administrator writes down the words recalled in the exact order as the subject says
them, including repetitions and intrusions. This is repeated for a total of five trials. The
administrator then reads a second word list (B), and writes down in exact order the subject’s recall
of the words, again including any repetitions and intrusions. After this trial, the administrator
returns to the first list (A), and records the number of words recalled by the subject in a “free
recall” condition. Each of the words on List A belongs to one of four categories of shopping items,
those being clothing, fruits, spices and herbs, and tools. Each of the words on List B also belongs
to one of four categories, namely fish, kitchen equipment, fruits, and spices and herbs (the latter
two which are categories that are also included on List A, but involve completely different words).
After the free recall condition, the subject completes a “cued recall” condition, in which they are
asked to recall items from each of the four individual categories. A 20-minute delay is imposed,
and list A is again recalled by the subject, under both free and cued conditions. A recognition trial
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is included at the end of the test as 44 items are presented orally and the subject is required to
identify whether each item was included on List A. All 16 items from List A are part of the
recognition trial, in addition to 8 from List B. Additional non-list items come from several sources,
including one of the four List A categories, phonetic resemblance to List A items, or other common
shopping items.
It is assumed that the CVLT measures not only verbal memory, but also its interaction
with conceptual ability. Test results provide information about use of learning strategies and the
effectiveness of those strategies. Reliability of the CVLT has been studied and found to be quite
good, with split-half reliability correlation coefficients between .77 and .86 (Delis, Kramer, Fridlund,
& Kaplan, 1990).
The Wechsler Adult Intelligence Scale - Third Edition (WAIS-III; Wechsler, 1997) is a
measure for assessing the general mental or intellectual ability of an individual. It is described as
helpful in the differential diagnosis of various neurological and psychiatric disorders that affect
mental functioning. Determining scores for the WAIS-III involves comparing the examinee's
performance to that of individuals of similar age. This is done to control for the differences in
performance across age groups and to assure that the results obtained are meaningful based
upon age-appropriate comparisons. Subtests from the WAIS-III that were used in the present
study were the Vocabulary, Digit Symbol, Block Design, and Digit Span.
The Vocabulary subtest is a task in which the subject is verbally and visually presented
with a series of words that must be defined orally. The test administrator records verbatim the
subject's response and scores the response based upon specific scoring guidelines. Scores of
two, one, or zero are assigned based upon the quality of the definition provided by the subject. All
word meanings recognized by standard dictionaries or otherwise show good understanding of the
word are assigned two points. Responses that are not incorrect but show a poverty of content are
assigned a score of one. Responses that are clearly incorrect are assigned a score of zero. If a
subject’s response if too vague or unclear to score easily, a neutral inquiry is made to determine if
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a superior response can be elicited. Only one query is allowed per word. The test continues until
the subject has defined all of the words included in the test (a total of 33) or until six responses in
a row are scored zero. The Vocabulary subtest is considered to be an excellent measure of
general mental ability and intellectual capacity. Split-half reliability coefficients are extremely high,
ranging from .90 to .95 across age groups, with the average across groups being .93. Test-retest
reliability for the Vocabulary subtest was excellent, with a reliability coefficient of .91. Interrater
reliability was very high, with a coefficient of .95 (Psychological Corporation, 1997).
The Digit Symbol-Coding subtest is a task of symbol substitution that consists of 133 split
squares with a randomly assigned number from one to nine in the upper half of the square. A key
is provided that pairs each number with a different nonsense symbol. The subject is to fill in the
blank half of each square with the symbol that corresponds to number in the upper half of the
square. The subject is to complete as many squares as possible in a 2-minute period. Incidental
memory, a measure of the subject’s ability to recall the nonsense symbols from memory without
prior knowledge that this will be requested, can be assessed by several optional procedures of the
Digit Symbol subtest as well. Incidental Learning-Pairing is an assessment of the subject’s ability
to recall the nonsense symbols and match them to the correct numbers from memory. The subject
is presented with two rows of nine split squares with each of the numbers one through nine in
random order to which the subject is requested to provide the appropriate nonsense symbol.
Incidental Learning-Free Recall is an assessment of the subject’s ability to recall the nonsense
symbols independent of the matching number. The subject is presented with a blank page and is
requested to recall as many of the nonsense symbols as possible, without needing to match them
to numbers. If these procedures are to be administered, the subject is allowed additional time, if
needed, to complete a total of four rows during the Digit Symbol-Coding portion of the subtest.
These optional procedures assist the administrator is determining what abilities (i.e., memory
retention) may be deficient if the subject obtains a low score on the Digit Symbol-Coding task. The
Digit Symbol subtest is a measure of complex attention and is considered to be one of the most
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sensitive of neurocognitive tests to brain damage (Lezak, 1995). Test-retest reliability is very
good, with correlation coefficients ranging from .81 to .87 across age groups, with the average
across groups being .84 (Psychological Corporation, 1997) for most individuals, but as low as .38
for persons with schizophrenia (Lezak, 1995).
The Block Design subtest is a task in which the subject is presented with blocks which are
to be used in the construction of a variety of designs ranging in difficulty and number of blocks
needed (two, four, or nine). Each block has two red sides, two white sides, and two half-red and
half-white sides divided along the diagonal. The designs to be replicated are either put together by
the test administrator in a model to be duplicated by the subject or printed in smaller scale on
cards that are presented to the subject. The Block Design subtest is a measure of general mental
ability, and specifically assess visuospatial organization. Split-half reliability coefficients ranged
from .79 to .90 across age groups in the standardization population, with the average across
groups being .86. The test-retest reliability coefficient of .82 is very good for this subtest as well
(Psychological Corporation, 1997).
The Digit Span subtest is composed of two different tasks, Digits Forward and Digits
Backward. Digits Forward involves eight pairs of random number sequences of varying length that
the administrator reads aloud at the rate of one per second. Digits Backward involves seven pairs
of number sequences. In Digits Forward, the sequence ranges from two to nine digits, and the
subject repeats the numbers back to the administrator in the same order as they were presented.
In Digits Backward, the sequence ranges from two to eight digits, and the subject repeats the
numbers back in the opposite order as they were presented. The Digit Span subtest is a measure
of attention, specifically for span of immediate verbal recall. Split-half reliabilities ranged from .87
to .93 across age groups, with the average across the groups being .90. The stability of this
subtest over time is quite high, with a test-retest coefficient of .83 (Psychological Corporation,
1997).
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Procedures
Recruitment. Relevant staff at each recruitment site were requested to provide information
regarding potential subjects who could be contacted and requested to participate in the study.
This process generally involved discussing with each clinician their patient case load and
determining which patients were appropriate and stable enough for participation. In some cases,
the clinician discussed possible participation with individual patients before their names were
released to study staff. Patients were then contacted either by telephone or approached after an
appointment at the VA Medical Center. They were provided a standardized verbal description of
the study (See Appendix 0 ) to determine their interest in participating. If interested, they answered
various demographic questions (See Appendix E) and scheduled to participate.
For outreach programs, recruitment information was posted at each site or included in
newsletters, and interested participants were encouraged to contact research staff. For these
potential participants, a more extensive telephone screening process (See Appendix F) was
employed to assure criteria was met for inclusion in the research project. Those who met criteria
and were interested in participating answered the same demographics questions and were
scheduled for appointments.
Those patients who agreed to participate were asked to provide written consent after
reading through a detailed consent form, having an opportunity to ask any questions, and
answering several questions about their participation to assess for understanding of the study
(Appendix G). Each participant was provided with a copy of their signed consent form.
Risks to the participants and negative effects of the research were minimized through a
number of procedures. The informed consent and release of information documents allowed the
participants to have complete information and accurate expectations regarding their participation
so that they were able to make an informed decision whether or not to participate. Participants
were provided with general information about their ongoing participation and the procedures they
were completing. In addition, participants were encouraged to ask questions and identify any
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distress or discomfort that they were experiencing. It was explained to all participants that they
could terminate their participation at any time. All assessment results and other information about
the participants were identified using only a code number rather than by name or other identifying
information. A master list matching each participant code number with the name of the subject
was kept separately by the project coordinator in a secure location. All research personnel were
required to complete training on issues related to confidentiality and research procedures.
A variety of additional measures were collected as part of a larger study, however this
report will focus on the variables of symptomatology, language production, quality of life, social
adjustment, and neurocognitive functioning.
Initial procedures. Once individuals agreed to participate in the research study, a
comprehensive review of the medical record was completed, using the previously described chart
review form. In addition to gathering the information on the chart review form, copies of various
reports and current progress notes were obtained. This was to provide additional information
about symptomatology during psychotic episodes and descriptions of current functioning and
presentation. Medical records for patients at the Minneapolis VA Medical Center were reviewed as
part of their participation. Subjects recruited from other sites were asked to sign release of
information forms (See Appendix H) in order to obtain relevant psychiatric information from prior
hospitalizations and other service providers. These forms were standard Release of Information
forms used throughout the Department of Veteran’s Affairs.
Daily oral doses and depot doses of antipsychotic medications were converted to
chlorpromazine equivalents according to guidelines suggested by Bezchlibnyk-Butler and Jeffries
(2001). This process involved applying the “apparent clinical equivalence in schizophrenia” (pp
89-91) for a specific dose of a given medication and converting it to an equivalent dosage of
chlorpromazine. This is accomplished by dividing the individual’s medication dosage by the listed
apparent clinical equivalence and then multiplying this by 100 (the clinical equivalence of
chlorpromazine) to obtain the chlorpromazine equivalence for the given medication and dosage.
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Medications were broken down into two classes, novel agents and conventional agents. See
Table 1 for a description of the medications prescribed to study participants, average daily
dosage, class of medication, and the assigned chlorpromazine equivalence for each.
Training and reliability for clinical assessments. Clinicians for this study went through
extensive training for the DIGS, BPRS, and GAF. Initially, all clinicians met as a group to review
and become familiar with the DIGS. Any questions that arose were addressed to the developers
of the interview and the responses were discussed among the clinicians and descriptive or
explanatory notes were added to the body of the interview. Videotapes containing clinical
interviews produced by the creators of the BPRS were reviewed and rated by each clinician.
These ratings were then compared to “gold standard” ratings provided with the videos. After
training, reliability coefficients for the BPRS training interviews were found to range from .92 to .97
across the different clinicians. The clinicians then alternated administering the DIGS to volunteer
psychiatric patients from the Minneapolis VAMC with the other clinicians present and following
along while independently rating the DIGS. These interviews were video taped for future
reference. After the completion of the interview, the group of clinicians discussed their ratings for
the DIGS and any significant deviations were explored and a “gold standard” for the interview was
generated. In addition, the BPRS and the GAF were also rated. After the completion of each
interview, the clinicians discussed their ratings for the BPRS and the GAF, and a “gold standard”
for each according to our research group was developed. Reliability coefficients were found to
range between .87 and .92 on the BPRS, and all ratings were within five points on the GAF, a
standard developed by this research group. No specific reliability coefficients were calculated for
the DIGS, as it was deemed more important to be reliable with ratings on the BPRS and GAF than
on individual items on the DIGS.
Training on the QOLI included instructing interviewers to present questions to participants
in a standardized format without bias. Reliability on the QOLI tends not to be undertaken, as the
interviewer records only what ratings the participant provides (Lehman, 1983).
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Clinical assessments. All participants were administered the DIGS by a trained clinician,
who also rated the individual on the BPRS and the GAF. The interviewing clinician used available
chart review information, as release of information records were not always received in a timely
manner, to inform and guide their interview with the patient. A reliability assessment was
completed after each interview to assess the overall credibility of the data provided by the patient
and to identify any sections of the interview that may contain information of a jumbled or
inconsistent nature. The SAS-II and the QOLI were administered by a trained research staff.
Again, after each interview, a reliability assessment was completed by the rater to assess the
overall quality of the data provided by the participant and to identify any sections of the interviews,
which may have contained information of a jumbled or inconsistent nature. These interviews were
generally administered on one day as part of a longer session that included additional interviews
for the larger research study.
Once the DIGS was completed with the participant, the interviewing clinician rated the
questions needed to score the OPCRIT. The item responses were next entered into the OPCRIT
program that then provided a diagnosis based upon the algorithmic scoring program. Although
diagnoses that correspond to a variety of different diagnostic systems are provided, DSM-IV
(1994) diagnoses were used for the purposes of this study.
After diagnosis had been established by the interviewing clinician and any additional
information relevant to the participant's psychiatric history had been received, a second
“diagnostic” clinician also reviewed all the available information and independently rated the
OPCRIT. This diagnostic clinician was blind to the interviewing clinician's OPCRIT diagnosis. For
all cases where there was agreement, this was the accepted diagnosis. For situations in which the
two clinicians did not obtain the same diagnosis, they met for a “consensus meeting” in which
items were compared and discussed so that a consensus diagnosis could be established. This
consensus diagnosis was then used as the final diagnosis for the individual.
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As previously noted, symptomatology was rated by the BPRS, and the four factors as
identified by Ventura et al. (2000) through a principal components analysis were examined. A total
score was calculated by summing the ratings from all 24 of the items. The four BPRS symptom
factors were Positive Symptoms, Negative Symptoms, Manic-Excitement, and DepressionAnxiety. The Positive Symptom scale included items of suspiciousness, hallucinations, unusual
thought content, bizarre behavior, and disorientation. The Negative Symptom scale included items
of self-neglect, blunted affect, emotional withdrawal, and motor retardation. The Manic-Excitement
scale included hostility, elevated mood, grandiosity, excitement, distractibility, and motor
hyperactivity. The Depression-Anxiety scale included anxiety, depressed mood, suicidality, and
guilt feelings. The other five items on the BPRS (somatic concern, conceptual disorganization,
tension, uncooperativeness, and mannerisms/posturing) did not load onto any of these factors. A
score for each of the four scales was calculated by taking the mean of the individual items that
loaded on the factor.
Neurocognitive assessment. The neurocognitive assessment was completed by trained
research staff on a different day than the clinical interviews, usually within a few days, but always
within a two week time period. All measures were administered according to established standard
procedures. The administration order of the tests varied across participants due to the fact that
this study was part of a larger project in which the tests were not administered in a fixed order and
other procedures were also completed during the testing session. Participants were also allowed
breaks when requested or when it appeared to the tester that the participant was fatigued.
Behavioral observations were made of each assessment to identify any procedures that may not
have reflected accurate performance by the subject. All measures were scored based upon
standardized norms provided with the tests, unless otherwise specified above.
Impairment index. Impairment scores for the neurocognitive test scores were calculated
by identifying each of the test scores as impaired if it was more than one standard deviation below
the mean of the published norm. One standard deviation below the mean is equivalent to a
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percentile score of less than 16%, a T score under 40, or lower than an age-scaled score of 7.
This level was selected to assure that even more subtle incidences of impaired performance for
these individuals were identified. The practice of determining “impairment” as below one standard
deviation is quite common in the field and is recommended by experienced clinicians (Heaton,
Grant & Matthews, 1991). According to these authors, using a cut-off of one standard deviation
results in a false positive rate of up to about 15%, an acceptable level of specificity. An
Impairment Index score for each participant was calculated by summing the total number of test
scores that fell below the cutoff of one standard deviation and dividing this by the total number of
test scores that were obtained from the participant. Thus a frequency score was obtained, rather
than an absolute score. This means of generating the Impairment Index was established to
accurately reflect level of overall impairment when participants were missing scores on one or
more tests. The Impairment Index is a global measure of the overall neurocognitive impairment as
exhibited by the participant.
Neurocognitive domain summary scores. Domain summary scores for the neurocognitive
test results were calculated in two different ways, depending on the type of analysis that was to be
completed. For analyses involving correlations, raw scores on each test were converted to z
scores (resulting in a mean of 0 and a standard deviation of 1) and averaged across the
measures included in the domain. For analyses involving within subject comparisons across
domains, appropriately-corrected (for age, gender, and education when available) scores were
converted to percentiles and averaged across the measures included in the domain. General
Mental Ability was comprised of the Vocabulary and Block Design subtests of the WAIS-III. The
Attention summary score was made up of the Digit Span subtest of the WAIS-III and Trail Making
Test part A. The Verbal Fluency domain reflected the COWAT score. Verbal Memory included
scores from the CVLT, specifically total score, first presentation recall, fifth presentation recall,
short delay recall, long delay recall, and recognition. The domain of Higher Cognitive Ability was
comprised of the Perseverative Errors, Failure to Maintain Set, and Categories Completed scores
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on the WCST, and the Trail Making Test, part B, for the domain scores that averaged z-scores.
For the domain score that averaged percentiles, the scores of Failure to Maintain Set and
Categories Completed were not included because these two scores are not assigned discrete
percentile scores, but rather performance is reported as a percentile range (i.e., < 1%, 2-5%, 610%, 11-16%, or >16%). Scores in this format could not be included in the average performance
score for the Higher Cognitive Ability domain.
Speech samples and communication disturbance ratings. A ten-minute speech sample
was also obtained during the testing session. The participant was described the speech sample
procedure and then signed an audio taping consent form (See Appendix I). All speech samples
were identified only by subject number without any other personal information. Participants were
instructed to discuss neutral topics of their choice, such as their daily activities, and were provided
with additional topics for discussion as needed to complete the ten minutes. In addition,
participants were asked not to provide any identifying information and avoid discussing their
mental illness during the collection of the speech sample.
Each speech sample was transcribed by one of several trained research assistants.
Training initially included an explanation of the interview procedure and instructions on how to
transcribe verbatim the person’s speech. Several practice cases (either real cases from the study
or “artificial” sample cases) were transcribed and discussed with the research assistant.
Throughout the transcription phase of the study, research assistants were encouraged to discuss
with the primary researcher and other transcriptionists any difficulties they may have encountered
and questions they had regarding their tapes. The accuracy of the transcriptions were assessed
by a different research assistant who again listened to the speech sample and made any changes
or additions to the transcript to assure the accurate reflection of all of the content of the
participant’s speech sample.
Speech sample ratings using the CDI were made by trained research assistants. Training
materials were provided to this research group by the author of the CDI who indicated that
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achieving reliability within our research group should be the primary objective for the training, with
a secondary goal of establishing CDI levels close to those of her group’s published research. In
addition, the author made herself available for consultation regarding use of the CDI and accurate
rating procedures. Training was composed of several different components recommended by the
author of the measure. The first stage involved didactic presentations on the CDI and the six
subtypes of unclear references. The second stage involved reviewing practice speech samples
and making ratings as a group. The third stage involved research assistants making independent
ratings on speech samples. The fourth stage involved group comparisons of the independent
ratings and discussions of any differences.
As previously noted, the author of the CDI recommended that we strive to achieve similar
means for ratings as those in her published articles. This was attempted and our means were
found to be fairly similar to those of the Docherty group (Docherty et al., 1996; Docherty, Hall, et
al., 1998; Docherty, et al., 1999; Docherty & Gottesman, 2000; Docherty et al., 2000; Gordinier &
Docherty, 2001), although our participants exhibited somewhat more Vague References and
slightly fewer Structural Unclarities than found in those previous studies.
Once training was completed, research assistants were assigned a randomly selected
16% of the speech samples from the present study to rate independently. Interrater reliabilities for
each of the six types of disturbance and total communication disturbance, reported by intraclass
correlation coefficients, are reported in Table 2. Overall, adequate reliability was achieved,
especially for Total Communication Disturbances, although less agreement was established for
Confused References and Wrong Word References. Cicchetti and Sparrow (1981) have
established guidelines for interpreting interrater reliability coefficients. They indicate that less than
.40 is “poor," that .40 to .59 is “fair,” .60 to .74 is “good,” and greater than .75 is “excellent.” Based
on these guidelines, the interrater reliability across the three raters in this study was found to be
fair for Confused References, good for Wrong Word References, and excellent for the remaining
scales.
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Scores for each of the six CDI unclear references were calculated as instances of the
specific disturbance per every hundred words of speech. Total CDI ratings were calculated as
instances of the total sum of all six unclarities per every hundred words of speech.
Data entry. Data entry was completed primarily by research assistants. Measures such as
the BPRS and GAF were filled out on scannable forms. These forms were scanned and double
checked for accuracy using the TELEform scanning system. Other measures were hand-entered
onto templates corresponding to the data collection sheets through the File Maker Pro 4.0
program. These measures were then double-checked for accuracy by a different research
assistant. Both the TELEform and File Maker Pro programs allow exportation of the data to other
programs in a spreadsheet format.
Power Analysis
A power analysis was completed in order to determine sample size needed to detect
significant correlations between variables. As most of the hypotheses specified directionality for
correlations, determination of significance for one-tailed tests was completed. An analysis using
the nQuery Advisor 3.0 program setting alpha to .05 and requiring the power to be at least .67 to
detect a correlation of .3 was found to require at least 46 subjects. A sample size of 55 was used
for the present study. An additional analysis determined that when the sample size is 55 and
alpha is set to .05 for a one-tailed test, a normally distributed covariate would have 74% power to
detect a correlation of .03.
Statistical Analyses
Frequency statistics were calculated for the demographic and clinical variables of gender,
race, diagnosis, recruitment source, marital status, current living arrangements, employment
status, income level, current medications, and current therapy. Descriptive statistics were
calculated for the demographic and clinical variables of age, years of education, GAF scores, age
at onset of symptoms, age at first hospitalization, number of previous hospitalizations, and
chlorpromazine equivalents for medications.
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To evaluate the effects of selected demographic and clinical variables on the constructs
on interest in the study, a multivariate analysis of variance (MANOVA) was completed with each
factor variable of gender (male/female), race (Caucasian/other), marital status (mamed/other),
work status (working at least part-time/no work), and living arrangements (living with others/living
alone). A separate MANOVA was completed for each of the previously factors on each of the
following dependent variables which were grouped into theoretically meaningful constructs, such
as satisfaction (subjective) ratings on the QOLI, objective scales on the QOLI, SAS global ratings,
BPRS and GAF scores, and neurocognitive measures. If any of the dependent variable groupings
were found to be significantly related to the factor variable (based upon Wilks’ Lambda), a test of
between-subjects effects was completed to determine which of the dependent variables
contributed to the significance. This procedure allowed fewer comparisons to be made initially,
which was deemed appropriate based on the number of comparisons being made as part of this
study. For those comparisons that were significant, the results from both the original multivariate
test and then the follow-up between-subjects tests are reported. For analyses involving Pearson
product moment correlations, no specific correction for multiple comparisons was applied,
however, as the number of comparisons was quite large, caution should be taken when
considering the results.
In addition, specific analyses for each of the hypotheses were as follows:
1. Pearson product-moment correlation coefficients were used to determine the
correlations between overall symptom presentation and the measures of quality of life and
neurocognitive functioning (using z scores that had been converted from raw scores).
2. Pearson product-moment correlation coefficients were used to determine the
correlation between overall symptom presentation and communication disturbances.
3. Pearson product-moment correlation coefficients (compared using Fisher’s z
transformation) were used to determine the correlations between both negative and positive
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symptoms and each of the measures of quality of life and neurocognitive functioning (using z
scores that had been converted from raw scores).
4. Pearson product-moment correlation coefficients were used to determine the
correlations between quality of life (subjective) and measures of verbal memory, attention, and
higher cognitive functioning within the domain of neurocognitive abilities. Domain scores were
calculated from averages of z scores (that were converted from raw scores) for each measure
included in the domain.
5. A paired sample f-test was used to compare the numbers of ambiguous word meanings
with the other types of unclear references, and then again to compare missing information
references with the remaining four unclear references, within the area of communication
disturbances.
6. Pearson product-moment correlation coefficients were used to determine the
correlations between communication disturbances (unclear references) and performance in the
specific neurocognitive domains of memory, attention, and verbal fluency. Domain scores were
calculated from averages of z scores (that were converted from raw scores) for each measure
included in the domain.
7. Paired samples f-tests were used to determine the relationships between areas of
verbal memory, word fluency, attention, and higher cognitive functioning and the other domain of
neurocognitive functioning (general mental ability) using domain scores that were calculated from
averages of percentile scores for each measure included in the domain.
8. Multiple regression was used to predict individual scores on the QOLI from the other
variables of the study.
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Results
The results will be presented in several steps. General findings for each of the measures
used in the study will be described. Then individual hypotheses (identified by number and a brief
description) will be reported. At the end of the results section, each hypothesis is listed and a
notation is provided to indicate whether each was completely or partially confirmed, or went
unsupported.
Demographic and Clinical Characteristics of Participants
Tables 3 and 4 describe the relevant demographic characteristics of the participants in
this study. The average age of participants was about 47 years (ranging from 24 to 59), and
85.5% of the participants were male. The ethnic/racial distribution of the participants was 87.3%
Caucasian, and the remaining 12.7% African-American, Native American, Asian, or Hispanic.
Educational levels for the participants averaged 14 years (ranging from 8 to 19), and about 42% of
the participants were currently employed in some capacity or attending school. Annual income for
study participants averaged between $10,000 and $20,000. In terms of marital status, only 18%
were married, the remaining 82% were single (never married, or separated, divorced, or
widowed). Forty-two percent of the patients were involved in some shared living arrangements
(either partner/spouse, other family member or roommate), 9% lived in a residential treatment
facility, and the remaining 49% lived alone.
Tables 3 and 4 also show selected clinical characteristics of the participants. These tables
indicate that participants experienced persistent mental illness evidenced by early age of onset,
duration of illness, and number of hospitalizations. Schizophrenia was the diagnosis of 45
participants, and the other 10 were diagnosed with Schizoaffective Disorder. The average age for
onset of psychiatric symptoms was between 23 and 24 years old (ranging from 13 to 47), and
average age for first hospitalization was between 25 and 26 years old (ranging from 13 to 50), for
the 53 participants who had been previously hospitalized. The average age of the 53 previously
hospitalized participants did not differ from that of the entire sample. Status of chronic mental
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illness was also revealed by an average of more than six psychiatric hospitalizations per patient
(ranging from 0 to 32) and average current Global Assessment of Functioning (GAF) score of
48.07 (ranging from 25 to 68). This average GAF score corresponds to a rating of “Any serious
symptomatology or impairment in functioning that most clinicians would think obviously requires
treatment or attention.” Current treatment included medication focused (96.4% of participants),
therapy or supportive counseling (34.4%), group therapy (21.8%), and other treatment (9.1 %)
such as case management. Numerous participants were involved in multiple forms of treatment;
thus percentages total greater than 100%.
Current medications of the study participants were as follows; 54.5% were prescribed
antidepressants, 29.1% mood stabilizers, and 27.3% antiparkinsonians. Of the participants, 96.4%
were currently prescribed at least one antipsychotic medication, with an average chlorpromazine
equivalence of 416.5 mg/day (ranging from 16.6 to 1825 mg/day). Novel antipsychotics only were
prescribed to 69.1% of the sample, averaging 323.9 chlorpromazine equivalents per day while the
other 27.3% were receiving conventional antipsychotics, with an average chlorpromazine
equivalence of 500 mg/day. See Table 1 for a description of medications that are included in each
of the novel and conventional categories and average daily dosages for study participants. Steps
taken to calculate these equivalents are presented in the Initial Procedures portion of the
Procedures section of the paper. Of those receiving conventional antipsychotic medications, six
individuals were prescribed an additional chlorpromazine equivalence of 400 mg/day of novel
antipsychotics. Antipsychotic medication level, as measured by total chlorpromazine equivalence,
was not correlated with any other demographic variable other than with age (r = -.363, p = .01).
These results indicate that the older participants tended to be prescribed lower dosages of
antipsychotic medications.
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Symptom Presentation
Additional clinical characteristics involving psychopathology, measured by the Brief
Psychiatric Rating Scale (BPRS), are described in Table 5. The BPRS factor scores revealed that
these patients with schizophrenia exhibited very mild to mild positive symptoms (Mean = 2.37,
SD = .96), very mild negative symptoms (1.95, SD = .83), none to very mild manic-excitement
symptoms (1.54, SD = .77), very mild depression-anxiety symptoms (1.80, SD = .85), and very
mild average overall symptoms (1.83, SD = .53).
Correlations of symptom presentation and demographic and clinical variables. After
completing multivariate and correlational analyses, it was found that none of the demographic
variables of age, gender, race, chlorpromazine equivalents for medications, marital status, years
of education, and current living arrangements, were correlated with any scale from the BPRS or
the GAF. Only current employment status was related to this group of scores, F (6 ,4 8 ) = 3.60,
p = .005, specifically BPRS Total Score, F (1 , 53) = 9.59, p = .003, the BPRS Positive Symptom
scale, F (1, 53) = 7.77, p = .007, the BPRS Negative Symptom scale, F (1, 53) = 6.23, p = .016,
and the GAF, F (1,53) = 22.05, p < .001. These results indicate that individuals who are currently
employed at least half-time experience significantly fewer total, positive, and negative symptoms,
and exhibit better overall functioning.
Quality of Life
Results of Quality of Life Interview (QOLI) Scales. Clinical characteristics involving quality
of life as measured by the QOLI are described in Table 6. When considering objective ratings of
Quality of Life, the QOLI scores indicated that on average these individuals engaged in at least
four activities outside the home during the past week (out of a possible total of 8 activities). In
addition, they generally had contact with other people in social situations and had contact with
family members at least once per month during the past year. The participants generally did have
sufficient funds to cover basic expenses in the past year, and on the average had $276
(reportedly ranging from $0 to $2500) per month to spend on themselves. Of these persons with
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schizophrenia, 30 (54.5%) were currently working or had worked in the past year, while the
remainder had not worked at all in the past year. In regards to legal and safety issues, 4 (7.3%) of
the participants reported that they had been the victim of a violent crime (e.g., assault, mugging)
in the past year, 12 (21.8%) had been the victim of a nonviolent crime (e.g., theft, being cheated)
in the past year, and 4 (7.2%) indicated that they had been arrested at least once during the past
year.
When considering subjective ratings of Quality of Life, all means for the participants in this
study are at least slightly above the midpoint of the scale. These individuals reported feeling
mixed to mostly satisfied with their general life circumstances. The participants also reported
feeling mixed to mostly satisfied with their daily activities, family relations, social relations, overall
finances, and health. In addition, they indicated feeling mostly satisfied with their living situations.
Finally, the study participants indicated they were mostly satisfied to pleased with their legal/safety
circumstances and employment, at least for those currently working.
Correlations of QOLI scales with demographic and clinical variables. After completing
multivariate and correlational tests, it was found that none of the demographic variables of age,
gender, chlorpromazine equivalents for medications, marital status, employment status, and years
of education, was correlated with any objective scales from the QOLI. Race was related to this
group of scores, F (5 ,49 ) = 2.90, p = .023, specifically to number of daily activities, F (1, 53) =
4.43, p = .040, and number of family contacts, F (1 , 53) = 4.12, p = .047. These results indicate
that the Caucasian participants tended to engage in more activities outside of the home and had
more contact with their family members. Age was found to be negatively correlated with money
available to spend on self (r = -.274, p < .05) and years of education was found to be negatively
correlated with number of contacts with family members (r= -.317, p < .05). These results indicate
that older participants tended to have less discretionary funds and those who had more years of
education tended to have less contact with their family members.
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Correlations between QOLI global life satisfaction and other QOLI scales. One significant
correlation was observed between the Global Life Satisfaction rating and the objective scales on
the QOLI. Having more social contacts on a regular basis related to a greater overall life
satisfaction (r = .340, p < .01). Subjective scales on the QOLI were found to correlate more
strongly with Global Life Satisfaction than the objective scales. Table 7 shows that the highest
correlations (p < .01) to Global Life Satisfaction were in the areas of satisfaction with daily
activities (r = .627), health (r= .582), finances (r= .508), living situation (r= .438), and social
relations (r = .349). Other areas that were also related (p < .05) to the Global Life Satisfaction
rating were satisfaction with family relations (r = .272), and legal and safety (r= .258). These
results indicate that for these participants, greater satisfaction in these specific areas of their lives
is associated with increased in satisfaction in their overall life situation.
Social Adjustment
Results of Social Adjustment Scale - II (SAS-II) ratings. Clinical characteristics involving
social adjustment and functioning as measured by the SAS-II are presented in Table 8. Ratings
were made on a scale of 0 = excellent adjustment, to 6 = severe maladjustment. Global ratings
revealed that the participating individuals exhibited a mostly poor (Mean = 3.74, SO = 1.68)
adjustment to their work role, whether it was employment, household responsibilities, or
educational activities. For those subjects who were living with other people (n = 28), there was
evidence of mainly good (2.18, SD = 1.09) adjustment with regard to the mutual relationship with
the other primary person in their household. Participants also reported mostly fair (2.78,
SD = 1.31) adjustment in their relationships with family members outside of the household. Social
leisure adjustment was found to be mostly fair (3.22, SD = 1.06) when considering outside
activities and interactions with others. General adjustment was determined to be mostly fair (3.11,
SD = .79) for these individuals.
Correlations of SAS-II ratings with demographic and clinical variables. After completing
multivariate and correlational tests, it was found that none of the demographic variables of age,
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race, chlorpromazine equivalents for medications, marital status, and years of education, were
correlated with any global ratings from the SAS. The relationship between household member
global rating and current living arrangement (alone or with someone else) was not specifically
analyzed as this item is only rated for those who are not living alone. Gender was related to this
group of scores, F (4,49) = 3.19, p = .021, specifically to the ratings of relationships with
household member, F (1,25) = 4.82, p = .038, and external family, F (1, 52) = 7.35, p = .009.
These results indicate that females tend to have poorer adjustment in their relationships with the
people who they live with and their extended families. Current employment status was also related
to this group of scores, F (4,49) = 4.61, p = .003, specifically the ratings for work and daily
responsibilities, F (1, 52) = 18.97, p < .001, and global adjustment, F (1, 52) = 7.75, p = .007.
These results indicate that individuals who are working at least part-time have better adjustment in
engaging in their daily responsibilities and with their overall social functioning.
Correlations of SAS-II ratings with symptom presentation. After completing correlational
analyses, several social adjustment global ratings were found to be significantly correlated with
overall symptom presentation as measured by the BPRS. These areas were relationship with
external family (r= .315, p = .01), social leisure activities (r= .377, p < .01), and general social
adjustment (r = .413, p = .001). These results indicate that as participants were rated as more
impaired in their social interactions with external family members, pursuit of social leisure
activities, and general social interactions, they also experienced higher levels of current
symptomatology.
Correlations of SAS-II ratings with neurocognitive functioning. After completing
correlational analyses, several neurocognitive domains were found to be significantly related to
several of the social adjustment global ratings. The neurocognitive domain of Verbal Memory was
correlated with social adjustment in work and daily responsibilities (r= -.439, p < .001) and
general adjustment (r= -.258, p < .05). The domain of Attention was correlated with adjustment in
social and leisure activities (r = -.287, p < .05), while General Mental ability was correlated with
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adjustment with primary household member (r = -.391, p < .05). These correlations are actually in
the positive direction, as lower scores on the SAS-II indicate better social adjustment. These
results indicate that participants who perform better on abilities of verbal memory also experience
better adjustment at work and completing daily activities, as well as in their overall social
interactions. Also, as these persons with schizophrenia experience higher levels of attentional
skills, they also pursued more social and leisure activities. Lastly, participants with stronger
abilities of general mental ability tended to have more positive interactions with their primary
household member.
Communication Disturbances Index (CDI) Scores
Amounts of speech gathered during the collection of the speech sample varied across
participants; overall they produced a mean of 1222.2 (SO = 371.9) words, ranging from 453 to
2230 words. Means and standard deviations for each of the communication disturbances are
presented in Table 9. The Total Communication Disturbance score was 2.88 (SO = 1.24), which
corresponds to number of disturbances per 100 words of speech. These scores are fairly similar
to those previously published by Docherty’s research group (Docherty et al., 1996; Docherty, Hall,
et al., 1998; Docherty, et al., 1999; Docherty & Gottesman, 2000; Docherty et al., 2000; Gordinier
& Docherty, 2001), although it appears that participants in the present study exhibited more
Vague References and fewer Structural Unclarities than those in Docherty's studies. However, the
total number of communication disturbances were found to be in the same range as those
reported by the Docherty group.
Correlations among CDI scores. Correlations were computed among the communication
disturbance variables to assess their co-occurrence within participants. Most of the individual
communication disturbances were significantly correlated with the others at p < .01. These results
are presented in Table 10. Confused References was the only type of disturbance that was not
correlated with the other types of failure, other than with the total CDI score (r = .270, p < .05).
These findings indicate that, for the most part, as patients exhibit frequent communication
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disturbances of one type, they generally exhibit other disturbances as well. This is consistent with
the results reported by Docherty, et al. (1996). In addition, to determine the internal consistency of
the scales on the CDI, a Cronbach’s alpha was calculated and found to be .74, which is generally
considered to be an adequate level of internal consistency.
Correlations of CDI ratings with demographic and clinical variables. After completing
multivariate and correlational analyses, it was found that demographic and clinical variables such
as age, gender, race, chlorpromazine equivalents for medication, years of education, living
situation, employment status, and marital status were not correlated with any of the ratings from
the CDI.
Relationships among Communication Disturbances (Hypothesis 5). A paired samples
f-test was computed to compare the frequency of Ambiguous Word Meanings to the other
communication disturbances. The Ambiguous Word meanings were found to occur much more
frequently than Vague References, t (52) = 6.59, p < .001, Confused References, t (52) = 5.92,
p < .001, Missing Information References, t (52) = 3.53, p = .001, Wrong Word References,
t (52) = 7.84, p < .001, and Structural Unclarities, t (52) = 7.60, p < .001. This is consistent with
results published by the author of the measure (Docherty, et al., 1996).
A second paired samples t-test was computed to compare the frequency of Missing
Information References to the remaining communication disturbances. The Missing Information
References were found to occur more frequency than the remaining four deviances, Vague
References, t (52) = 3.21, p = .002, Confused References, t (52) = 3.88, p < .001, Wrong Word
References, t (52) = 5.25, p < .001, and Structural Unclarities, t (52) = 4.93, p < .001. Again, this is
consistent with results published by Docherty et al. (1996).
Neurocognitive Performance
Neurocognitive test performance results will initially be presented according to the
individual measure. Raw scores will be reported and corresponding percentiles will be provided.
These percentiles were calculated after age, gender, and education corrections (when available)
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were applied, after which corresponding percentile scores were determined based upon the
standardized norms provided for each measure. These percentile scores are based upon the
assumption that the scores across populations are normally distributed. For clarification, Table 11
lists standard scores, age scaled scores, T scores, z scores, and the corresponding percentiles.
Table 12 presents neurocognitive performance for the participants.
WAIS-III subtests. Scores from the Wechsler Adult Intelligence Scale - Third Edition
(W AIS-III) are reported as raw scores and percentile scores that were converted from age scaled
scores. Participants averaged a raw score of 43.6 on the Vocabulary subtest of WAIS-III with
performance at 51%, which is in the average range. This percentile score indicates that the
participants’ average performance was in the 51s1percentile when compared to normative
samples, not that they completed 51 % of the items correctly. Average raw score on the Block
Design subtest was 33.85, with performance at 42%, which is also in the average range.
Participants averaged a raw score of 15.6 on the Digit Span subtest, with performance at 41%,
which is in the average range. Average raw score on the Digit Symbol subtest was 54.78, with the
performance at 24%, which is in the low average range.
When considering incidental learning as measured by the Digit Symbol subtest, these
participants recalled an average of 10.44 items (SD = 4.63) in a paired-to-symbol condition (out of
a possible 18), and 6.56 (SD = 1.38) in a free recall condition (out of a possible 9). Percentiles
were difficult to determine for these scores, as the standard scoring procedures (Wechsler, 1997)
report these values as cumulative percentages associated with given raw scores, which in this
sample range from 1% to >50%. However, the median percentile was determined to be 33.3% for
the paired condition and 25% for the free condition. These median percentiles are both in the
average range of performance.
COWAT. Performance on the Controlled Oral Word Association Test (COWAT) was
found to be 31% (in the average range of performance), with an average of 32.58 (SD = 10.39)
total words produced by participants (ranging from 12 to 58 words). For each of the letters C, F,
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and L, participants produced an average of 11.07 words (SO = 4.38; range 3 - 21), 11.16 words
(SO = 4.09; range 3 - 21), and 11.64 words (SD = 9.84; range 1 - 21), respectively.
Trail Making Test Performance for visual sequencing abilities, as measured by the Trail
Making Test, was found to be 33%, which is in the average range of performance, under a simple
condition (Part A) in which participants are required to connect a series of circles with numbers in
them. The average time to complete this condition was 34.63 seconds (SD = 11.05), with 0.40
errors. Under a condition requiring set shifting (alternating numbers and letters; Part B),
performance was found to be at 32% (also in the average range of performance). The average
time to complete this condition was 94.7 seconds (SD = 41.97) with 0.81 errors.
WCST. Some scores on the Wisconsin Card Sorting Test (W CST) cannot be
standardized to discrete percentiles due to the manner in which results are reported (Heaton, et
al., 1993). The standardized results report the scores for Failure to Maintain Set and Categories
Completed as falling into percentile ranges (i.e., <1%, 2-5%, 6-10%, 11-16%, and >16%), thus an
actual percentile score cannot be determined for the performance. Average raw scores of 1.31
(SD = 1.34) for Failure to Maintain Set, and 4.24 (SD = 1.94) for Categories Completed were
found. For each of these scores, the median percentile range was determined to be >16% and 1116%, respectively. These median percentiles both fell in the low average range of performances.
Raw scores on the remaining variable, Perseverative Errors, were converted into T-scores and
the average corresponding age and education corrected percentile was determined to be 23.35%
(SD = 22.83), a value that falls in the low average range of performance. The average number of
Perseverative Errors was found to be 22.37 (SD = 13.57).
CVLT. Participants recalled a total of 41.27 (SD = 11.67) words on the California Verbal
Learning Test (CVLT). This level of performance averaged 13.8% (percentile score), which was
determined by converting standard scores that had been scaled to T scores (provided by the
standard scoring report) into percentiles. Percentiles for other scores from the CVLT were
converted from z scores that were provided by the scoring report. Participants recalled 5.22
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(SD = 1.65) words on the first presentation and 9.73 (SD = 2.88) by the fifth presentation of the
word list. Performance on the first and fifth word lists fell at 17.34% and 17.75%, respectively,
both of which are in the low average range of performance. These participants produced 8.2
(SD = 3.11) words during the short delay recall condition, and 8.56 (SD = 3.38) words during the
long delay condition. Performance on the short and long delay recall lists fell at 23.28% and
24.74%, respectively, both of which are again in the low average range of performance.
Participants correctly identified 13.4 (SD = 2.71) of the 16 words from the list during the
recognition portion of the task. Performance on the recognition task fell at 30.76%, in the average
range of performance.
Neurocognitive domain scores. Participants’ corrected (for age, gender, and/or education
when available) percentile scores were collapsed into five different areas of functioning within the
neurocognitive domain. Each of the percentile scores for tests that measure abilities of the given
domain area was used to compute an averaged which made up the domain score. Each of the
domain areas and the tests scores that contributed to the domain summary scores were Verbal
Memory (CVLT total, list 1, list 5, short delay, long delay recall scores, and recognition score),
Attention (Digit Span and Trail Making Test, Part A), Verbal Fluency (COWAT total score),
General Intellectual (Vocabulary and Block Design scores), and Higher Cognitive (WCST
Perseverative Error score, Digit Symbol total score, and Trail Making Test, Part B). Performance
in General Intellectual abilities fell at 46.72% (SD = 20.29). Performance for Attention (32.2%,
SD = 18.49), Verbal Fluency (31.46%, SD = 29.1), and Higher Cognitive abilities (29.25%,
SD = 18.08) were similar in score. Performance in Verbal Memory was the lowest, falling at
21.28% (SD = 20.08).
In addition to domain averages calculated using percentile scores, neurocognitive domain
averages were also calculated using z scores converted from raw scores on each of the
measures. These z score converted domain scores were used for a variety of the analyses.
Average scores for these values are not being reported here because the resulting average z
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scores are very small and contain more meaningful information when considering the individual
rather than averaging across a group. For results reported later in this paper, descriptions are
included to indicate whether domain summary scores were calculated using z scores or percentile
scores.
Correlations of neurocognitive domain summary scores with demographic and clinical
variables. After completing multivariate and correlational analyses, it was found that demographic
and clinical variables such as age, gender, race, chlorpromazine equivalents for medication, living
situation, employment status, and marital status were not correlated with any of the summary
scores. The only variable to be associated with the domain summary scores was years of
education, which was found to be related to General Mental abilities (r= .294, p < .05). These
results indicate that participants who had more years of education tended to perform better in the
domain of General Mental abilities.
Relationships among different domains of neurocognitive functioning (Hypothesis 7).
Using summary scores for each of the five domains of neurocognitive functioning (calculated by
averaging percentiles for each of the neurocognitive measures that contributed to the particular
domain), paired samples f-tests were conducted to assess the differences between the domain of
General Mental ability and the other four domains. An analysis of the results revealed that that the
participants performed significantly worse in the areas of Verbal Memory, t (54) = 6.57, p < .001,
Verbal Fluency, t (54) = 3.77, p = .001, Attention, t (54) = 3.46, p < .001, and Higher Cognitive,
t (54) = 8.12, p < .001, than they did in the area of General Mental ability. Participants did not
exhibit a significant difference in their performance on measures within the domain of General
Mental ability as measured by percentile scores on the Vocabulary and Block Design subtests of
the WAIS-III, although there was a trend that participants performed better on the Vocabulary
subtest, t (54) = 1.970, p = .054. The only differences found among the other four domains was
that performance in the domain of Attention was significantly better than both Verbal Memory,
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t (54) = 4.02, p < .001, and Higher Cognitive, t (54) = 3.50, p = .001. In addition, performance in
the domain of Verbal Fluency was found to be better than Verbal Memory, t (54) = 2.14, p < .05.
Pearson product moment correlational analyses were conducted to assess the
relationships among the five domains of neurocognitive functioning. Table 13 describes the
findings. Attention was not significantly related to any of the other four domains, while Verbal
Fluency was positively related to the other three domains of Higher Cognitive (r = .253, p < .05),
General Mental (r = .393, p < .01), and Verbal Memory (r = .287, p < .05). Higher Cognitive was
also positively associated with General Mental (r = .260, p < .05).
Neurocognitive impairment index. Impairment cut-off scores of more than one standard
deviation below the mean are listed in Table 12 for each of the neurocognitive measures along
with the percentage of participants who were found to be impaired on that particular measure.
This cut-off of one standard deviation below the mean is directly equivalent to a T score of 40, a
scaled score of 7, or a percentile score of 16%. Scores used to identify performance as impaired
were age scaled scores for the W AIS-III, standard scores for the CVLT, or percentile scores
corresponding to corrected raw scores (provided by test authors or available in the literature) for
the other measures. Again, refer to Table 11 to see how these various scores are related.
Participants as a group produced mean performance scores that were below average (i.e.,
T = 50, scaled score = 10, or percentile = 50%) on all of the measures administered except for
the Vocabulary subtest of the W AIS-III. The percentage of participants that were identified as
impaired on each measure ranged from 7.3% (n = 4) on the Digit Span subtest of the W AIS-III, to
72.7% (n = 40) on the total CVLT recall score.
Because several subjects were missing one or more individual tests, a percentage of the
total available tests that were impaired was calculated for each participant. Thus a frequency
rather than an absolute score is obtained. The percentage of impaired scores reflects the
Impairment Index for each person. The average Impairment Index across participants was
36.38% (SD = 22.77), which indicates that on average, participants were impaired on more than
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one-third of the tests. This corresponds to an average of 6.55 (SD = 4.10) impaired scores per
subject, which ranged from 0 to 16 impaired scores per participant across the sample.
Relationship Between Quality of Life and Psychiatric Status/Symptom Presentation (Hypotheses
1a and 3a)
Pearson product moment correlational analyses were conducted to assess the
relationships among quality of life scales and symptom presentation. Table 14 presents these
findings. Several mental health symptom ratings were correlated with the QOLI subscales. The
Total Score from the BPRS was significantly related to satisfaction with social interactions
(r = -.349, p < .01). These results indicate that higher levels of psychiatric symptoms over the past
month are associated with less satisfaction with social relations.
A significant relationship with satisfaction with social interactions as measured by the
QOLI was found for both the BPRS scales of Positive Symptoms (r = -.256, p < .05), and Negative
Symptoms (r= -.371, p < .01). These results indicate that participants with higher levels of positive
or negative symptoms also tended to experience less satisfaction with their social contacts. An
analysis comparing the magnitude of the correlations between each of the symptom factors and
the satisfaction with social interactions was computed using a test of significant differences
between correlated correlations based on a corrected Fisher’s z statistic (Meng, Rosenthal, &
Rubin, 1992). Results indicated that there was not a significant difference between the two
correlations (z = -.788, p = .215).
Additional analyses revealed that the Depressive Symptom scale from the BPRS was
correlated with Global Life Satisfaction (r= -.554, p < .001), satisfaction with living situation
(r =

-.254, p < .05), satisfaction with daily activities (r = -.422, p < .01), satisfaction with family

contacts (r = -.246, p < .05), satisfaction with finances (r = -.226, p < .05), and satisfaction with
overall health (r = -.428, p < .01). These results indicate that for these participants, higher levels of
depressive-anxiety symptoms are associated with decreased satisfaction in each of these areas
of their lives. The Manic Symptom scale was related only to victimization within the past year
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(r = .321, p < .01) and arrests within the past year (r = .411, p < .01). These results indicate that
participants who exhibited greater levels of manic-excitement symptoms, also tended to have
greater safety concerns and victimization, and more contacts with the law resulting in arrest.
Also, GAF scores were positively correlated with satisfaction with both family (r = .313,
p < .05) and social (r= .416, p < .01) relations, as well as satisfaction with their safety (r= .241,
p < .05) and number of social contacts (r = .237, p < .01). These results indicate that better overall
psychiatric functioning is associated with higher satisfaction with both social interactions and
safety issues, an increase in the number of social contacts, and greater satisfaction with those
contacts.
Relationship Between Communication Disturbances and Psychiatric Status/Symptom
Presentation (Hypothesis 2)
Pearson product moment correlational analyses were conducted to assess the
relationships between communication disturbances on the CDI and symptom presentation as
measured by the BPRS. Table 15 presents these correlations. None of the communication
disturbances were significantly related to overall symptom presentation as measured by the total
score on the BPRS, or to the specific BPRS scales of Negative Symptoms or Manic-Excitement.
Missing Information References were related to the factor of Positive Symptoms (r = .261, p < .05)
and Ambiguous Word Meanings were related to the factor of Depression-Anxiety (r = .242,
p < .05). These results indicate that participants with more positive symptoms also exhibited more
missing information references in their speech, while greater levels of depressive-anxiety
symptoms are related to a greater number of ambiguous word meanings in their speech.
Relationship between Neurocognitive Abilities and Psychiatric Status/Symptom Presentation
(Hypotheses 1b and 3b)
Pearson product moment correlational analyses were conducted to assess the
relationships among overall symptom presentation and neurocognitive functioning. Table 16
presents these correlations. Only performance on the Digit Symbol - Coding subtest of the WAIS-
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III was related to the Total Score on the BPRS (r= -.228, p < .05). This result indicates that more
psychiatric symptoms are related to a decline in symbol coding task performance.
Pearson product moment correlational analyses were conducted to assess the
relationships between the Positive and Negative Symptom scales on the BPRS, and measures of
neurocognitive functioning. Table 16 also presents these correlations. Several neurocognitive
measures were related to the Negative Symptom scale on the BPRS. These include Digit Symbol
- Coding (r = -.329, p <.01), Digit Symbol - Pairing (r= -.243, p < .05), Trail Making Test - Part A
(r= .360, p < .01). Only Digit Span performance was related to the Positive Symptom scale on the
BPRS (r = .243, p < .05). These results indicate that higher levels of negative symptoms are
associated with fewer correctly coded symbols and greater time to complete the Trail Making Test
- Part A. And, participants with more positive symptom presentation also tended to perform better
when repeating lists of numbers.
Pearson product moment correlational analyses were conducted to determine the
relationship between Total Score on the BPRS, as well as both the Positive and Negative
Symptom scales, with the neurocognitive domain summary scores. Table 17 presents these
findings. There were no significant relationships between BPRS Total Score and any of the five
neurocognitive domains. These domain summary scores were calculated by averaging across z
scores converted from raw scores for each of the neurocognitive measures that contributed to the
particular. The domain of Attention was related to the Negative Symptom score (r = .252, p < .05)
and Verbal Fluency was related to the Depressive-Anxiety Symptom scale (r = .230, p < .05).
These results indicate that within this group greater negative symptom presentation is related to
better performance on measures of attention and concentration. In addition, within the sample
more depressive-anxiety symptomatology is associated with better performance on tasks of
verbal fluency.
Also, when assessing current functioning, it was found that scores on the GAF
significantly correlated with the domains of Verbal Memory (r = .335, p < .01) and Higher Cognitive
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abilities (r = .244, p < .05). These results indicate that as participants were rated higher in overall
functioning, they also exhibited better verbal memory and higher cognitive abilities.
Relationship between Quality of Life and Social Adjustment
Several significant correlations were identified between the social adjustment
global rating scales on the SAS-II and the Global Life Satisfaction rating on the QOLI. Adjustment
in the domain of social and leisure activities was related to the global life satisfaction (r = -.270,
p < .05). This is actually in a positive direction, as lower scores on the SAS-II indicate better
adjustment, while higher scores on the QOLI indicate greater satisfaction. This was also true for
the relationships between the Global Life Satisfaction on the QOLI and both household member
adjustment rating (r = -.485, p < .01) and the overall social adjustment rating (r = -.355, p < .01) on
the SAS-II. The ratings of work and external family adjustment on the SAS did not relate to the
global life satisfaction rating on the QOLI. These results indicate that participants who experience
greater global life satisfaction also tend to experience increased social functioning in relationships
with household members, greater involvement in social and leisure activities, and greater overall
social adjustment. Table 18 presents correlations between the scales on the QOLI and those on
the SAS-II.
Relationship between Quality of Life and Neurocognitive Abilities (Hypothesis 4)
Pearson product moment correlational analyses were conducted to assess the
relationship among subjective measures of quality of life and the Verbal Memory, Attention, and
Higher Cognitive summary score domains of cognitive functioning. These domain summary
scores were calculated by averaging across z scores converted from raw scores for each of the
neurocognitive measures that contributed to the particular domain. None of the summary score
domains were found to correlate with Global Life Satisfaction as measured by the QOLI. There
were two significant correlations between these neurocognitive domains and other subjective
quality of life scales. There was a significant association between Attention and number of social
contacts (r = .268, p < .05), and between Verbal Memory and both satisfaction with finances
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(r= .250, p < .05) and satisfaction with legal and safety issues (r= .276, p < .05). These results
indicate that participants who exhibit better performance on tasks of attention and concentration
also tend engage in more social contacts. Also, better performance in verbal memory is
associated with greater satisfaction with finances and legal and safety concerns. Table 19
presents correlations between scales on the QOLI and these three domains of cognitive
functioning.
Relationship between Communication Disturbances and Neurocognitive Abilities (Hypothesis 6)
Pearson product moment correlational analyses were conducted to assess the
relationship between each of the communication disturbances and the Verbal Memory, Attention,
and Verbal Fluency summary score domains of cognitive functioning. These domain summary
scores were calculated by averaging across z scores converted from raw scores for each of the
neurocognitive measures that contributed to the particular domain. Table 20 presents these
findings. Missing Information References were related to Verbal Memory (r = -.263, p < .05) while
Confused References were related to Attention (r = -.248, p < .05). No communication
disturbances were related to the cognitive summary domain of Verbal Fluency. These results
indicate that poorer performance on tasks of verbal memory is associated with greater numbers
of missing information references in speech, and poorer performance on tasks of attention and
concentration is associated with more confused references in the speech of participants.
Relationship between Neurocognitive Abilities and Social Adjustment
Pearson product moment correlational analyses were conducted to assess the
relationships among measures of social adjustment and neurocognitive functioning. Table 21
presents these findings. Only the neurocognitive domain of Verbal Memory was found to
significantly correlate with the overall global rating (r = -.258, p = .05) on the SAS-II. This
relationship is actually in the positive direction, as lower scores on the SAS-II indicate better social
adjustment. Verbal Memory was also found to be significantly associated with work adjustment
(r = -.439, p <.001), while Attention was correlated with social and leisure adjustment (r = -.287,
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p < .05) and General Mental was related to household member adjustment (r = -.391, p < .05).
Again, these are all in the positive direction as lower scores on the SAS-II indicate better social
adjustment. These results indicate that participants who exhibit better performance on tasks of
verbal memory also tend to experience better adjustment in work and daily responsibilities, as well
as overall social functioning. In addition, better performance on tasks of attention and
concentration was associated with better adjustment in social and leisure activities, while better
performance on tasks of general mental abilities was associated with greater social adjustment
with household members.
Predictors of Quality of Life - Global Life Satisfaction (Hypothesis 8)
Multiple regression analyses were conducted to determine which of the study variable
predicted the Global Life Satisfaction score from the QOLI. Variables were initially grouped into
predictor sets according to theoretical similarity to the construct measured (e.g., social adjustment
scores, cognitive domains, etc). Using a stepwise regression analysis, only the variables
predicting variance from within each predictor set were retained. Because depressive
symptomatology has been found to be strongly associated with, and at times indistinguishable
from, subjective ratings of quality of life (Lehman, 1983; Lehman, 1996; Packer, et al., 1997), and
as a result of the high correlation between depressive symptomatology as measured by the BPRS
and Global Life Satisfaction (r= -.554, p < .001) in the present study, controlling for this factor
became an issue. Lehman (1988) recommends interpreting results from the QOLI with caution
when considering the issue of depression, and in his own research has factored out the effects of
depression (Lehman, 1983). Thus, in the present study, the variance accounted for by depressive
symptomatology was removed by forcing the Depressive-Anxiety Symptom score from the BPRS
into the regression analyses as the first predictor variable for both the initial analyses and the final
regression. In the final regression analysis the retained predictor variables were entered to
determine the relative contribution of each in explaining the variance in Global Life Satisfaction.
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For initial analyses, the predictor sets were identified by individual scores related to social
adjustment, communication disturbances, neurocognitive domains, symptomatology and
psychiatric status, and demographics. The only variable retained from the social adjustment set
was the rating of global social adjustment. The only variable retained from the communication
disturbances set was Ambiguous Word Meanings. No variables were retained from the
neurocognitive, symptomatology and psychiatric status, and the demographics sets.
For the final regression, depressive-anxiety symptomatology was forced into the equation
as the first variable. Then the global social adjustment and Ambiguous Word Meanings variables
were entered into the equation in a stepwise fashion. When entered together, and after taking into
account the effects of depressive symptomatology, both variables still accounted for a significant
amount of the variance in the QOLI rating of global life satisfaction. Table 22 describes these
results.
Overview of Hypotheses: General Social Adjustment Hypotheses
A. The hypothesis that overall symptom presentation would be positively correlated with
impairment in social interactions was confirmed.
B. The hypothesis that neurocognitive functioning would be positively related to ratings of social
adjustment was confirmed.
C. The hypothesis that global life satisfaction on the QOLI would be related to increased social
adjustment was confirmed.
Overview of Hypotheses: Specific Hypotheses
1a. The hypothesis that overall symptom presentation would be negatively correlated
with quality of life was partially confirmed as total symptoms are not related to
global life satisfaction, but are related to subjective rating of satisfaction with social
interactions
1b. The hypothesis that overall symptom presentation would be negatively correlated
with neurocognitive functioning was not confirmed.
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2.

The hypothesis that overall symptom presentation would be positively correlated with the
ratings of communication disturbances was not confirmed.

3a. The hypothesis that negative symptoms would have a stronger negative relationship
with quality of life than positive symptoms was not confirmed.
3b. The hypothesis that negative symptoms would have a stronger relationship with
neurocognitive functioning than positive symptoms was partially confirmed as
negative symptoms are related to a few neurocognitive measures sensitive to brain
dysfunction, and positive symptoms are related to only one measure
4.

The hypothesis that specific neurocognitive domains would be positively correlated with
quality of life was partially confirmed as the domain of Attention is related to objective rating of
number of social contacts, while no other relationships between domains or quality of life were
found

5.

The hypothesis that participants would exhibit more Ambiguous Word Meanings than other
communication failures, followed by Missing Information References was confirmed.

6.

The hypothesis that communication failures would be negatively associated with the
neurocognitive domains of Verbal Memory, Attention, and Verbal Fluency was partially
confirmed as Ambiguous Word Meanings are associated with the domain of Verbal Memory,
and Confused References are associated with Attention

7.

The hypothesis that participants would have greater deficits in the areas of Verbal Memory,
Verbal Fluency, Attention, and Higher Cognitive functioning than in the domain of General
Mental ability was confirmed.

8.

The hypothesis that the quality of life rating of global life satisfaction would be predicted from
the other variables of the study was confirmed.
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Discussion
The objective of this study was to explore a number of variables implicated in the
functioning of persons with schizophrenia and to determine the relationship of each of these
variables primarily to quality of life, and secondarily to one another. The anticipated result of this
study was to increase understanding of the factors that contribute to quality of life and to identity
potential strategies to assist in the improvement of the quality of life of persons with
schizophrenia. General results will be discussed first, and then each of the specific hypotheses
will be addressed. Final concluding comments will follow.
The participants in the present study could be best described as having chronic mental
illness, as evidenced by the early average age of onset of psychiatric symptoms (between 23 and
24 years old), the early age of first hospitalization (between 25 and 26 years old), and the long
duration of illness, as the average age of participants was 47 years. During their participation,
most participants were essentially in a residual phase of their illness, or were experiencing
baseline symptoms. However, all were documented to have had florid psychotic symptoms in the
past. In addition, participants averaged at least six previous psychiatric hospitalizations, and
almost 95% were currently prescribed an antipsychotic medication. Other participant
characteristics associated with severe and persistent mental illness include decreased
interpersonal functioning as evidenced by lack of employment, general inability to maintain a
marital relationship, and tendency to live alone. These findings are consistent with other
descriptions of persons with chronic schizophrenia (DSM-IV-TR; Schultz & Andreasen, 1999).
As previously noted, almost 95% of the participants in the sample were prescribed
antipsychotic medications. The average chlorpromazine equivalence for the participants was
416.5 mg/day, which ranged from 16.6 to a very substantial 1825 mg/day. As the typical dose for
chlorpromazine ranges from 75 to 1000 mg/day (Bezchlibnyk-Butler & Jeffries, 2001), the
participants in this study on average are prescribed medications well within the suggested clinical
range. The results of initial analyses showed that age of participants negatively correlated with
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daily medication dosage in chlorpromazine equivalents. Thus, older participants tended to be
prescribed lower doses of medications. This may be a result of pharmacokinetics, or how the
body handles the drug. Older individuals tend to metabolize medications at a slower rate, so
dosages need to be lower because the medication remains in the system longer. In addition,
changing body composition with age (i.e., more fat and less muscle) also impacts how the drug is
distributed and metabolized within the body. Differences in medication could also be due to overall
stabilization of symptoms and the experience of fewer positive or floridly psychotic symptoms later
in the course of the illness, as medications are traditionally prescribed more to control the positive
symptoms of schizophrenia. This is consistent with reports that the negative syndrome is more
prevalent in the chronic state of schizophrenia (Crow, 1987) and that a percentage of persons with
schizophrenia improve from the effects of the disorder over time (Harding, Zubin, & Strauss,
1987). However, debate regarding the course of schizophrenia continues, as was discussed
previously in the literature review on course of the illness.
The study found that participants were exhibiting fairly mild psychiatric symptoms as
measured by the Brief Psychiatric Rating Scale (BPRS), which, although warranting attention by
professionals, did not result in serious impairment in functioning, as classified by the Global
Assessment of Functioning (GAF). This finding lends support to the notion that older persons with
schizophrenia, such as those in the current sample, tend to exhibit fewer psychotic symptoms,
although symptom reduction could also be a function of the effective treatment and clinical
management of medications and other services that the participants were receiving at the time.
Specifically, the use of novel antipsychotic medications may speak to the relatively asymptomatic
status and high functioning of the study participants. The results of initial analyses showed that
lack of current employment was related to higher symptom presentation, including both positive
and negative symptoms, and decreased global functioning. This is not a surprising finding, as one
would expect that individuals exhibiting greater psychiatric symptoms and impairment in
functioning would not be able to maintain or have interest in obtaining employment. Alternatively, it
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may be that persons who are unable to find and maintain employment become despondent or
unhappy with their circumstances and then begin to exhibit greater symptomatology.
Quality of Life
The present study provides evidence that despite having a chronic mental illness,
participants report feeling “mixed” to “mostly satisfied” with their general life circumstances. This
may be due in part to the participants’ reports, regarding objective quality of life, which indicated
that participants did engage in a number of activities outside of the home, had at least semi
regular social contact with relatives and friends, and tended to have sufficient funds to cover basic
living expenses such as food, clothing, and housing. In addition, these individuals were not likely
to have been a victim of a crime or otherwise have had contact with the legal system in the past
year. Satisfaction with general life circumstances may also stem from the satisfaction participants
reported in more specific areas, such as daily activities, social interactions, finances, living
situation, safety, and employment (at least for those who were working). Overall, these individuals
felt that their basic needs were generally addressed to a satisfactory degree, and felt content with
most areas of their lives. These findings are similar to those in other studies using the Quality of
Life Interview (Lehman, et al., 1986; Sullivan, et a!., 1991 ;Trauer, Duckmanton, & Chiu, 1998).
The results of the present study revealed that demographic variables such as age and
gender did not have any association with the ratings of quality of life. This contrasts with previous
research with the QOLI (Lehman, et al., 1992), that had found that gender and decade of life
appear to play a role in the quality of life experiences for persons with schizophrenia and other
severe mental illness. It was discovered by these other authors that as individuals age, their
reports regarding objective quality of life such as number of family contacts, and social and leisure
activities, decrease for both males and females. In addition, across the life span, females were
found to engage in more social activities while males tended to have more spending money
available. When considering the present study, it may be that because this was an older sample,
and because the participants tended to be fairly close in age across the group, no effects of age
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were noted. Again, the size of the gender groups may play a part in the current lack of differences
between males and females, as a larger sample size for females was not available.
Correlational analysis revealed several significant relationships between satisfaction
ratings on general life circumstances and the other ratings on the QOLI. Specifically, all of the
subjective ratings except satisfaction with work were significantly related to the overall global life
satisfaction rating. This is to be expected, considering that satisfaction in each of the individual
areas contributes to overall life satisfaction. The item on satisfaction with work was only rated by
those who were currently working, and so it does not contribute to overall life satisfaction across
the entire sample. Strong correlations among the subjective ratings have been found in previous
research (Trauer, et al., 1998), primarily because these rate satisfaction with different areas of
one's life, and satisfaction in one area can directly impact satisfaction in another. In the literature,
areas of life satisfaction, as well as domains of psychiatric outcome, tend sometimes to be
correlated, but exhibit surprising independence in other studies (Strauss & Carpenter, 1972).
Only one objective rating, having more numerous social interactions, was found to be
associated with general life satisfaction. It is not known specifically why the other objective ratings,
such as number of contacts with family members or amount of spending money, do not contribute,
although this is consistent with other research on the QOLI (Trauer, et al., 1998). It may be that
participants have adapted to their current circumstances and are satisfied with their experiences.
Previous long-term studies of schizophrenia reveal that much of the deterioration in schizophrenia
occurs in the early stages of the illness (Davidson & McGlashan, 1997; McGlashan, 1988). Most
of the participants in the current study are older with a long course of illness, and it could be
argued that they are more stable in their illness and/or have found methods to cope with, or
become reconciled to, some of the changes in functioning or deterioration, and as a result are
more satisfied with their life circumstances. Alternatively, the number of contacts with family
members may not be as important to persons with schizophrenia as the quality of the contacts
that they already have. Although having a social support network comprised of family members
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has been found to be a positive factor in the lives of some persons with schizophrenia (Sullivan, et
al., 1991), the presence of family members can also contribute to difficulties (Hooley, 1998), or
possibly be a mixed blessing depending on how relatives attribute the individual’s psychiatric
symptoms (Hooley, et al., 1987). Also, having sufficient funds to meet basic needs may be more
important than additional spending money for these individuals.
Again, the issue of current medications should be considered when evaluating the
relatively high functioning and satisfaction that has been exhibited by this group. Not only do novel
antipsychotic medications contribute to a decrease in both the positive and negative symptoms
and improvement in overall functioning, but they are associated with a lower rate of side effects,
which can also contribute to the satisfaction that these individuals report with their lives.
Another hypothesis could be that, as many of the participants were patients at a large VA
Medical Center and a great number of these patients were receiving disability payments and other
services or resources as part of their comprehensive care, many of their basic needs - both
concrete and social - were addressed. Payments and additional services that VA patients obtain
can be quite considerable in some cases, which may allow the individuals to maintain a slightly
higher standard of living than other persons with severe and persistent mental illness. In addition,
many patients spend considerable time at the Medical Center socializing with other veterans and
engage in regular interactions with a variety of staff. This may translate into greater satisfaction
with numerous areas of their lives and higher scores on the subjective ratings on the QOLI.
Alternatively, these participants may exhibit response bias in their ratings of satisfaction
with different areas of their lives. Social desirability is a phenomenon that is commonly studied in
the general population (Edwards, 1957). Such a response bias may be especially relevant for
those participants who receive their ongoing care at the VA Medical Center and could be
concerned about the opinions of research staff or the perceived possibility that information would
be shared with their providers. These factors may have lent unanticipated demand characteristics
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to the context of this research. In addition, these participants just may not want to acknowledge
that they are not sufficiently satisfied with the various areas of their lives.
Social Adjustment
The results indicate that social adjustment in the five areas measured (work and daily
responsibilities, household member, external family, social and leisure, and global adjustment)
varied in range from above average (good) to below average (poor) for these participants. This is
similar to other findings that indicate persons with schizophrenia are able to function with varying
degrees of social deficits depending on the specific area being assessed (Glazer, et al., 1982;
Weissman, et al., 1978). These individuals exhibited the most impaired social functioning in
relation to their work role, whether it was employment, household responsibilities, or educational
activities. Average adjustment was seen in the areas of relationships with external family, social
and leisure activities, and general social functioning. These participants reported slightly higher
than average adjustment in their mutual relationship with the primary person in their household.
The conclusion to be drawn here is that these persons with schizophrenia function adequately in
their social interactions, even though definite improvements could be made.
Limitations to the use of the Social Adjustment Scale-ll (SAS-II) include the instruction to
“skip out” of a section if it does not apply to an individual. For example, those participants who had
no household member because they were living alone or have no children were not asked those
particular sections of the interview. As a result, they could not be rated in those section and no
global rating for that social domain was available. Thus, the average global ratings for the sample
include only those individuals for whom ratings were made, and as a result, the average ratings
may not fully address the true social impairments of the participants. For example, the fact that an
individual does not live with others or is not a parent may reflect poor social adjustment and an
inability to maintain relationships. Another potential drawback to this scale is that the global ratings
are made based upon the interviewer’s comparison of the participant to their conception of a
“normal” person in the community. This is a very subjective procedure, and as such, interviewer
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biases may enter into the rating. However, these ratings do avoid some of the problems of subject
response bias, as they are made by an “outside observer."
As with completing the QOLI, the concern of response bias still may also arise with the
SAS-II. Some participants may be reluctant to indicate the extent to which their social functioning
is impaired and may instead over-report social activities and interactions or under-report
limitations or social difficulties that they experience. This was addressed to an extent through
completion of a “Current Informant” interview as part of the larger study from which this data was
obtained. At times, participant reports were very consistent with those of the current informant. But
just as often, the reports were dissimilar or the current informant did not have sufficient
information or knowledge to address the questions. This was especially evident for those
participants who lived alone and had limited regular social contacts with others. In those cases
where a discrepancy was evident, efforts were taken to determine which was the more accurate
report, based upon the amount of detail, consistency across the interviews, and recent progress
notes that described the individual’s current functioning as observed by his or her provider.
Although the ratings on the SAS-II and the QOLI were not altered, the more accurate report was
taken into consideration when making diagnostic decisions and symptom ratings.
The results of initial analyses revealed that female participants exhibited significantly
more impaired social adjustment in their relationship with their primary household member and
external family members. Due to the vast difference in the sample size of the gender groups (47
males, 8 females), it is difficult to determine if this is a meaningful or clinically significant
difference. More of the female participants lived with others and so this may have put them in
situations where strained relationships are more likely to develop. Current employment was also
found to be significantly related to adjustment in work and daily responsibilities, as well as in
overall social adjustment. This is not surprising, as individuals who are functioning well enough to
maintain employment would presumably exhibit improved social skills in interactions with people
in other areas of their lives as compared to those who do not maintain employment.
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Communication Disturbances.
Examination of the communication disturbances results suggests that the speech of ail
persons with schizophrenia contains some level of unclear references, however no comparison to
a control sample or other psychiatric group was done as part of this study. In addition, these
individuals produced varying amounts of speech, as the total number of words for a 10-minute
speech sample ranged from approximately 450 to well over 2200 words. To account for
differences in amount of speech, this measure does provide scores based upon disturbances per
100 words of speech, resulting in proportional frequency rather than absolute scores. All six of the
communication failures as measured by the CDI were present in the speech of these persons with
schizophrenia. Study participants produced more Ambiguous Word Meanings than any other type
of communication failures. This is reflected in their frequent use of words for which the intended
meaning is not obvious, especially in situations when a word or phrase has more than one
possible definition and the listener is unsure as to which the speaker is referring.
Ratings of all the communication failures other than Confused References were
correlated with one other, and all of the communication failures, including Confused References,
were correlated with the Total Communication Disturbance score. This indicates that as
participants exhibited frequent communication failures of one type, they generally exhibited other
failures as well.
Limitations to this measure, as described by its author (Docherty, et al., 1996), include the
fact that the measure does not take into consideration the complexity of the individual speech
sample or the severity of the communication failures because only frequencies are recorded, with
no weighting based on severity. Some communication failures can be quite subtle and the basic
idea of the phrase can still be understood (e.g., “I would sit in the cafe and just glare out into the
night”), while others are more extreme and the listener is unable to understand the phrase (e.g., “I
was trying to predict them people that I need”). Each of these examples would be rated only as
one instance of Wrong Word Reference with no impact of the severity of the failure. Generally,
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those speech samples containing severe failures also contain frequent failures. However, it is
possible that those participants who produced little speech and exhibited only a few severe
communication failures would appear to be exhibiting less overall communication disturbance than
those participants who produced extensive speech and more numerous but more subtle errors.
There is no way to control for or evaluate this possibility unless a qualitative analysis of the
speech samples was completed. Such a procedure was not undertaken in this study. Additional
concerns about these results include the limitations to the interrater reliability across the three
raters, as reliability for Confused References and Wrong Word References were determined to be
fair and good, respectively. However, all other reliability coefficients for the ratings on the CDI
were determined to be excellent across the three raters.
Neurocognitive Performance
Findings of the current study demonstrated that participants as a group were performing
in the average to low average range on all of the neurocognitive measures. No control group was
used in the present study, and so comparisons of performance level cannot be made in this way.
However, norm-based standardized scores were used as part of the examination of performance,
and so comparisons to a normative sample can be made. For example, none of the subjects on
any of the measures, other than the Vocabulary subtest of the Wechsler Adult Intelligence Scale Third Edition (WAIS-III), demonstrated performance in greater than the 50th percentile. One would
expect more of the scores to be closer to the mean for a normative sample; therefore the results
for these participants as a whole can be considered lower than what would be anticipated in the
general population. In addition, based primarily on performance on the Vocabulary subtest (one of
the best predictors of expected level of performance) and secondarily on performance on the
Block Design subtest (another often-used indicator of expected performance) these participants
are exhibiting lower-than-expected performance on the other neurocognitive tasks. It can be
concluded that these individuals are exhibiting some level of deficit on their neurocognitive
performance. Such a conclusion is consistent with findings that the performance of persons with
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schizophrenia tends to be impaired on a wide range of measures, which indicates generalized but
evident cognitive deficits (Chapman & Chapman, 1973; Rund, 1998).
Five domain scores were generated to assess the performance of these participants in
particular areas of neurocognitive functioning. Percentile scores on measures that were
hypothesized to tap into similar constructs were grouped together and combined in order to better
examine specific areas of performance. The results provide evidence that participants as a group
were performing in the average range in the domains of General Mental abilities, Attention, Verbal
Fluency, and Higher Cognitive abilities, while they performed in the low average range in the
domain of Verbal Memory. Again, as no control group was used, comparisons based on
performance within the study cannot be made, but as none of these domains achieved a score
greater than in the 50th percentile, the domain abilities can be considered lower than what would
be expected in the general population. In addition, based upon comparison with the General
Mental ability domain (composed of the Vocabulary and Block Design subtests of the WAIS-III),
which is the best indicator of expected performance for this group, the participants are performing
lower than expected on the other domains. (See also section regarding Hypothesis 7 for additional
discussion on this topic).
Results of initial analyses revealed that participants’ years of education were significantly
related to the domain of General Mental ability, as those individuals with more education tended to
perform better in this domain. This finding is not surprising, given that the General Mental domain
includes a measure of word knowledge, which can be strongly influenced by education. In
addition, the two tests that contribute to the General Mental domain (the Vocabulary and Block
Design subtests of the W AIS-III) are considered to be good indicators of premorbid functioning, a
factor itself which can be associated with educational pursuits.
When averaging over a group, individual differences are generally minimized. Thus it is
important to consider an individual's performance across measures, especially when considering
that patterns in neurocognitive deficits of persons with schizophrenia exhibit considerable variation
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(Heinrichs & Zakzanis, 1998; Rund, 1998). The Impairment Index provides an estimate of the
individual functioning of each of those who participated in the current study. Using a cut-off score
of one standard deviation below the mean (from normative data provided by test authors or
selected from the literature based on the measures’ psychometric properties), the Impairment
Index reflects the percentage of measures on which the participant demonstrated impaired
performance. Results indicate that, individually, participants were impaired on more than 36% of
the measures that they completed. This percentage corresponds to an average of more than 6.5
impaired measures per individual. This is fairly consistent with the finding that persons with
schizophrenia are generally impaired on 40 to 60% of neurocognitive measures (Goldberg, et al.,
1988) and with descriptions of generalized deficits in schizophrenia discussed above. The number
of impaired scores varied across individuals as well, ranging from a low of 0, to as many as 16.
Such a finding speaks to the variability of functioning within persons with schizophrenia, the
variability of functioning across persons with schizophrenia, and that no one impairment can be
presumed to be diagnostic of the illness (Heinrichs & Zakzanis).
A limitation to the neurocognitive performance results is that many of the correlations
between neurocognitive performance and other variables were made using neurocognitive
domain scores calculated from z scores that were obtained from raw scores on each of the
measures. As a result, these z scores represent each participant’s performance relative to the
total group of participants, rather than compared to normative data. As a result, many of the
scores may be in the average range as compared to the performance of the group as whole,
when in fact the scores would be otherwise considered impaired if they had been compared to a
normative sample. Thus, only the most impaired of individuals as compared to the other
participants obtained z scores in the impaired range. As a result, the performance of these
participants has been artificially elevated and not all impairments are evident in the data.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 113
Hypotheses Related to Social Adjustment
The current study hypothesized that overall symptom presentation would be positively
correlated with impairment in social interactions. The results support this hypothesis, as higher
levels of current symptomatology were associated with difficulty in relationships with external
family members, a decrease in pursuits of social and leisure activities, and impaired overall social
functioning. This is not surprising, as one would expect those persons with schizophrenia who are
experiencing more symptomatology to have difficulty in their interactions with others and social
pursuits. Psychiatric symptoms can have a detrimental effect on the interpersonally relevant
behaviors of an individual, especially if they are experiencing psychotic symptoms that are not
well understood by others, or more negative symptoms which often result in withdrawal and
inactivity. It is for such reasons that when persons with schizophrenia begin to exhibit serious
symptomatology, they are often hospitalized because they are unable to care for themselves and
maintain life in the community, or lack sufficient social support.
This study speculated that better neurocognitive functioning would be positively related to
ratings of social adjustment. A review of the current data confirms this hypothesis. Participants
were found to experience higher levels of adjustment in work and completing daily responsibilities,
as well as with general social interactions, as they also exhibited better performance in abilities of
verbal memory. This is not unexpected, as such a skill facilitates the accomplishment of work and
daily responsibilities and is strongly involved in general social interactions, whether it is in
following instructions, engaging in conversations, or participation in activities, for example.
Attention was found to be related to adjustment in social and leisure activities. This is also not
surprising, as attentional ability is needed in many leisure pursuits, such as reading, watching
television or movies, or engaging in hobbies. Attention is also required for interactions with others
in a social context, for example in following conversations and participating in activities. General
Mental ability was found to be correlated with adjustment in relationship with primary household
member. One explanation for this finding is that ongoing interactions with a given person may
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become strained when it appears that the person with schizophrenia does not have the ability to
engage in routine tasks or maintain a basic skill level.
Previous research has resulted in varying conclusions regarding the relationship between
neurocognitive functioning and social adjustment. In some cases no neurocognitive associations
were found with social functioning as a whole (Addington, et al.t 1998), or only with certain
aspects of social functioning, such as social problem solving (Addington & Addington, 1999). In
other research, specific neurocognitive tasks measuring spatial organization and visual spatial
abilities (Dickerson, et al., 1996), verbal memory and vigilance (Green, 1996), or, in the case of
females, verbal memory alone (Mueser, et al., 1995) were related to overall social adjustment and
competence.
The current study showed that specific areas of neurocognitive functioning are related to
specific areas of social functioning. As persons with schizophrenia are identified as having deficits
in one or more of these particular areas of social functioning and when it has been determined
that their social functioning is an area for rehabilitation, steps can be taken to assist the individual
in improving their neurocognitive abilities and developing compensatory skills that presumably will
have a direct effect on their social functioning as well. Based on these results, developing
rehabilitative strategies to improve verbal memory and attention may also result in better social
functioning in work, social-leisure, and general social interactions.
However, it appears that more research into the impact of neurocognitive functioning on
social adjustment is needed. Also, researchers need to specifically identify which aspects of social
adjustment are to be studied and select neurocognitive measures that are theoretically related to
the social adjustment domains under consideration.
This research hypothesized that social adjustment would be related to the quality of life
rating of Global Life Satisfaction. This hypothesis was supported as the data reveals that
adjustment in the areas of relationship with primary household member, social and leisure
activities, and global social functioning were all significantly related to Global Life Satisfaction.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 115
Thus one can conclude that persons with schizophrenia tend to be more satisfied with their lives
when they are also experiencing positive relationships with the primary person in their
households, more social and leisure pursuits, and overall have better social functioning. It can be
argued that social interactions bring meaning and pleasure into most people's lives, and it appears
to be the case with the participants in this study.
These results are also expected when considering the individual quality of life scales that
were associated with the Global Life Satisfaction, including satisfaction with daily activities, living
situation, social relations, family relations, and greater number of social contacts. Having these
similarities between scales • both in terms of content sampling and of their intercorrelations indicates that there was consistency across reports for the interviews. Also, as the SAS-II is an
interviewer-rated measure and the QOLI Is based on self-report, the convergence of ratings
suggests that similar information was being taken into consideration for the ratings. This also
speaks to the previously discussed issue of the reliability of persons with schizophrenia in
reporting their satisfaction and quality of life.
Specific Hypotheses
Hypothesis 1a (Correlation between overall symptom presentation and quality of life). The
study hypothesized that overall symptom presentation would be negatively correlated with the
measures of quality of life. The results partially confirm this hypothesis. Although overall symptom
presentation is not related to Global Life Satisfaction, it is significantly associated with the
subjective measure of satisfaction with social interactions. Based on these findings, it would
appear that in those persons with schizophrenia who experience more psychiatric symptoms, the
quality of their social interactions is less. This may be a direct result of their exacerbating
psychiatric status and the impact that it has on the individual’s presentation and behaviors, and
even desire to engage in social interactions. These factors can lead to difficult or inappropriate
interactions and behaviors, a reduction in the number of social interactions, or the avoidance of
interactions all together. Alternatively, participants may experience reduced satisfaction with their
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social interactions, for unrelated reasons, and as a result become distressed or displeased. Such
negative feelings could lead to depression and/or the expression of negative symptoms.
Hypothesis 3a (Correlation between symptom factors and quality of life). The present
research hypothesized that negative symptoms would have a stronger relationship with quality of
life than positive symptoms. Both symptom domains were found to have a significant association
with quality of life as measured by satisfaction with social interactions. However, there was no
difference between the magnitude of each of these correlations, therefore the hypothesis was not
proven to be true. Instead positive and negative symptoms maintain a similar relationship with
participants' ratings of satisfaction with social interactions. Such a finding may be a result of the
relatively low level of symptoms displayed by the participants in the study and limited variation in
symptom presentations.
Several additional results reveal that other BPRS factors were associated with various
scales from the QOLI. Manic symptoms are associated with victimization and arrests within the
last year. A possible explanation for this finding is that persons who are experiencing manic
symptomatology may find themselves in situations which result in contact with the legal system,
whether as a result of victimization, illegal, or inappropriate activity. Depressive-anxiety symptoms
were strongly related to less global life satisfaction, satisfaction with daily activities, and
satisfaction with health. The symptoms were also moderately correlated with lower satisfaction
with living situation, family contacts, and finances. This is not surprising in light of the previous
discussion that depressive symptomatology is often indistinguishable from global quality of life,
and these life areas should be taken into consideration when the global life satisfaction rating is
made by the participants. It is interesting to note that the BPRS is a clinician-rated measure, while
the satisfaction ratings on the QOLI are provided by the person with schizophrenia. One
conclusion to be drawn is that the clinicians and participants are exhibiting strong parallels in their
ratings of the participants' experiences. An alternative conclusion is that the QOLI measures
primarily the effects of depressive symptomatology on a variety of life circumstances rather than
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patient-rated quality of life. If this were the case, it may be that interventions specifically targeting
depressive symptomatology, in addition to those psychotic symptoms typically associated with
schizophrenia, would be warranted. Such a goal could be accomplished by antidepressant
medications or psychotherapy targeted at the depressive process. Additional research is needed
to fully explore the relationship between depressive symptoms and their effects on ratings of
quality of life as measured by the QOLI.
Future research may want to consider the possibility of exploring the relationship between
specific individual symptoms (as rated by individual BPRS items or using other instruments) and
quality of life. It may be possible to differentiate the effects of various symptoms from one another
and their impact on ratings of quality of life. Such knowledge may improve services that are
provided to persons with schizophrenia as their individual symptoms can be targeted with the goal
of improving Global Life Satisfaction and other areas of quality of life.
Hypothesis 4 (Correlation between neurocognitive domains and quality of life.) The study
hypothesized that quality of life (objective) would be positively correlated with the neurocognitive
domains of Verbal Memory, Attention, and Higher Cognitive functioning. This hypothesis was not
strongly supported by the results. The only objective rating of quality of life to be related to any of
the domain scores was the number of social contacts reported by the individual with the domain of
Attention. The reason for this may be similar to issues discussed above in relating social
adjustment to Attention. It may appear that persons with schizophrenia would engage in more
social contacts (either by making plans or being asked by others) when they are better able to
attend to interactions with others and the activities that they engage in. In addition, none of these
neurocognitive domain scores were associated with global life satisfaction. This may indicate that
persons with schizophrenia can be sufficiently satisfied with their overall life circumstances
despite any neurocognitive impairments they may experience, a conclusion that other researchers
have also drawn (Heslegrave, et al., 1997). Alternatively, it may be that although these
participants are exhibiting some neurocognitive deficits, as can be seen by the Impairment Index
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indicating that on average participants are impaired on more than one-third of the measures, the
impairments are not severe enough to significantly affect functioning and quality of life. It is
possible that a less stable or more neurocognitively impaired group would have rated their Global
Life Satisfaction lower than the group of the present study.
Hypothesis 1b (Correlation between overall symptom presentation and neurocognitive
functioning). This research hypothesized that overall symptom presentation would be negatively
correlated with performance on neurocognitive tasks. As a whole, this hypothesis was not
supported. The only neurocognitive task to be significantly associated with current
symptomatology was the Digit Symbol - Coding subtest of the WAIS-III. This finding may again be
a result of the limited symptomatology that was currently being exhibited by the study participants.
However, as this particular measure is generally considered to be the most sensitive
neurocognitive assessment to any form of brain dysfunction (Lezak, 1995), it may have been the
only measure able to discriminate the small but significant effects of overall symptoms. Again,
additional correlations with other measures may have been observed if the sample as a whole
had been more symptomatic or if more sensitive measures of general brain dysfunction were
used.
Hypothesis 3b (Correlation between symptom factors and neurocognitive functioning.)
The present study hypothesized that negative symptoms would have a stronger relationship with
neurocognitive functioning than positive symptoms. This hypothesis was somewhat supported by
the data. The negative symptom dimension was found to be significantly associated with poorer
performance on the Digit Symbol - Coding and Pairing subtests of the W AIS-III, as well as to the
total time on the Trail Making Test - Part A. The positive symptom dimension was found to be
related only to performance on the Digit Span subtest of the WAIS-III. These results again speak
to the sensitivity of the Digit Symbol subtest and its ability to discriminate the subtle effects of
negative symptoms. Also, it has been shown in the literature that negative symptoms tend to
impact cognitive functioning to a greater extent than positive symptoms (Paulsen, et al., 1995) and
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more so in the areas of visual-motor and visual-spatial skills (Green & Walker, 1985; Strauss,
1993), abilities which both the Digit Symbol and Trail Making Test tap into. It is unclear why
positive symptoms are related to improved performance on the Digit Span subtest of the WAIS-III.
This is an unexpected finding as positive symptoms have been found to be related to deficits on
tasks of short-term verbal memory (Green & Walker) and auditory processing (Strauss), areas
which the Digit Span subtest taps into. It may be that the participants who were currently
experiencing some positive symptoms, possibly on a chronic basis, have adapted to the
occurrence and have in fact developed coping strategies to adjust for the impact of the positive
symptoms.
Hypothesis 7 - Relative Deficits Among the Neurocognitive Domains. The current study
hypothesized that the participants would exhibit greater deficits in the areas of Verbal Memory,
Verbal Fluency, Attention, and Higher Cognitive functioning than in the domain of General Mental
ability. The results supported this hypothesis as performance in the four indicated domains was
significantly worse than performance in the area of General Mental ability. This is consistent with
reports that persons with schizophrenia demonstrate mild to moderate impairments on measures
of verbal ability, learning, attention, abstraction, and flexibility of thinking (Heaton, etal., 1994;
Heinrichs & Zakzanis, 1998). These results indicate that as a whole participants are performing
below their expected neurocognitive level (as estimated by performance on the tasks included in
the General Mental domain) even though their aggregated scores in these other four domains are
still in the average to low average range. This again speaks to the variability of neurocognitive
performance across persons with schizophrenia, and the potential effects that higher performing
individuals can exert on group scores.
Hypothesis 2 (Correlation between symptom presentation and communication
disturbances). This study hypothesized that overall symptom presentation would be positively
correlated with the ratings of communication disturbances. The results did not support this
hypothesis, as overall symptom presentation was not correlated with any other ratings of
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communication failure or with the Total Communication Disturbance rating. An explanation for this
finding may be again that as the participants were exhibiting relatively few overall symptoms, the
symptoms did not impact the communication disturbance ratings. In addition, much of previous
research completed by Docherty’s group (Docherty & Gottesman, 2000; Docherty, et al., 1996,
Docherty, et al., 1998; Docherty, et al., 2001) did not report on current symptomatology and so
expectations for symptom effects are not clear. Several of the studies did report symptomatology,
but only by correlating BPRS total scores with other measures after the influence of conceptual
disorganization was removed (Docherty & Gordinier, 1999; Docherty, et al., 2000) or in relating
patient symptomatology to the speech disturbances of relatives (Docherty, et al., 1999). No total
scores for symptoms were reported in these studies. Thus, it is not clear what role current
symptomatology plays in the expression of communication failures. However, as the total number
of communication disturbances rated in the present study was similar to that found in previous
studies, and as our population exhibited a somewhat greater number of Vague References and
slightly fewer Structural Unclarities than found in other research using the CDI, it can be
hypothesized that overall symptoms may influence the relative frequencies of communication
failures that are expressed by individuals, rather than the total number of each type of
disturbance. Additional exploration of the relationship between current symptomatology and
expression of communication disturbances is warranted.
Hypothesis 5 - Frequencies of Ambiguous Word Meanings and Missing Information
References. The study hypothesized that participants would exhibit more Ambiguous Word
Meanings than other communication failures, followed by Missing Information References. The
results upheld this hypothesis as Ambiguous Word Meanings were found to occur much more
frequently than other communication failures in the speech samples of the participants, and that
Missing Information References were more prevalent than the other four communication failures.
This is consistent with previous studies using the CDI (Docherty, DeRosa, et al., 1996; Docherty,
Hall, et al., 1998; Docherty, et al., 1999; Docherty & Gottesman, 2000; Docherty et al., 2000;
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Gordinier & Docherty, 2001) that have found Ambiguous Word Meanings to be the most common
communication failure in the speech of all participants, regardless of group membership or
psychiatric status. Missing Information References have been found to best differentiate the
speech of persons with schizophrenia from other diagnostic groups and controls (Docherty,
DeRosa, et al., 1996), and thus has been described as the most “schizophrenic” in quality. This
type of communication failure makes references to information that is completely unknown to the
listener and often makes the speaker especially difficult to follow. Missing Information References
have also been found to be more prevalent in the speech of nonpsychiatric relatives of persons
with schizophrenia (Docherty, et al., 1998; Docherty, et al., 1999) and has been identified as a
possible indicator of a schizophrenic genotype (Docherty & Gottesman, 2000). It is not known at
this time how Missing Information References relate to the expression of schizophrenia. Future
research could consider clinical factors such as severity of the illness, duration, or age of onset, to
determine differences among subgroups of persons with schizophrenia when analyzing
communication disturbances.
Hypothesis 6 (Correlation of communication disturbances with neurocognitive
functioning). The current study speculated that communication failures would be negatively
associated with the neurocognitive domains of Verbal Memory, Attention, and Verbal Fluency.
This hypothesis was partially supported by the data. Specifically, Missing Information References
were found to be correlated with deficits in Verbal Memory, and Confused References were
correlated with deficits in Attention. No communication failures were found to correlate with Verbal
Fluency. Missing Information References have been noted to occur by Docherty and her
colleagues (2000) as an inability to remember what has actually been said to the listener as
opposed to only thought by the speaker. Thus, the relationship between Verbal Memory and
Missing Information References is understandable. Confused References were described as an
inability to remember discourse long enough to execute it. Again, the relationship between
Attention and Confused References is understandable. However, in their research, Docherty and
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colleagues instead have found that Missing Information References were related to performance
on a continuous performance task of Attention, and Confused References were related to
immediate auditory memory as measured by a digit span task. This Confused References finding
is consistent with the present study, as half of the Attention domain score is attributed to a digit
span task. Docherty’s group did not administer a list learning task, and the present study did not
include a continuous performance task. Thus, it is difficult to determine what similarity or
differences there are in the two studies’ findings. However, based on the description of the
process underlying Missing Information References, verbal memory could certainly be implicated.
Additional research in this area involving a more theoretically-driven selection of neurocognitive
measures is needed.
Hypothesis 8 (Prediction of quality of life from other variables). The study hypothesized
that the quality of life rating of global life satisfaction could be predicted from the other variables of
the study. This hypothesis was supported by the data. After removing the effects of depressive
symptomatology, because certain aspects of psychopathology, especially depression and anxiety,
correlate moderately with QOL and should be taken into consideration (Lehman, 1988), it was
found that Ambiguous Word Meanings from the COI and the global rating of general social
adjustment from the SAS-II best predicted global life satisfaction from the QOLI. Thus it appears
that global life satisfaction is most closely related to fewer depressive symptoms, more frequent
communication failures involving ambiguous word meanings, and better overall social functioning.
Having global life satisfaction predicted by less depressive symptoms and greater social
adjustment is expected, as improved psychiatric status and social interactions are important
considerations for consumers of mental health services, and can contribute to a more pleasant
and meaningful life. However, predicting global life satisfaction from a greater number of a
particular communication failure is less expected. One potential explanation is that Ambiguous
Word Meanings are the most frequently observed communication disturbance in the speech of
normals. It may be that for these persons with schizophrenia, as their speech becomes more

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 123
similar to that of normals (i.e., fewer other disturbances and more Ambiguous Word Meanings),
their functioning is improving, which could then result in improved life satisfaction.
Limitations to the Study
Certain characteristics of the study must be kept in mind when interpreting and attempting
to generalize from the results. In particular, the sample comprised predominantly of male veterans
with schizophrenia or schizoaffective disorder who were receiving care at a large midwestem
Veteran's Administration Medical Center. A smaller proportion of participants was recruited from
other sites in the same metro area that also provide services to the mentally ill. It is not known to
what extent the veterans may differ from the general population or to what extent their military
experiences may impact their functioning. In addition, this study did not address the issue of
possible heterogeneity among the study’s small subsamples. It is certainly possible that the
results of the present study are unduly influenced by the unique experiences of the individuals
under consideration, and as such may not be generalizable to the general population.
Another factor to consider is that this study was part of a larger more extensive project in
which persons with schizophrenia were recruited to participate. Numerous potential subjects
declined to participate due to the intensive nature of the larger project or due to the request that
immediate family members be approached about possible participation as well. As a result, the
refusal rate for participation was quite high and those who agreed to participate may be reflective
of a higher functioning or otherwise amenable group of persons with schizophrenia. Similar
difficulties in schizophrenia research recruitment, including refusal rates, exclusion due to
behavioral problems, and exclusion due to medical problems, have been described elsewhere
(Schreiber, Breier, & Pickar, 1990).
All persons approached to participate in this study already met criteria for participation
because their medical backgrounds were reviewed for exclusionary criteria and providers were
consulted regarding appropriateness and ability to participate in the study. Accordingly, no
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additional analyses were completed to determine if significant differences existed between the
groups of participants, refusers, and those initially excluded or deemed unable to participate.
Although limited findings were obtained from this research regarding the present sample,
some speculation can be made applying these results had another group been evaluated.
Presumably, other groups of persons with schizophrenia could be more symptomatic and lower
functioning. These persons would probably have fewer of their needs met, have less access to
resources, and in general report lower satisfaction with their overall life circumstances. Social
adjustment would be lower, in relationships with others, pursuit of social and leisure activities, and
in accomplishing work and daily responsibilities. This would result in a lessened overall social
adjustment. Neurocognitive performance would be similar to the present group, especially in light
of the fact that cognitive abilities tend to remain stable over time and that cognitive deficits vary
across individuals with schizophrenia. However, one would expect relationships between
neurocognitive performance and other variables to be stronger, possibly because functioning
would be more impaired and impacted by even relatively subtle deficits. A lower functioning group
would probably exhibit a greater frequency of overall communication failures, specifically more
Missing Information References, as this is deemed the most “schizophrenic" of the failures, and
potentially those other failures that are also more related to neurocognitive impairment (Confused
References, Ambiguous Word Meanings, and Grammatical Unclarities) as other skills may not be
able to compensate for difficulties in cognitive functioning when more symptomatic or acutely ill.
Conclusion
The concept of quality of life has developed into an important and popular concept in the
field of mental health. It has increasingly been used as a means to establish new perspectives
regarding the experiences of an individual, as well as to measure outcome of interventions. The
concept of quality of life has contributed to a common understanding about the functioning of
persons with schizophrenia for all involved, the individuals themselves, relatives, providers, and
policy makers. The objective of this study was to explore a number of variables implicated in the
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functioning of persons with schizophrenia and to determine the relationship of each of these
variables to quality of life. It is apparent that the manner in which an individual functions, whether
exhibited through symptoms, language, or neurocognitive abilities, can greatly impact his or her
interactions with others, general social adjustment, and overall quality of life. The results of this
study have immediate implications for researchers and clinicians to assist in the understanding of
the factors that contribute to quality of life and to identify potential strategies to assist in the
improvement of the quality of life of persons with schizophrenia.
The theory prevalent in the literature is that schizophrenia is a heterogeneous disorder
that nonetheless has a strong genetic component which may result in a vulnerability to the illness,
manifesting through an interaction with specific environmental factors (Gottesman, McGuffin, &
Farmer, 1987; Schultz & Andreasen, 1999). Although the exact cause of schizophrenia is
unknown, the most likely alternative is that the individual carries a susceptibility or vulnerability to
developing the illness from birth, and this vulnerability interacts with an environmental agonist
which results in the expression of the illness. In relation to the results of the current study, several
notions can be considered. The neurocognitive deficits exhibited by persons with schizophrenia
may be both a result of a genetic or early influence on brain development as well as the ongoing
impact of symptomatology that the individual experiences. Interventions in this area can aid in
improving functioning, but probably would not change the overall disease process, as it is clear by
the variation that is found among individuals with schizophrenia that cognitive impairments in and
of themselves are not diagnostic of the illness nor presumably cause the variety of impairments in
functioning that are experienced by those persons.
Potentially language disturbances are reflective of an overall brain dysfunction not specific
to schizophrenia, especially as communication failures are witnessed in the speech of normals,
other psychiatric groups, and relatives of persons with schizophrenia (Docherty, DeRosa, et al.,
1996; Docherty, et al., 1999). Thus, language production may be an accurate measure of an
individual’s functioning rather than a specific area for intervention. Language production may be a
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reflection of the disease process and be a good indicator of current functioning, similar to the role
that symptomatology plays in the assessment of schizophrenia. The subjective quality of life and
social functioning of a person with schizophrenia are probably best regarded as results of the
disease process, but are areas in which interventions can be surely be focused.
An alternative explanation is that this type of communication failure and language
production is in some way actually representative of an adaptive process. Although the CDI does
not purport to measure formal thought disorder, but rather measures the unclear references that
occur even in the speech of normals, the ambiguous references may in some way indicate that
the persons with schizophrenia are adapting to the disorder or that the communication
disturbance may in some way be helpful for the individual. Additional research exploring the
relationship between unclear references, specifically ambiguous word meanings, and adaptive,
functional, or creative aspects of the disorder of schizophrenia is certainly warranted.
It may be that both communication failures and neurocognitive performance, rather than
being diagnostic or pathognomic of the disorder, are instead more simple characteristics
associated with the genetic liability for schizophrenia and not the full expression of the disorder,
what has been called an “endophenotype" (see locono, 1998 for a review). These
endophenotypes provide additional avenues for research and attempts at understanding the
transmission and presentation of schizophrenia. These characteristics may be ones to be
monitored to determine the stage or severity of the illness, the individual’s current functioning, and
relationship to the genetic expression of the disorder, rather than representing areas to be
specifically targeted for intervention.
An important question to consider concerns how different these constructs of interest for
the present study really are. Based on the results, it is clear that Quality of Life and social
adjustment are definitely related to one another, and that an individual’s interactions with others
and ability to engage in social activities plays a large role in their satisfaction with different areas
of their life. However, as social adjustment is more an assessment of a person’s functioning, and
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quality of life involves both objective ratings of life circumstances and one’s satisfaction with those
circumstances, they should not be considered to be the same construct. However, it is not difficult
to presume that if a person's social adjustment were to improve, satisfaction with their life situation
would also increase.
The most important finding of this study is that quality of life can be best predicted by less
depressive symptomatology, better overall social functioning, and observations of language
production to identify the frequency with which persons with schizophrenia use words in such a
way that the intended meaning is not clear. These results are relevant at least to the present
group, although it is unclear whether they are generalizable to other populations or subgroups of
persons with schizophrenia. Future research may want to include additional participants who
represent a greater age range, more varied backgrounds, and who were more symptomatic than
those in the present study. A number of the present study’s results may have been specific to the
functioning of the current group, most of whom were quite stable at the time of participation. This
recommendation for future research corresponds to the suggestion by Sullivan, et al. (1992),
which indicated factors that predict greater quality of life may vary in different populations or even
within different systems of service provision. Also, this present study was purely correlational and
did not examine causal relationships between variables. Thus, predictions about how to improve
the quality of life of persons with schizophrenia are only speculative at this point, for it is not
known how changing one variable will actually alter others.
In this population, the variables of interest show an important relationship to the quality of
life of persons with schizophrenia who continue to function in the community. After considering the
overall results of this study, several possible interventions are apparent to assist in the
improvement of the quality of life of persons with schizophrenia. Strategies include decreasing
symptomatology, perhaps through medication or therapy, increasing the number of social contacts
and leisure activities of the individual, improving social relationships with family and friends,
possibly through increased contact, varied activities, or counseling, and developing rehabilitative
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or compensation strategies in the areas of verbal memory and attention. Although communication
failures in the form of Ambiguous Word References are also implicated, monitoring their frequency
may be a better indicator of an individual’s performance rather than a domain for intervention.
However, this could be an effective focus for intervention if an individual was taught strategies to
monitor their speech (focusing on areas of verbal memory and attention to attend to and evaluate
what has been said) and then to clarify instances of communication failure as they arise. In
summary, the ultimate goal for persons with schizophrenia, their relatives, and providers should
be to increase the individual’s general ability to function adequately within the community in the
hopes of improving their global life satisfaction.
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Appendix A
Checklist for Exclusionary Criteria Used During Initial Chart Review

Checklist for Exclusionary Criteria
Name:________________________ _
DOB:_____________

Last F o u r___________

Age:_______

Gender M F

Education:____________________

Ethnicity: Caucasian African-American Hispanic Asian Native American Other
Chart Diagnosis:______________

Psychotic Features: Y N

Please note pass or fail for each criterion item based on a review of the patient's
medical record or any additional sources of information.
Please note with date and source (progress note, discharge summary, psych
assessment etc.) reason why patient failed a particular criteria.

P = pass
F = fail

Source

_______

______

2) Charted IQ of less than 70 or diagnosis of mental
retardation

_______

______

3) Current alcohol or drug abuse: current or past
suostance dependence

_______

______

4) Current or past central nervous system (CNS) disease
or condition

_______

_______

5)

_______

_______

6) History of head injury with skull fracture, or loss of
consciousness of greater than 20 minutes

_______

_______

7) Physical problem that would render study measures
difficult or impossible to administer or interpret
(e.g.. blindness, hearing impairment, paralysis
in upper extremeties. etc.)

_______

_______

8) Subject is younger than 18 or older than 60______________ _______

_______

9) Significant tardive dyskinesia (i.e., DISCUS score________________
greater than 7 (total) or greater than 3 in facial
areas)

_______

10) History of electro-convulsive (shock) therapy____________ _______

_______

11) Adopted__________________________________________ _______

_______

1)

English is not subject's primary language

Medical condition or disease with likely CNS effects
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Explanation for failure:

If patient passes all exclusionary criteria, please note any mention of family in the
area who may be involved with the patient.

Central nervous system and medical diseases/conditions with likely CNS system
effects:
Cerebrovascular accident (CVA, stroke)
Transient Ischemic Attacks (TIA's)
Multi-infarct dementia
Alzheimer's disease
Frontal lobe dementia
Parkinson's disease
Huntington's disease
Multiple sclerosis (MS)
AIDS dementia
Brain tumor
Seizure disorder (epilepsy)
Cerebral palsy
Thyroid disease
Encephalitis
Lyme disease
Learning disability, dyslexia. ADHD. ADD (if diagnosed by a professional)
Hypoxic episode (loss of blood flow to brain, related to cardiac arrest caused by heart attack,
severe injury.e tc.)
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Appendix B
Comprehensive Chart Review Form

CHART REVIEW

Subject number___________
Date of entry into the study____________
Date of chart review_____________
Chan reviewed b y ____________ (Check if review is completed ____ )
Number of chan volumes________
General Chart Review Procedures

Confirm subject's self-reported socio-demographic information
Note any discrepancies:
Confirm subject's self-reported use of alcohol and other drugs
Note any discrepancies:
Confirm subject's self-reported history of onset and hospitalizations
Note any discrepancies:
Obtain copies of reports documenting symptoms of the episode leading to the first
hospitaiization or treatment. Place these in the subject’s file. Do not rely only on the
subject's retrospective self-report describing the first episode.

Medical and Psychiatric Conditions and Treatments

DISCUS Score:________

Date of DISCUS:__________

Medical Disorders ( See DSM-IV Appendix G for codes)
Review discharge summaries and note medical conditions from .Axis ID. Include all
chronic, persistent conditions from discharge summaries. Do not review outpatient notes.
Medical Condition I :
Medical Condition 2:
Medical Condition j:
Medical Condition 4:
Medical Condition 5:
Medical Condition 6:
Medical Condition 7:
Medical Condition 8:
Medical Condition 9:
Medical Condition 10:
Medical Condition 11:
Medical Condition 12:

Current
Current
Current
Current
Current
Current
Current
Current
Current
Current
Current
Current

Past onlv
Past onlv
Past onlv
Past only
Past onlv
Past onlv
Past onlv
Past onlv
Past onlv
Past onlv
Past only
Past onlv

Code
Code
Code
Code
Code
Code
Code
Code
Code
Code
Code
Code
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Current Psvchotropic Medication
Decanoate medication C ode:__
Drue I Code
Drue 2 Code
Drug 3 Code
Drue 4 Code
Drue 5 Code
Drue 6 Code
Drue 7 Code
Drue 8 Code
Drue 9 Code
Drue 10 Code:
Drue 11 Code:
Drue 12 Code:

Dose:
Dose:
Dose:
Dose:
Dose:
Dose:
Dose:
Dose:
Dose:
Dose:
Dose:
Dose:

Subject number

Dose:____ mg per injection Weeks_
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav
me/dav

Route:
Route:
Route:
Route:
Route:
Route:
Route:
Route:
Route:
Route:
Route:
Route:

Medication Compliance: _____
Rate the subject's typical level o f medication compliance for the entire six month period
prior to entry into the study. (Use outpatient notes.)
00 = Not applicable
01 = Excellent - Takes all psychiatric medications as prescribed and rarely, if ever,
forgets or chooses not to take medications
02 = Good - Generally takes all psychiatric medications as prescribed, occasionally
forgets or chooses not to take medications
03 = Fair - Although regularly takes psychiatric medications, does not take as prescribed
(i.e. alters dose or frequency), frequently forgets or chooses not to take medications.
Rarely goes longer than a week without taking medications.
04 = Poor - Takes medication inconsistently and not as prescribed, has prolonged periods
(2-3 weeks) when no medications are taken.
05 = Non-compliant - Refuses to take psychiatric medications
06 = Mixed - Has periods of compliance that would be rated at least 2 (Good) and other
periods that would be rated 4 (Poor) or lower.
09 = Unknown
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Current Outpatient Therapy
Rate period prior to entry into the study.
Therapy I:Type
Therapy 2:Type
Therapy 3:Type
Therapy 4:Type

Date began:___________
Date began:___________
Date began:___________
Date began:___________

Frequency:
Frequency:
Frequency:
Frequency:

Tvnes:
01 = Somatic: almost completely medication oriented
02 = Talk: supportive counseling, problem solving therapy, etc., where the focus is not
medication
03 = Behavioral (almost exclusively)
04 = Psychotherapy; distinguish from 2 if a specific therapeutic approach (e.g.
psychodynamic, cognitive behavioral) is noted
05 = Group therapy
06 = Case management
07 = Other
08 = IPCC
09 = Unknown
Frequency codes:
01 = once per week or more often
02 = at least once per month, but less than once per week
03 = less than once per month
History of ECT:
Use these codes for type of ECT. These are organized by courses of ECT in which an
interruption of two weeks or more in a series of ECT divided the series into two courses.
ECT 1 Type:___
ECT 2 Type
ECT 3 Type
ECT 4 Type
ECT 5 Type
ECT 6 Type

Date began:
Date began:
Date began:
Date began:
Date began:
Date began:

Date ended:.
Date ended:.
Date ended:.
Date ended: _
Date ended:.
Date ended:

Number o f treatments
Number o f treatments
Number o f treatments _
Number o f treatments _
Number o f treatments _
Number o f treatments

Current Treatment
See attached list for drug codes.
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Has patient's treatment regimen been stable for the two months prior to entry into the
study? Yes __ N o ___
Last date when psychotropic medication was changed prior to entry into the study:__
If medication is taken more than once per day. calculate to get mg. per day.
What was changed?
From: Code:
To:
Code:

Dose:
Dose:

me/dav Route:
me/day Route:

From: Code:
To:
Code:

Dose:
Dose:

me/dav Route:
me/dav Route:

From: Code:
To:
Code:

Dose:
Dose:

me/dav Route:
me/day Route:

From: Code:
To:
Code:

Dose:
Dose:

me/dav Route:
me/dav Route:

Was a decanoate drug changed? Code in weeks.
From: Code:__
Dose:
mg per injection W eeks___
To: Code:___
Dose:____ mg per injection W eeks___
Route/Interval
If NOT decanoate. enter route codes as follows
01 = Oral
02 = IV (intravenous)
03 = IM (intramuscular)
04 = Other (specify)
05 = Unknown
If coding decanoate. code the interval at which injections are received in weeks.
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Record o f Hospitalizations
! Admitted I Discharged

Davs

Location

Presenting Issues

I

T

3

4

5

6

7

8

9

10

II
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I Diagnosis

Functioning in Schizophrenia 154

12

13

14

15

16

17

18

19

20

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 155
Appendix C
Examples of the Six Communication Failures from the
Communication Disturbances Index (CDI)

Examples from the Communication Disturbances Index (CDI)

Six types of communication failure were determined to exist in the speech samples of
persons with schizophrenia. These types are described below, and examples are given.
Unclear references are boldfaced (from Docherty. DeRosa. & Andreason (1996), pp
359-360.)
1 Vague references are words or phrases that are unclear because they are
ovennclusive. They are scored only if their lack of specificity is important and
significantly diminishes the meaning communication by the utterance. They are not
usually blatantly deviant, but they leave the listener with an amorphous and questionable
impression rather than a clearty communicated meaning.
1.1 i'm hoping they don t get caught up in some o f the ills of our life, of our

society.
1.2 It seems so. you know, this, that, or the other.
2. Confused references are unclear because they could refer to one of at least two clearcut alternative referent, and the correct choice is not obvious. Confused references are
often but not always, pronouns.
2 1 He staPbed the dude and I kicked him. I thought he punched him. I thought
he was an the ground just acting like he was hurt.
2.2 My son has two children and my daughter has three. The kids have counted
on me for a lot.
3 Missing information references seem to assume that the listener has prior information
that ne or she does not have and should not be expected to have. Unqualified
references to persons, places, or things unknown to the listener are classified here, as
well as comparative references for which the basis of companson is unknown.
3 1 / like to work all right. Some of those shops were filthy. I liked the bakeries,
some of the shops are clean. (No pnor mention of any shops or bakeries.)
3.2 They let George go home, so why not me? (No prior mention of George, and
listener does not know him.)
3 3 I love the place best in the winter It’s just a total opposite then, (missing
information comparison; 'opposite' in what way? Listener does not know the
basis of comparison.)
4. Ambiguous word meanings are instances in which a word or phrase is used in such a
way that its intended definitional meaning is uncertain. This does not include instances in
which is seems that the wrong word has been chosen, but rather the word used could
have a number of different meanings in its current context, and the correct meaning is
not obvious.
4 1 He was a man that was pow in a minute. ("Pow" is unclear because the
intended definitional meaning is uncertain. Does it mean that he became violent
easily, or he was a man of action, or...?)
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4.2 Those people don't belong on the earth. God will get them.
4.3 I had a chance to grow with him but I got a divorce because I couldnt

5. Wrong word references are unclear because of a seemingly incorrect choice of word
or phrase. The meaning of the utterance seems dear, but doubt is case because of the
use of an odd of apparently inappropriate word or expression.
5.1 We 've had our qualms about me bowling, but I've always won out. (Does
she mean ‘quarrels’?)
5.2 I used to sit in the cafe, have something to eat, and just glare out into the
night. (Does he mean “stare"?)
6. Structural unclarities are instances in which meaning is unclear due to a breakdown or
inadequacy of grammatical structure. Incorrect grammar is not scored unless it results in
a loss of clarity of meaning.
6.1 I got a sister in Buffalo, New York. I've been there...must have been about

twice since I was up there.
6.2 We went to Arizona. We stopped off lots of towns between Chicago.
(Spoken by a person living in Connecticut)
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Appendix 0
First Contact Script for Participants Known to Meet Criteria for Participation

Patient Pirst-Ccrtac; Scnot
(by chone or ;n person!
10/25/CO
Heilc. this :s (research staff’s nam e) from the Minneapolis VA Meoical Center. I'm
contacting you to invite you to particioate in a study If you choose to participate, you will
be askeo to complete the procedures of the study ana will be oaid for vcur time. I'm
wcncenng :f this is a gooc time for you to talk with me about it.
Cur research is acout cognition anc cram functioning. This study examines brain wave
activity m order to determine whicn parts of the oram are affectec wnen someone has
mental or emotional difficulties. This study may help us to better understand why some
incivicuals develop these types of problems, and why others, even from within the same
family oc not. As a pan of this study we will ask your permission to contact members of
your immediate family and ask if they are willing to participate as well. W e will talk to
one of vcur family memoers about your cnildhccc and ear.y adulthood. W e will also ask
to speak with someone wno currently knows you well and can describe your social,
wcrk. anc emotional functioning.
If you participate, you would spend about ten to twelve hours 'with us at the Minneapolis
VA Medical Center, and some additional time talking with us on the phene. We will
arrange days anc times for you to come to the VA based on what fits your schedule. As
socn as you have completed the stucy. ycu will be oaid Si 20 for your time.
As part cf the stucy we will measure your brain waves while you are at rest and when
ycu are perfcrming a numoer of tasks. Measunng brain waves involves attaching
senscrs tc your cooy and heac. W e also ask ycu tc participate in a set of interviews
accut your mental anc emotional functioning ounng your life. These Interviews will touch
or areas many cecole see as sensitive and personal. You will aiso complete an
assessment cf tnmking abilities, allow us tc draw a small amount of blcod. and undergo
a neurological exam
Because we ask ycu to do so many things. I want to emphasize that any information you
tell us acout yourself or your family members is kept strictly confiaentiai. We assign a
stucy number to you and use that number to identify your information rather than your
name Also none of the information you tell us will be accessible to mecical personnel
anc will in no way affect any benefits you may receive from the VA cr any other military
cr governmental organization.
Do you have any questions7
I'd like tc ask you a couple questions to make sure you understand the nature of the
stuoy
Z What is this project studying7
I Will we ask tc contact your relatives about them participating in the study?
I Will we ask ore of your relatives about your childhood and early adulthood?
I Will we ask tc contact someone who knows you well about your social, work, and
emotional functioning?
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Does this sound like something you would be interested in doing?
Then let me ask you a few questions before we go on. (DEMOGRAPHICS
QUESTIONS)
Let's schedule you to come in to begin the study. (ASK ABOUT TRANSPORTATION.)
SCHEDULE APPOINTMENT
When you amve we will review the content of the study. You'll also have time to ask
questions.
We’d like to get more information about getting in touch with your immediate family
members when you come in to see us. Please bring your address book when you come
to your appointment. Also. I would like to get the name and phone number of a person
who knows you well nght now who would be able to tell us about you. Who would be a
good person for us to contact (GET C UR RENT INFORMANTS NAME. NUMBER, AND
RELATIONSHIP TO PATIENT).
Before coming in we will mail you a confirmation letter and a short questionnaire for you
to fill out. This letter will have additional information about the study schedule and the
location of your appointments within the VA. Could I get your address so that I can send
this letter out to you? (PUT ON FIRST PAGE) Also. I need to get your social security
number so that we can fill out the paperwork so that you can get paid for your
participation. (PUT ON FIRST PAGE)
Finally. I want to explain one part of the study in greater detail. For the EEG portion, you
will be in a laboratory working on different listening and computer tasks for about 4-5
hours. You will be given several opportunities for breaks throughout the session. While
in the lab. you will wear an elastic cap, much like a swimming cap, that holds a set of
sensors in place on your head while we record your brain activity. Wearing this cap may
leave small red marks on the scalp. For most people, these marks disappear in several
hours. W e suggest that you bnng along a hat to wear home after we are finished (like a
baseball cap or something). Also, it can get a bit chilly in the lab. and we recommend
that people bring a sweater or a sweatshirt in case they get cold.
Do you have any questions7 If you have any questions that come up in the meantime,
please call me at (612)725-2000 extension 3914 ask for (name of caller) or (other
contact person on study).
Thank you very much. W e look forward to seeing you on th e
clock.

a t ________ o

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 159
Appendix E
Participant Demographic Information Form

Demographic Information Form

Suoject I D ___
Sucjec: .mtiais

Interview date __
Interviewer initials

1. G en cer Male ’• Female
2. Birth d a te :_____ /____ /________
3. Current Age
4 Current Marital Status (circle one):
t
2
3
4
5
S

=
=
=
=
=
=

Mam ed, never divorced
Divorced and not remarried
Divorced and remained
Separated
Widowed
Never M arnecA nnulled

5. Hew many times have you been married7 _____
S. Have you ever been widowed7 Yes / No
~ Hew many chiicren do you nave"’ ___________
S. What are your current living arrangements?
' = Alone
2 = With partner, not legally married
3 = With spouse and/or chilaren
4 = With parents or adult children
5 = With siblings or other relatives
S = With frienas / roommates
7 = In a residential treatment facility
9.

Where were you born? City and Country of Birth:

10. Are you aware of any complications that occurred during your birth? Yes / No
If yes. oesenbe:
11. Is English your primary language? Yes / No
What is the ethnic background of your biological parents? (Code up to four ethnicities if
possible. See list on next page)
12. Father's country of birth / Ethnic background:_____________________ ____________
13 Mother’s country of birth / Ethnic background:____________________ ____________
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1 = Anglo Saxon
2 = Northern European (e.g.. Norwegian)
3 = West European (e.g.. French, German)
4 = East European. Slavic
5 = Russian
6 = Mediterranean
7 = Ashkenazi Jew
8 = Sephardic Jew
9 = Hispanic (not Puerto Rican)
10 = Puerto Rican Hispanic
11 = Mexican Hispanic
12 = Asian
13 = Arab
14 = Native American / Alaska Native
15 = African American, not of Hispanic Origin
16 = Other, Specify_______________________
99 = Unknown
14 Education: Highest completed grade/degree:

a) subject
1
2
3
4
5

b) fa th e r

c) mother

d) spouse___

7th grade or less
Between 7th and 9th grade
Between 10th and 12th, but not graduated.
High school graduate (includes GED)
Partial college (includes business school, vocational/technical, RN)
6 = 4 year college/university graduate
7 = Graduate degree (M .A., Ph.D., M.D.. J.D.. etc.)
9 = Unknown

14.

=
=
=
=
=

Usual Work Status:
a), s u b je c t
b). father.
1
2
3
4
5
6
7

=
=
=
=
=
=
=

. c). mother.

full time (40 hrs/week or more)
half-time (approx 20 hours/week)
quarter time (approx 10 hours/week)
unemployed
retired
homemaker
student

d). spouse____
8 = volunteer work -fu ll time
9 = volunteer work -p a rt time
10 = disabled
11 = never worked at least 30% time
12 = other (specify)
99 = unknown

15 Have you been working or going to school in the past month? Y / N
15a. (If unemployed) How long have you been unemployed?
(Code length in months. Use as anchor point either last job of at least two
months duration or last period in school. Use age 18 if subject has never been
employed. Do not code as unemployment scheduled vacations from school or voluntary
homemakers.)
Length of unemployment in months:_________
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16 W hat is your present occupation? (Code occupation using chart below.)
Record response.______________________________________
17 W hat is the most responsible job you have ever held? (Code occupation using chart
below i
Record response:_____________________________________
18. (IF SUBJECT IS NOT HEAD OF HOUSEHOLD:) What is/was the occupation of the
head of household dunng most of their working career? (Code occupation using chart
below.)
Record response:______________________________________

Managerial and Professional Specialty Occupations
1 = Executive, administrative, and managerial occupations
2 = Professional specialty occupations
3 = Writers, artists, entertainers, and athletes

Technical. Sales, and Administrative Support Occupations
4 = Technicians and related support occupations
5 = Sales occupations
6 = Administrative suoport occupations, including clerical

Service Occupations
7 = Pnvate household occupations
8 = Protective service occupations
9 = Service occupations except protective and private household

Farming. Forestry. And Fishing Occupations
10 = Farm operators and managers
11 = Other farming, forestry, and fishing occupations

Precision Production. Craft and Repair Occupations
12 = Mechanics and repairers, construction trades, extractive occupations,
precision production occupations

Operators. Fabricators, and Laborers
13 = Machine operators, assemblers, and inspectors
14 = Transportation and material-moving occupations
15 = Handlers, equipment cleaners, helpers, and laborers

Other
16
17
18
19
20
21
22
99

= Armed Services
= Disabled
= Housewife / homemaker
= Never worked
= Full time student
= Unemployed
= Retired
= Unknown
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13.

Annual Income: Average annual household income in past 5 years.
(Gross income based on tax returns.)
1
2
3
4
5

=
=
=
=
=

Under 510,000
S10 ,0 0 0 -$ 2 0 ,0 0 0
S20.000 - 530,000
S30.000 - 550,000
S50.000 - 595,000

o = S95.000 and up
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Appendix F
First Contact Script for Participants Undetermined to Meet Criteria for Participation

Unscreened Patient First-Contac: Script
(by phone)
3/20/01

Hello, this is (research s ia ff s name) from the Minneapolis V.A Medical Center. I'm contacting you
to because you expressed an interest in finding out more about our research study. If you choose to
participate, you will be asked to complete the procedures of die study and will be paid for your
time I'm wondering i: this is a good time for you to talk with me about it.
Our research is about cognition and brain functioning. This study examines brain wave activity in
order to determine which parts of the brain are affected when someone has mental or emotional
difficulties. This study may help us to better understand why some individuals develop these types
of problems, and why others, even from within the same family. do not. As a pan of this study we
will ask your permission to contact members of your immediate family and ask if they are willing
to participate as well. Immediate family members include parents under the age of TO. full brothers
and sisters or adult children. Do you nave anyone who fits that description who lives in the area?
We will talk to one o f your family members about your childhood and early adulthood. We will
aiso ask to speak with someone who currently knows you well and can describe your social, work,
and emotional functioning right now.
I: you participate, you would spend about twelve to fifteen hours with us at the Minneapolis VA
Medicai Center. W'e will arrange days and times for you to come to the VA based on what fits your
schedule. As soon as you 'nave completed the study, you will be paid SI30 for your time.
As part of the study we will measure your brain waves while you are at rest, just sitting in a chair,
ltd when you are performing a number of tasks on a computer. Measuring brain waves involves
attaching sensors to your body and head: it's like having an EEG. if you've had one of those done
before. We aiso ask you to participate in a set of interviews about your mental and emotional
functioning during your life. These interviews will touch on areas many people see as sensitive and
personal. You will also complete an assessment of thinking abilities, allow us to draw a small
amount of blood (less than a teaspoon), and undergo a neurological exam. That's when the doctor
looks at your reflexes, watches the way you walk, looks to see if there's any tremor in your hands,
and asks you to do a few simple tasks on a computer.
Because we ask you to do so many things. I want to emphasize that any information you tell us
about yourself or your family members is kept strictly confidential, and that begins now with
anything you say to me on the phone. We assign a study number to you and use that number to
identify- your information rather than your name. Also, none of the information you tell us will be
accessible to medical personnel and will in no way axfec: any benefits you may receive from the
Y A or a n y other military or governmental organization.
Do you have any questions?
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I'd like to ask you a couple questions to make sure you understand the nature of the study.
What is this project studying?
6 Will we ask to contact your relatives about them participating in the study?
Si Will we ask one of your relatives about your childhood and early adulthood?
fi Will we ask to contact someone who knows you well about your social, work, and emotional
functioning?
Does this sound like something you would be interested in doing?
In order to determine if you would be eligible to participate in this study, [ would need to go
through a short interview with you. I will ask you some questions about your physical health,
background, and life experiences. Do you have time to do that now? (IF AGREES TO
INTERVIEW NOW): At this time I would like to make sure that I have your permission to ask you
a series of personal questions about your background over the phone today, for the purpose o f
determining if you fit our requirements for participating in this study.
(VERBAL CONSENT IS REQUIRED BEFORE PROCEEDING. ANSWER ANY QUESTIONS
THEY HAVE.)
Do I have your permission?
(IF YES PROCEED TO “HEALTH HISTORY SCREEN" AND “DEMOGRAPHIC
INFORMATION FORM”)
If caller is excluded at any point during screening interview, skip to excluded / wait list script
(last page).
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ACCEPTED SUBJECTS:
Let's schedule you to come in to begin the study. (ASK ABOUT TRANSPORTATION.)
SCHEDULE APPOINTMENT
When you arrive we will review the content of the study. You'll read and sign a consent form and
we'll make a copy for you to take. You'll also have time to ask questions.
We'd like to get more information about getting in touch with your immediate family members
when you come in to see us. Please bring your address book when you come to your appointment.
Also. I would like to get the name and phone number of a person who knows you well right now
who would be able to tell us about you. Who would be a good person for us to contact (GET
CURRENT INFORMANT'S NAME. NUMBER, AND RELATIONSHIP TO PATIENT).
Before coming in we will mail you a confirmation letter and a short questionnaire for you to fill out.
This letter will have additional information about the study schedule and the location o f your
appointments within the VA. Could I get your address so that I can send this letter out to you?
(PUT ON FIRST PAGE) Also. I need to get your social security number so that we can fill out the
paperwork so that you can get paid for your participation. (PUT ON FIRST PAGE)
We would also like to have your permission to review your medical records so that we can get more
information about your background and the treatment you have received. We will ask you to sign a
release of information to document that it's okay with you for us to look at these records. I will put
this in with your confirmation letter along with a return envelope. Please sign the release and send
it back right away so that we have time to look at your records in advance, before you come in for
the study.
Finally. I want to explain one part of the study in greater detail. For the EEG portion, you will be in
a laboratory working on different listening and computer tasks for about 4-5 hours. You will be
given several opportunities for breaks throughout the session. While in the lab. you will wear an
elastic cap. much like a swimming cap. that holds a set of sensors in place on your head while we
record your brain activity. Wearing this cap may leave small red marks on the scalp. For most
people, these marks disappear in several hours. We also use a substance that looks like hair gel or
vaseline so that the sensors work properly. It gets in your hair and gets a bit messy. We do have
shampoo if you'd like to wash your hair when you're done. Otherwise, we suggest that you bring
along a hat to wear home after we are finished (like a baseball cap or something). Also, it can get a
bit chilly in the lab. and we recommend that people bring a sweater or a sweatshirt in case they get
cold. Finally, we ask that the day before you come in for the lab you not drink any alcohol and that
you do your best to get a good night's sleep so you will be well rested and not sleepy during the
testing.
Do you have any questions? If you have any questions that come up in the meantime, please call me
at (612)725-2000 extension 3914 ask for (name o f caller) or {other contact person on study).
Thank you very much. We look forward to seeing you on the

a t_______ o clock.
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IF CALLER WAS EXCLUDED OR LIKELY TO BE EXCLUDED:
I warn to thank you for completing this interview. Unfortunately, we are looking for people with a
slightly different background than your own to participate in the study, so we cannot schedule you
at this time. Would you be interested in keeping your name on a waiting list in case this changes?
(circle YES ' N'O) If we do not call you back about participating in this study, would you like us to
keep your name and possibly contact you about other studies we may do in the future? (circle YES
' NO) Thank you again for taking an interest in our research.

IF CALLER MIGHT BE APPROPRIATE FOR STUDY:
I want to thank you for completing this interview. I would like to double check on the backgrounds
o f the current group o f people who are already in the study. If we need people with backgrounds
like yours, we would call you back within two weeks. When would be a good time to reach you?
May I leave a message for you? Thank you again for taking an interest in our research.
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Health History Screen

I f English is nor the subject s primary language, they are excluded-you can ask at any point if vou
suspect they are not a native English speaker
General Note: Conditions that are ALWAYS exclusions are underlined For conditions that \L4 Y
OR .VIA Y NOT be exclusions, ask follow-up questions to get more information (use the ones
provided plus your own i f necessary). then go to the "Might be appropriate " wait list script. We
will discuss these cases and call them back to let them know i f we will include them or not.
1. How old are you? ______ Exclude i f over 60 or under 18.
2. Are you adopted? Y / N
3. Since this is a family study, in order for you to participate you need to have fa m ily members
who may be willing to participate as well. Which o f your family members live in the area?

4. Do you have other family members that don't live in the area but visit you on a regular basis?

(THERE MUST BE AT LEAST TWO RELATIVES WHO WOULD BE ELIGIBLE FOR THE
STUDY WHO LIVE CLOSE ENOUGH OR VISIT REGULARLY ENOUGH TO MAKE
PARTICIPATION POSSIBLE.)
(IF FAMILY MEMBERS .ARE AVAILABLE. NEXT VERIFY THAT PATIENT HAS
PSYCHOTIC SYMPTOMS.)
5. Are you currently receiving treatment for mental or emotional problems?
Brief description (ensure that caller fits one o f the patient groups):

IF PATIENT DOES NOT SPONTANEOUSLY REPORT PSYCHOTIC SYMPTOMS. ASK THE
FOLLOWING QUESTIONS FROM THE DIGS:
I would like to read you a list of experiences that other people have reported. Tell me which ones
you have had.
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Has there been a time when...
Vou heard voices'? For example, some people have had the experience o f hearing people's voices
whispering or talking to them, even when no one was actually present.

You had visions or saw things that were not visible to others?

You had oeliefs or ideas that others did not share or you later found out were not true—like people
being against you. people trying to harm you. or people talking about you?

You believed you were being given special messages (e.g. through the TV or the radio)?

You believed that you had done something terrible for which you should be punished?

You believed that you were especially important in some way. or that you had powers to do things
that other people could not do?

You had the feeling that you were under the control of some force or power other than yourself?

You had a change in your body or in your physical appearance that others could not see?

6. Do you currently have any medical problems or conditions?
YIN
6a. Specify_______________________________________________________________

7. .Are you currently taking any kind of medication? Y / N’
7a. Specify’_______________________________________________________________

7b. (If taking medication that may potentially cause TD, ask): What side effects are you
experiencing?_____________________________________________________________

8.

Have you ever been hospitalized for a medical problem? Y / N
8a - 8b. What for. and how long?
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9. Have you ever had an injury to your head"?
Y.N
9a. IF YES: Did you have to go to the hospital? Y ’N
10. Have you ever been unconscious?
Y!N
10a. IF YES: For how long? _______
11. Have you ever had a seizure or convulsion?

Y •' N'

12. Do you have any other kind of problem with vour brain or spinal cord?
12a. IF YES.’ Specify________________

Y 'N

Exclusions: Seizure, convulsion, hospitalization overnight for head injury, any significant problems
with brain or other part o f central nervous system.
13. Have you ever received ECT? Y / N
14. Do you have any problems with your eyes? Y /N (Exclusion: Visual problem not correctable
with glasses or contacts that would interfere with doing study procedures.)
15. Do you wear a hearing aid? Y /N (Exclusion, interferes with EEG.)
16. Do you have any problems such as paralysis, serious arthritis, back pain (anything that would
make it very difficult for them to perform tasks or tolerate sitting fo r long periods o f timef!

17.

What are your drinking habits like? (Frequency, amount, current problems or treatment.)
(If you suspect current abuse or dependence, skip to SCID questions)
(Exclude for current abuse or dependence, past abuse or dependence is acceptable.)

18. .Are you currently using any street drugs? (Frequency, amount, current problems or treatment.)
(If you suspect current abuse or dependence, skip to SCID questions)
(Exclude for current abuse and fo r current or past dependence. Past abuse is acceptable.)

18a. When in your life were you using drugs the most?
(Skip to SCID questions if past dependence seems possible.)
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Let me check for some more specific medical problems:
19. Do you have any serious or chronic illnesses like cancer, diabetes, cerebral palsv. M.S.
(Multiple Sclerosis), or HTV?
Y N
19a. Specify-_____________________________________________
(If Yes lo cerebral palsy or M.S., exclude. I f yes lo cancer, diabetes, or HIV. get more
information,)
Follow-up questions:

For cancer, diabetes, and HIV:
19b. Have you noticed any changes in your thinking since being diagnosed? Y / N'
19c. .Any problems with memory, concentration, or attention? Y /N
I9d. Has your doctor told you that your central nervous system (brain and spinal cord) has
been affected in any way? Y / N
Diabetes:
I9e. How well-controlled is it? ________________________________________
19f. What complications have you experienced? ___________________________
Cancer: 19g.What kind do you have?_____________________________________________
I9h. Are you receiving treatment at the present time?_________________________
I9i. How is it affecting you physically and mentally?_________________________
HIV:
19j. What symptoms are you having?________________________________________
19k. How is it affecting you physically and mentally?___________________________
20. What about any endocrine diseases, thvroid disease, historv of encephalitis, or eoilepsv?
Y N (If Yes to encephalitis or epilepsy, exclude. Endocrine, thyroid - more infoi
Follow-up questions for endocrine or thyroid diseases:

20a. Which one do you have?__________________________________________________
20b. Have you noticed any changes in your thinking since being diagnosed? Y /N
20c. .Any problems with memory, concentration, or attention? Y / N
20d. Has your doctor told you that your central nervous system (brain and spinal cord) has
been affected in any way? Y ' N
21. Do you have any heart or cardiovascular problems (history of heart attack, stroke, or T.I.A.l?
Y . N (Exclude for stroke. TLA. do not exclude fo r high blood pressure, angina, etc.)
Heart attacks may or may not be excluded-get more information.
Follow-up questions for heart attacks:

21a. When was it?___________________________________________________________
21b. How serious was it?_____________________________________________________
21c. Was blood flow to your brain interrupted at all during the attack? Y /N
2Id. IF YES, for approximately how long?_______________________
21e. Have you noticed any changes in your thinking since this happened? Y ' N
21 f. .Any problems with memory, concentration, or attention? Y / N
21 g. Has your doctor told you that your central nervous system (brain and spinal cord) was
affected in any way? Y /N
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Attached questions from SCID are to be used as necessary to clarify problems. Skip if not
needed. I f subject has not been excluded, proceed to Demographic Information.
SUBSTANCE USE
Alcohol Abuse Criteria (Current Only):

Have you ever missed work or school because you were intoxicated or very hung over? (How
often?)

Did you ever drink in a situation in which it might have been dangerous to drink at all? (Did you
ever drive while you were really too drunk to drive?)

Has your drinking ever gotten you into trouble with the law? (How often?)

Has your drinking caused problems with other people, such as your family, friends, or people at
work?
(Have you ever gotten into physical fights or bad arguments because of your drinking? Did you
keep drinking anyway?)

If YES to arty one o f the four above, this indicates alcohol abuse. Exclude if current ('within the
past month) abuse or dependence.
Drug Abuse and Dependence

Have you ever used street drugs? IF YES: What. when, and how often.

Have you ever gotten "hooked" on a prescribed medication, or taken a lot more o f it than you were
supposed to? fF YES: What. when, and how often.

For the following questions, focus on the drug used the most.
Drug Abuse Criteria (Current only):

Have you ever missed work or school because you were high or very hung over? (How often?)

Did you ever use drugs in a situation in which it might have been dangerous to use any drugs at all?
(Did you ever drive while you were really too high to drive?)
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Has your drug use ever gotten you into trouble with the law? (How often?)

Has your drug use caused problems with other people, such as your family, (fiends, or people at
work? (Have you ever gotten into physical fights or bad arguments because of your drug use? Did
you keep using anyway?)

It' YES to any one o f the four above, this indicates drug abuse. Exclude if current (within the past
month). I f past history o f drug abuse, proceed to assess fo r dependence.
Drug Dependence Criteria (Any time in subject’s life)

Have you often found that when you started using (drug) you ended up using much more than you
were planning to? (IF NO: What about using it for a much longer period of time than you were
planning to?)
Have you tried to cut down or stop using (drug)? (IF NO: Did you want to stop or cut down?)
(Evaluate whether there is a persistent desire or multiple unsuccessful attempts to reduce use.)

Have you spent a lot of time using (drug) or recovering from its effects?

Have you had times when you would drink so often that you used (drug) instead of doing other
things, like working, spending time with family or friends, or spending time at hobbies?

Has your drug use ever caused you psychological problems like making you depressed or anxious,
making it difficult to sleep, or causing blackouts? Has your drug use ever caused physical health
problems, or made a physical problem worse? (IF YES TO EITHER: Did you keep using it
anyway?)

Have you found that you needed to use a lot more of the (drug) to get the feeling you wanted than
you did when you first started? (IF YES: How much more? IF NO: What about finding that when
you used the same amount, it had much less effect than before?) (Indicates tolerance.)

Have you ever had any withdrawal symptoms when you cut down or stopped using (drug)? What
about using some (drug) to keep yourself from getting sick?

(ASK IF UNKNOWN) Did these problems (review symptoms subject endorsed) all occur at the
same time? (If at least three o f the above symptoms occurred within the same 12 month period, this
indicates drug dependence, and subject is excluded.)
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Appendix G
Participant Consent Form

Department o f Veterans Affairs
V a RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M50901)
(page 1 of 7)
Subject Name:________________________ Date:______________
Title o f Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator Scott R. Sponheim. Ph.D. V'aMC: Minneapolis
INTRODUCTION

It is important that you read and understand the following explanation of the proposed
research study before you agree to participate. This consent form describes:
• The purpose.
• The description of the study.
• The benefits.
• The risks and/or discomforts /including any potential for pain).
• Steps taken to decrease or eliminate the risks, discomforts, or possible pain.
• .Any other treatments that may be available, and

• Confidentiality and use of research results.
Whether you decide to participate or not. treatment at die VA or the University of
Minnesota for which you are eligible will not be affected.
This consent form may contain words that you do not understand. Please ask the
study doctor or the study staff to explain any words or information that are unclear
to you.
PURPOSE OF THE STUDY

The purpose o f this study is to understand thinking functions in individuals with mental
disorders and their relatives. By measuring your brain wave activity while you perform a
number of tasks, this study may enhance the understanding o f the brain mechanisms that
account for mentai disorders. The results o f this study may lead to wavs of treating
problems that lead to mental disorders. You have been asked to participate in this study
because you are a person who may suffer from a disturbance in thought processes. Your
participation is expected to last about one month.
DESCRIPTION OF THE STUDY

If you agree to be in this study, we would ask you to do the following things:
ai Clinical Interview. You will be asked a standard set o f questions regarding
your health, emotions, personal life, and mental health treatment. These procedures
assess the degree to which any emotional disturbance is affecting your life and how to
classify any emotional problems you might be having. You may have already completed
portions o f the interview by telephone.
b i Questionnaires. You will complete a set of questionnaires that ask about your
health, emotions, personal life, opinions, and experiences.
c) Neuropsychological Assessment. You will complete a 3-hour testing session
Subject's Signature________________________
Subject Social Security
VA Form 10-1086

-

_______________________
Consent form as of 3/20/01
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Department of Veterans Affairs
VA RESEARCH CONSENT FORM
Protocol #2511
Subject Name:________________
Title o f Study: Cognitive Deficits as Indicators o f Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis

with a research staff member that assesses your cognitive functioning. During the session
you will be given tests of memory, attention, problem solving, reasoning, motor skills,
and language.
d) Application o f Electrodes and Psvchophvsiological Session. You will be asked
to sit in a comfortable chair while your head size is measured with a measuring tape and
electrodes are applied to your body and an electrode cap is fitted to your head. The
electrode cap is a close-fitting cloth cap. It has recording electrodes embedded in its
surface. The first step is to simply put it on your head. Each electrode site is then rubbed
briefly to establish a secure contact between the electrode and scalp. In addition, a small
dab o f gel, similar to Vaseline, is applied to the scalp where each electrode is located.
The gel makes it easier for the electrical signals from your brain be measured. We will
also place electrodes behind or on each ear. near each eye. and on your arms and legs in
order to measure your eye movements and other bodily electrical signals. The electrode
cap is held firmly in place with a chinstrap or elastic strip that is placed around your
chest. Once the electrodes are in place, you will complete several tasks that will be given
by a computer. Some of these tasks may be mentally challenging and can last about 30
minutes. Other tasks are quite simple and last only several minutes. These tasks will be
conducted while you are wearing the electrode cap and your brain electrical activity is
recorded. The completion of the psvchophvsiological session will take between four and
five hours.
e) Neurological Exam. You will complete a one-hour standard neurological exam
where a trained researcher will make notes about your bodily features, ask you to perform
various movements while you are being observed, and test your reflexes. The researcher
will also examine your fingers under a microscope.
f) You will be asked to provide the name o f someone who can give reliable
information to study staff regarding your emotional and social functioning, and the name
and location of a family member who can provide reliable information regarding your
childhood development. You may have already provided some of this information by
telephone.
g) You will be asked to provide the names, telephone numbers, and locations of
individuals in your immediate family and family o f origin. Your relatives may be
contacted and invited to participate in the study.
h) You will have a small sample of blood (about 1 teaspoon) drawn by a vein stick
and stored for possible future genetic analysis. The blood sample will be stored in a
locked cabinet that only research staff can access. The blood sample and the DN'A

Subject's Signature___________________
Subject Social Security - _______________________
V A F o rm 10-1086

Consent fo rm as o f 3/20/01

of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 175

Department o f Veterans Affairs
VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M50901 )
(page 3 of 7)
Subject Name:_________________________Date:_______________
Title of Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scon R. Sponheim. Ph.D. VAMC: Minneapolis

obtained from the sample will be stored with a subject code for up to 20 years. Only the
principal investigator and the project coordinator will have access to the code linking
your name to your subject number, [f genetic analyses are carried out on the blood
sample or DN'A. they will be done on a "research” basis. This means that the results may
not ever be available to you. When the analyses are done the DNA sample will be
retained by the study staff or the lab doing the tests. If for some reason you withdraw
from the study the blood sample and DNA will be kept by the study unless you tell the
study staff you don’t want the sample kept. There is the possibility that you will be
approached at a later date for follow-up information or a follow-up DNA sample. If you
are contacted at a later date you have every right to refuse participation.
The total time o f all study procedures is 10 to 15 hours.
Exclusion criteria. You are not eligible for the study if 1) English is not your or
your family's primary language. 2) you have a measured IQ of less than 70 or a diagnosis
of mental retardation. 3) you have a history of dependence on alcohol or drugs, or are
currently abusing alcohol or drugs. 4) you have a history of central nervous system
disease. 5) you have suffered a head injury with skull fracture or significant loss of
consciousness, 6) you have a physical problem that would render study measures difficult
or impossible to administer or interpret (e.g.. blindness), 7) you are less than 18 years of
age or older and 60 years, or 8) a history of electro-convulsive therapy.
As part of this study you will have a 10 to 15 minute sample o f your speech
recorded for data collection purposes, and may have responses to questions recorded on
audio or videotape for data collection and educational purposes. The tapes and other
study data will be kept for up to 20 years, with no information that directly identifies you.
RISKS .AND/OR DISCOMFORTS

The study has several risks: First, you may become bored, tired, or uncomfortable while
completing the computer tasks. Second, you may find the tasks mentally challenging.
Third, use o f the electrode cap requires that we rub the electrode sites once the cap is
positioned on the head. This rubbing is scratchy which some people find uncomfortable.
We will measure your brain waves while you are at rest and when you are performing a
number of tasks. Although we will wash off gel from the electrode sites at the end of the
session, you may find a small bit left in your hair when we are finished. This gel will
wash out with shampoo. Some minor skin irritation is possible in reaction to the
electrode cap application: however, reddening of the skin from the pressure of the cap
typically resolves within 24 hours. Finally, as part of study interviews, questions may be
Subject’s Signature________________________
Subject Social Security - _______________________
V a Form 10-1086

Consent form as of 3/20/01

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Functioning in Schizophrenia 176

Department o f Veterans Affairs
VA RESEARCH CONSENT FORM
Protocol « 5 1 1 (HSC #0005M50901)
(page 4 o f 7)
Subject Name:________________________ Date:
Title o f Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis

asked which touch on sensitive issues. Consequently, you may experience pleasant or
unpleasant emotions during the interview process. You may refuse to answer any
questions you do not wish to answer at any time: however, this may lead to the
discontinuation of the study protocol. Finally, you may experience some pain when the
blood draw is completed to obtain a small sample of blood from your body. Possible side
effects from blood drawing include faintness, inflammation of the vein, bruising, or
bleeding at the site of the puncture. There is also a slight possibility o f infection.
BENEFITS

No benefit is guaranteed from your being in this study. The knowledge gained from this
study may benefit others in the future.
COMPENSATION

.After the completion o f the study, you will receive a payment of $ 130 for your
participation. Travel reimbursement will be provided to you at 17 cents a mile if you
have to travel more than 40 miles to the Medical Center to participate in the study. If you
withdraw your participation before finishing the study, you will be paid for the portion of
the study you have completed on a pro-rated hourly basis ($10 per hour).
CONFIDENTIALITY AND USE OF RESEARCH RESULTS

The results o f this study may be published or presented but your identity and records will
not be revealed unless required by Federal Law. A Federal Law allows the U.S. Food and
Drug Administration and the Institutional Review Board to review records. Because of
the need for these inspections, absolute confidentiality cannot be guaranteed.
COSTS TO YOU FOR PARTICIPATING

There is no cost to you for taking pan in this study. All the study costs, including any
procedures related directly to the study, will be paid for by the VA Medical Center.
Participants who must make a co-payment for their usual medications or treatments will
continue to be required to make such a co-payment for non-study related drugs. There
should be no additional medical costs to you for taking part in this study. However, study
visits may result in transportation costs and possible wages lost due to time missed from
work.
MEDICAL CARE IF YOU ARE INJURED

In case you are injured from this research study, treatment will be available, including
first aid, emergency treatment and follow-up care, as needed. The VA Medical Center
Subject's Signature_______________________
Subject Social Security = _______________________
VA Form 10-1086

Consent form as of 3/20/01
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Department of Veterans Affairs
VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M 5090l)
(page 5 o f7)
Subject Name:________________________ Date:______________
Title o f Study: Cognitive Deficits as Indicators o f Genetic Liabilitv in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis

will provide necessary medical treatment for any injury or iiiness that may arise from
your participation in this research study. The VA Medical Center will provide payment
for necessary emergency medical treatment. However, the VA Medical Center must be
contacted at (612) 725-2003 within 72 hours in the event of any non-VA treatment or else
you may lose any eligibility for VA payment o f emergency bills.
COMPENSATION FOR ANY INJURIES

You have not released the VA Medical Center for liability by signing this form. This
includes but is not limited to. free medical care other than as described in this consent
form, payment of lost wages, or compensation for pain and suffering. Compensation for
those items from the VA may be available under applicable Federal Law. You should
immediately report any injuries resulting from your participation in this study to Dr.
Sponheim at (612) 725-2074 during the day during the evenings or week-ends, by calling
the Psychiatry Fellow on call at (612) 725-2000.
NEW INFORMATION

You will be given any new significant information that is discovered during the course of
this study that may influence your willingness to continue the study.
OTHER INFORMATION

The researcher conducting this study is Dr. Scott R. Sponheim. You may ask any
questions you have now. If you have questions later or study-related problems arise, you
may contact him at the Psychology Service at the VA Medical Center in Minneapolis.
Phone:(612) 725-2074.
If you have any questions or concerns regarding the study and would like to talk to
someone other than the researcheifs), contact Patient Relations Department, B-310 Mayo
Memorial Building, 420 Delaware Street S.E.. Minneapolis. Minnesota 55455: telephone
(612)273-5050.
Your decision whether or not to participate will not affect your current or future
relationships with the University o f Minnesota or the Minneapolis VA Medical Center. If
you decide to participate, you are free to withdraw at any time without affecting those
relationships. When in the investigator's opinion, it would be detrimental for you to
continue, your participation in the study will be terminated.

Subject's Signature________________________
Subject Social Security e _______________________
VA Form 10-1086
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Department o f Veterans Affairs
VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M5090l)
(page 6 of 7)
Subject Name:________________________ Date:______________
Title of Study: Cognitive Deficits as Indicators o f Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis
RESEARCH SUBJECT'S RIGHTS: I have read or have had read to me all o f the
above. Dr. Sponheim or one of his research staff has explained the study to me and
answered all of my questions. I have been told of the risks or discomforts and possible
benefits of the study.

I understand that 1 do not have to take part in this study and my refusal to participate will
involve no penalty or loss of rights to which I am entitled. I may withdraw- from this
study at any time without penalty or loss of VA or other benefits to which I am entitled.
The results of possible future genetic analyses will not have an effect on my care.
Therefore, neither my doctor nor I will receive results of this testing. No medical report
will be added to my records. My medical records may be reviewed in the future for
purposes of obtaining more information about my health but my name and address will
remain confidential and will not be released.
The results of this study may be published but my identity and records will not be
revealed unless required by law.
In case there are medical problems or questions. I have been told I can call Dr. Sponheim
at (612) 725-2074 during the day and Psychiatry Fellow on call at (612) 725-2000 after
hours. If any medical problems occur in connection with this study the VA will provide
emergency care.
If I have any question about the rights of a research subject, I understand that I may
contact the VA Patient Representative at (612) 725-2106.
My questions have been answered and I voluntarily consent to participate in this study.
By signing this form. I have not given away any o f my legal rights, which I have as a
subject of this research study. I will receive a signed copy of this consent form.

Subject's Signature

Date

Signature of Investigator

Signature of person obtaining consent
if other than the investigator

Signature of Witness
Subject Social Security - ___
VA Form 10-1086

Approved: / / ~ /
Approval expires: j ! r
Chnlr, ESS: C-

‘■’ I __
' *7 ~
uT-

Consent form as^of 3/20/01
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Department o f Veterans Affairs
VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M50901)
(page 7 o f ? )
Subject Name:________________________ Date:_______________
Title of Study: Cognitive Deficits as Indicators o f Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis

SUBJECT’S UNDERSTANDING OF THE STUDY:

Please answer each of the four questions below to confirm that you understand this study.
As you answer these questions, you may look at other pages of this form and ask the
research staff any questions you may have regarding the study.
1) What are two risks or discomforts involved in this research study?
A. ____________________________________________________________________
B. ____________________________________________________________________
2) Name two things you will be asked to do during this study.
A. ____________________________________________________________________
B. ____________________________________________________________________
3) What would you do if you decided that you no longer wanted to participate in the
study?

4)

What would you do if you were experiencing distress or discomfort in the study0

Subject's Signature

Date

Signature of person obtaining consent

Subject Social Security = ________________
V A Form 10-1086

Consent form as of 3/20/01
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Appendix H
Department of Veteran’s Affairs Release of Information Form

D e p a r t m e n t o f V e t e r a n s A f f a ir s
Medical Center
One Veterans Oriue
Minneapolis M N 55417

r*. S « 0 ‘ V

.• '2 : 1 2 : .:

*0

1 * -»3

.< a s e :

S3'.::

'0 3 :

W e w o u ld appreciate your cooperation :n forw arding medical records or in fo rm a tio n to assist our medical
start m the examination and/ o r treatm ent or die patient named above:
• _ Final summary o r report or hospitalization _ _ _ _ _ _ _
(Dates.
L_ B rief report o f examination o r treatm ent .
(Dates.

_

X -ra y turns and report
O tner (specify;

Please use the preaddressed envelope/lace: as appropriate, to r forwarding die requester inform ation. X -ray
Sims anc laboratory slides w ill be returned after review.

Sincerely,

Chief, Medical Admuusrranon Service

? _ 2 a s 2 s a r .c a _ _ r e c c r a a
o r i c g a : H e g e -a r ., M.A..
M in r.a a p cli.3 VA M e d ic a l C ar.ca:
i 153
Or.e V a c a r a r .’ s D r iv e
M i a r . a a p c l i s , Mil
5 5 -1 7

E nds.

I authorize you to release the medical inform ation requested above :o the Veterans Adm inistration.
1 understand that I mav revoke this authorization at any time except to the extent that action has already
been taken to comply w ith it. W ith o u t my express revocation, this consent w ill automatically expire after
che requested inform ation has been supplied to the Veterans Admuustranon.

Signature o f Patient or A uthorized Representanve

Date

N O T E : The inform ation requested on this form letter is solicited under T id e 38, U .5.C and w ill authorize
the addressee to disclose the info rm atio n you specify to the Veterans A dm inistration. The miormanon w ill
be used to assise our medical sta ff in you r examination and treatment. Your disclosure o f che inform ation
requested is voluntary. However, you r failure to give your consent may result in incomplete inform ation on
w hich to base your treatment.

FL 1C-212
Fro 138CIM5)
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Table 1
Description of Novel and Conventional Antipsychotic Medications, Average Daily Dosages, and
Chlorpromazine Equivalents for Each

Medicationa
Generic Name

Trade Name

Average
Dosage
(mg/day)

Apparent
Chlorpromazine
Equivalence (mg)

Novel Agents
Clozapine

Clozaril

468.75

Olanzapine

Zyprexa

14.17

Quetiapine

Seroquel

225.00

Risperidone

Risperdal

6.27

100
4
150
2

Conventional Agents
Chlorpromazineb

Thorazine

Haloperidal

Haldol

Loxapine

Loxitane

Perphenazine

100
19.57

4

200.00

25

Trilafon

40.00

8

Thiothixene

Navane

40.00

10

Trifluoperazine

Stelazine

40.00

6

Note. Apparent Chlorpromazine equivalence corresponds to the “apparent clinical equivalence in
schizophrenia” from Clinical Handbook of Psychotropic Drugs (p. 89 - 91), by K. Z. BezchlibnykButler and J. J. Jeffries, 2001, Toronto, Canada: Hogrefe & Huber Publishers.
a The medication list refers only to those medications that were prescribed to participants in the
current study. This is not a complete list of antipsychotic medications, b No participants were
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prescribed Chlorpromazine, however this is included in the table for comparison purposes as
medications are reported as Chlorpromazine equivalents.
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Table 2
Interrater Reliabilities for Ratings of Communication Disturbances

CDI Communication
Disturbance

Intraclass r

Vague References

.93

Confused References

.58

Missing Information References

.80

Ambiguous Word Meanings

.92

Wrong Word References

.64

Structural Unclarities

.78

Total Communication Disturbances

.90

Note. Intraclass correlations across three raters who independently scored a randomly selected
16% of the speech samples from the current study.
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Table 3
Selected Demographic and Clinical Characteristics: Frequency and Percentage of Participants

Characteristic

Number of
Participants

Percentage
of Participants

Gender
Male

47

85.5

Female

8

14.5

48

87.3

African American

3

5.5

Native American

2

3.6

Asian

1

1.8

Hispanic

1

1.8

Race
Caucasian

Marital Status
Single, never married

36

65.5

Married

10

18.2

9

16.3

Alone

27

49.1

Spouse/significant other

10

18.2

Other family member

7

12.7

Roommate

6

10.9

Residential Treatment

5

9.1

Divorced or widowed
Living Arrangements

Employment Status
Working full-time

16.4
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12

21.8

5

9.1

24

43.6

Student

2

3.6

Retired

3

5.5

Under $10,000

14

25.5

$ 10- 20,000

28

50.9

$20-30,000

4

7.3

$30-50,000

8

14.5

$50-95,000

1

1.8

Schizophrenia

45

81.8

Schizoaffective Disorder

10

18.2

Antipsychotics

53

96.4

Antidepressants

30

54.5

Mood Stabilizers

16

29.1

Antipartkinsonians

15

27.3

Medication

53

96.4

Therapy/Supportive

19

34.4

Group Therapy

12

21.8

5

9.1

Working part-time
Unemployed
Disability

Annual Income3

Diagnosis

Current Medications^

Current Treatment0

Other Treatment
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a Income data collected only in these ranges, so averages are not available, b Numerous
participants were prescribed multiple medications, so totals are greater than 100% .c Numerous
participants were involved in multiple medications, so totals are greater than 100%.
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Table 4

Selected Demographic and Clinical Characteristics: Means, Standard Deviations, and Ranges

Characteristic

Mean

Standard
Deviation

Range

Age

46.84

8.07

24-59

Years of Education

14.25

2.18

8-19

Age at Onset of Symptoms

23.76

6.04

13-47

Age at First Hospitalization

25.43

7.60

13-50

Number of Hospitalizations

6.87

5.73

0-32

48.07

9.84

25-68

416.50

320.50

Current GAF score3
Chlorpromazine Equivalents^5

16.6-1825.0

Note. GAF = Global Assessment of Functioning.
3 Possible scores ranged from 0 to 100. b Measured in milligrams.
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Table 5
Means, Standard Deviations and Ranges for the 4-Factor Model of the Brief Psychiatric Rating
Scale (BPRS): Items and Scales

Standard
Deviation

BPRS Scale/Item

Mean

Positive Symptoms

2.37

0.96

Suspiciousness

2.80

2.08

1 -7

Hallucinations

2.75

1.86

1 -7

Unusual Thought Content

3.15

1.66

1-6

Bizarre Behavior

1.80

1.28

1 -5

Disorientation

1.35

0.67

1 -3

Negative Symptoms

1.95

0.83

Self-Neglect

1.82

1.11

1 -5

Blunted Affect

2.47

1.37

1-6

Emotional Withdrawal

2.00

1.05

1 -5

Motor Retardation

1.53

0.98

1 -5

1.54

0.77

Hostility

1.84

1.21

1 -5

Elevated Mood

1.22

0.74

1 -5

Grandiosity

2.11

2.03

1 -7

Excitement

1.33

1.09

1-6

Distractibility

1.51

0.88

1-4

Motor Hyperactivity

1.25

0.88

1 -5

1.80

0.85

2.07

1.32

Manic-Excitement

Depression-Anxiety
Anxiety

Range

1 -5
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Depressed Mood

2.22

1.47

1-6

Suicidality

1.15

0.52

1-3

Guilt Feelings

1.76

1.47

1-6

Somatic Concern

1.47

0.79

1- 4

Conceptual Disorganization

2.11

1.09

1 -5

Tension

1.62

1.03

1-5

Uncooperativeness

1.49

1.30

1-7

Mannerisms and Posturing

1.11

0.50

1 -4

Other Items

Total (average)

1.83

0.53

Note. Ratings were made on a 7-point scale (1 = Not Present, 7 = Extremely Severe).
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Table 6
Means and Standard Deviations for Quality of Life Interview (QOLI) Scales

QOLI Subscale

Mean

Standard Deviation

Objective Scales
Daily Activities a

4.60

1.62

Family Contact^

3.46

1.18

Social Contact*5

3.08

0.84

Financial Adequacy0

0.89

0.18

275.65

415.76

General Life

4.55

1.34

Living Situation

5.01

1.41

Daily Activities

4.61

1.26

Family Relations

4.66

1.46

Social Relations

4.67

1.25

Finances

4.42

1.74

Worke

5.35

0.92

Legal and Safety

5.42

1.16

Health

4.58

0.95

Spending Moneyd
Subjective Scale - Satisfaction

Note. Satisfaction ratings were made on 7-point scales (1 = terrible, 7 = delighted).
a Out of a possible total of 8 activities, b Values range from 1 = not at all, to 5 = at least once per
day.c Values represent percentile out of 5 costs that can be adequately covered by available
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finances. d Values represent reported spending money available. e For this group (participants
currently working), n = 22.
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Table 7
Correlations between Subscales/Other Indicators and Global Life Satisfaction (GLS) on the
Quality of Life Interview (QOLI)

Subscale/lndicator

GLS

Objective
Daily Activities

.139

Family Contact

-.040

Social Contact

.340**

Financial Adequacy

.176

Spending Money

.031

Victim of Crime

.195

Arrested in Last Year

.146

Subjective - Satisfaction
.438**

Daily Activities

.627**

Family Relations

.272*

Social Relations

.349**

Finances

cn
o

00
i

Living Situation

Work3

.353

Legal and Safety

.258*

Health

.528**

a For this group (those who are currently working), n = 22.
*p < .05. **p<.01.
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Table 8
Means, Standard Deviations, and Ranges of Social Adjustment Scale-ll (SAS-II) Global Ratings

Global Rating

Mean

Standard Deviation

Range

Worka

3.74

1.68

0 -6

Household Memberb

2.18

1.09

0 -5

External Family

2.78

1.31

1 -6

Social Leisure

3.22

1.06

1 -5

General Adjustment

3.11

0.79

2 -5

Note. Global ratings were made on a 7-point scale (0 = excellent adjustment, 6 = severe
maladjustment), therefore, lower scores reflect higher adjustment.
a This score refers to functioning in school or accomplishing daily responsibilities if the participant
is not currently employed, b For this group (living with others), n = 28.
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Table 9
Means and Standard Deviations of Scales on the Communication Disturbances Index (CDI)

CDI Scale

Mean

Standard Deviation

Vague References

.42

.30

Confused References

.36

.28

Missing Information References

.58

.36

Ambiguous Word Meanings

.86

.56

Wrong Word References

.34

.20

Structural Unclarities

.32

.24

2.88

1.24

Total Communication Disturbances

Note. Scores represent number of disturbances per 100 words of speech.
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Confused References

Missing Information References

Ambiguous Word References

Wrong Word References

Structural Unclarities

Total Communication Disturbances

2.

3.

4.

5.

6.

7.

* p < .05. * * p < .01.

Vague References

1.

CDI Scale

—

1

.379**
.562**

.072
.308*
--

.163
-

--

.054

.320**

-

.511**

.373**

-.072

5

3

2
4

Pearson Product Moment Correlations between Scales on the Communication Disturbances Index (CDI)

Table 10

.519**

--

--

.685**

.847**

.648**

.270*

.668**

7

.378**

.396**

.175

-.114

.264*

6
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Table 11
Score Conversions for Neurocognitive Measures: Standard Score, Age Scaled Score, T score, z
score, and Percentile Equivalents

Standard
Score

Age Scaled
Score

T score

z score

-3

Percentile

55

1

20

60

2

23

.80

65

3

26

1.00

70

4

30

75

5

33

5.00

80

6

37

9.00

85

7

40

90

8

43

25.00

95

9

46

37.00

100

10

50

105

11

53

63.00

110

12

57

75.00

115

13

60

120

14

63

91.00

125

15

66

95.00

130

16

70

135

17

73

99.00

140

18

77

99.20

145

19

80

150

20

83

-2

-1

0

1

2

3

.30

2.00

16.00

50.00

84.00

98.00

99.70
99.93
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10.44

Digit Symbol - Pairing

32.67
34.63
94.70

Trail Making Test - Trails A (time)

Trail Making Test - Trails B (time)

15.60

Digit Span

COWAT

33.85

Block Design

6.56

54.78

Digit Symbol - Total

Digit Symbol - Free recall

43.60

Mean

Vocabulary

WAIS-III

Assessment

Raw Scores

Participants Determined to be Impaired on Each Assessment

prohibited without permission.

32.00

41.97

25.78

26.07

29.10

31.46
32.91

23.35

40.84

11.05

10.81

3.16

10.29

24.64

—

25.003

1.38

42.36

-

33.303

4.63

20.90

23.56

12.32

27.45

SD

51.07

Mean

10.64

SD

Percentile

38.2
38.2

21

43.6

7.3

12.7

29.1

29.1

36.4

9.1

% of sample

21

24

4

7

16

16

20

5

N

Subjects Impaired

Means and Standard Deviations for Neurocognitive Assessment Raw Scores and Standardized Percentiles, and Number and Percentage of

Table 12
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9.73
8.20
8.56
13.40

Short Delay Recall

Long Delay Recall

Recognition Total

5.22

Recall List 1

Recall List 5

41.27

4.24

Categories Completed

Recall Total

1.31

22.37

Failure to Maintain Set

Perseverative Errors

2.71

3.38

3.11

2.88

1.65

11.67

1.94

1.34

13.57

30.76

24.74

23.28

17.75

17.34

29.92

28.56

27.97

24.64

20.76

20.32

--

11-16b

13.81

-

22.83

>16b

23.35

16

25

22

27

23

40

31

15

27

29.1

45.5

40.0

49.1

41.8

72.7

56.4

27.3

49.1

prohibited without permission.

the mean (<16%) thus impairment on the measure can still be determined. Pairing percentiles ranged from <1% to >50%. Free recall percentiles

table represent the median percentile value across participants. It is possible to determine if an individual score is one standard deviation below

percent. Therefore percentiles based on individual performance cannot be calculated and descriptive statistics cannot be obtained. Values in the

a Standard scoring procedures report these values as cumulative percentages associated with given raw scores, which range from 1 to >50

Sorting Test. CVLT = California Verbal Memory Test.

Note. WAIS-III = Wechsler Adult Intelligence Scale, Third Edition. COWAT = Controlled Oral Word Association Test. WCST = Wisconsin Card

WCST
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completed percentiles ranged from <1% to >16%. It is possible to determine is an individual score is one standard deviation below the mean

the table represent the median percentile value across subjects. Failure to Maintain Set percentiles ranged from <1% to >16%. Categories

ranged from 1.5% to >50% .b Standard scoring procedures report these values as percentile ranges rather than discrete percentiles. Values in
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Table 13
Pearson Product Moment Correlations among the Five Domains of Neurocognitive Abilities

Domain

1.

Attention

2.

Verbal Fluency

3.

Higher Cognitive

4.

General Mental

5.

Verbal Memory

1

-

2

-.105
-

3

-.033
.253*
-

4

5

.023

.138

.393**

.287*

.260*

.126

-

.200
-

Note. These domain summary scores were calculated by averaging across z scores converted
from raw scores for each of the neurocognitive measures that contributed to the particular domain
* p < .05. ** p < .01.
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.022
-.170
-.059

Worka

Legal and Safety

Health

prohibited without permission.

.112
-.046

Daily Activities

Family Contacts

Objective Scales

.034

-.219

Family Relations

Finances

-.102

Daily Activities

-.349**

-.063

Living Situation

Social Relations

-.170

Total

General Life

Subjective Scales - Satisfaction

QOLI Subscale

-.101

.115

-.149

-.135

.055

.034

-.256*

-.168

-.094

-.034

-.146

Positive

-.194

.032

.152

.189

-.025

-.083

.032

.080

.144

-.205

-.123

-.168

-.178

.045

-.371**

-.151

.151

-.093

.090
-.139

.048

.109

.026

-.428**

-.164

-.016

-.226*

-.183

-.246*

-.422**

-.254*

-.554**

ManicDepressiveAnxiety
Excitement

-.004

Negative

BPRS Score

.154

-.005

.008

.241*

.031

-.143

.416**

.313**

.112

.066

.123

GAF
Score

Pearson Product Moment Correlations between Quality of Life Interview (QOLI) Scales and Psychiatric Status and Symptom Presentation
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.132

-.119

-.040

-.031

-.068

-.091

• p < .05. * * p < .01.

a This rating was only made on those who were currently working, n = 22.

Note. BPRS = Brief Psychiatric Rating Scale. GAF = Global Assessment of Functioning.

-.004

-.169

Financial Adequacy

Spending Money

-.118

Social Contacts

-.018

-.114

-.073

-.011

-.124

-.141

.036

.037

.237’
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.261*

.200
.015

Missing Information

Ambiguous Word Meanings

Further reproduction

.076

-.072
.100

Structural Unclarities

Total Communication Disturbance

-.035

-.192

.064

-.082

.031

.049

.038

Negative

BPRS Score

* E < 05

Note. BPRS = Brief Psychiatric Rating Scale. GAF = Global Assessment of Functioning.

.051

.059

Wrong Word References

.020

-.043

.031

.084

Confused References

.014

Positive

.086

Total

Vague References

CDI Score

Symptom Presentation Measures

.070

-.121

.033

-.030

.183

.126

.086

ManicExcitement

.198

.034

.050

.242*

.097

.025

.166

DepressiveAnxiety

-.183

.027

-.102

-.174

-.191

.080

-.230*

GAF
Score

Pearson Product Moment Correlations between Scales on the Communication Disturbances Index (CDI) and Selected Psychiatric Status and

Table 15
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Table 16
Pearson Product Moment Correlations between Neurocognitive Measures and Selected Brief
Psychiatric Rating Scale (BPRS) Scores

BPRS Score
Neurocognitive Score3

Total

Positive

Negative

Vocabulary

-.133

-.053

-.162

Digit Symbol - Coding

-.228*

-.052

-.329**

Digit Symbol - Pairing

-.186

-.145

-.243*

Digit Symbol - Free Recall

-.098

-.022

-.163

Block Design

.024

.161

-.027

Digit Span

.080

.243*

-.069

COWAT

.050

.164

-.146

Trail Making Test - Part A

.112

-.034

.360**

Trail Making Test - Part B

-.062

-.139

.058

-.125

-.044

-.094

Failure to Maintain Set

.030

-.095

-.046

Categories Completed

.071

.087

.105

Recall Total

-.117

-.096

-.190

Recall List 1

-.017

-.061

-.023

Recall List 5

-.161

-.195

-.216

Short Delay Recall

-.128

-.077

-.162

Long Delay Recall

-.061

-.019

-.176

WAIS-III

WCST
Perseverative Errors

CVLT
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Recognition Total

-.009

-.049

.048

Note. WAIS-III = Wechsler Adult Intelligence Scale, Third Edition. COWAT = Controlled Oral
Word Association Test. WCST = Wisconsin Card Sorting Test. CVLT = California Verbal Memory
Test.
a Neurocognitive scores used for these correlations were z scores converted from raw scores for
each of the.
*p < .05. **p < .01.
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Table 17
Pearson Product Moment Correlations between Neurocognitive Domain Summary Scores and
Selected Psychiatric Status and Symptom Presentation Measures

BPRS Score
Neurocognitive Domain
Summary Score

Total

Positive

Negative

GAF
Score

-.100

-.101

Attention

.166

.181

Verbal Fluency

.050

.164

-.156

.213

General Mental

-.070

.069

-.122

.152

Higher Cognitive

-.172

-.135

-.166

.244*

Verbal Memory

-.147
.252*

.335**
-.119

Note. The domain summary scores were calculated by averaging across z-scores converted from
raw scores for each of the neurocognitive measures that contributed to the particular domain.
BPRS = Brief Psychiatric Rating Scale. GAF = Global Assessment of Functioning.
* p < .05. ** p < .01.
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Table 18
Pearson Product Moment Correlations between Scales on the Quality of Life Interview (QOLI)
and Global Ratings on the Social Adjustment Scale-ll (SAS-II)

SAS-II Global Rating
External
Family

General
Adjustment

Work

Household
Membera

General Life

-.143

-.485**

-.063

-.270*

-.355**

Living Situation

-.125

-.593**

-.241*

-.225

-.372**

Daily Activities

.018

-.411*

.089

-.432**

-.241*

-.636**

-.281*

-.463**

QOLI Scale

Social
and Leisure

Family Relations

(

00
o

Subjective Scales - Satisfaction

-.254

Social Relations

-.125

-.323

-.404**

-.546**

-.503**

Finances

-.184

-.177

-.108

-.095

-.191

Workb

-.152

.129

.020

-.357

-.257

Legal and Safety

-.201

-.214

.060

-.181

-.230*

Health

-.023

-.374*

.289*

-.157

-.093

.208

-.380*

.136

-.209

-.023

Family Contacts

-.066

.239

-.598**

-.166

-.226

Social Contacts

-.186

-.289

-.110

-.463**

-.365**

Financial Adequacy

-.293*

-.299

-.275*

-.225

-.312*

Spending Money

-.149

.217

-.050

-.049

-.068

Objective Scales
Daily Activities

a This rating was made only on those participants with lived with others, n = 27. b This rating was
made only on those participants who were currently working, n = 22.
* p < .05.* * p < . 0 1 .
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Table 19
Pearson Product Moment Correlations between Quality of Life Interview (QOLI) Scales and
Selected Neurocognitive Domain Summary Scores

QOLI Subscale

Neurocognitive Domain
Verbal
Memory
Attention

Higher
Cognitive

Subjective Scales - Satisfaction
Global Life

.186

.222

.059

Living Situation

-.065

.197

-.114

Daily Activities

.172

.158

-.059

Family Relations

.065

.137

-.099

Social Relations

.199

-.059

-.095

Finances

.250*

.114

-.002

Work3

.333

.252

-.093

Legal and Safety

.276*

.082

.183

Health

.129

.124

-.025

Daily Activities

-.199

.042

-.212

Family Contacts

-.040

-.013

-.054

Social Contacts

.034

.268*

-.056

Financial Adequacy

.072

.157

.000

Spending Money

.025

.113

.089

Objective Scales

Note. Domain summary scores were calculated by averaging across z scores converted from raw
scores for each of the neurocognitive measures that contributed to the particular domain,
a This rating was made only for those participants who were currently working, n = 22.
* p < .05.
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Table 20
Pearson Product Moment Correlations between Scales on the Communication
Disturbances Index (CDI) and Selected Neurocognitive Domain Summary Scores

Neurocognitive Domain
CDI Scale

Verbal Memory

Attention

Verbal Fluency

-.055

-.020

-.184

.117

-.248*

.133

Missing Information

-.263*

-.013

-.163

Ambiguous Word Meanings

-.114

-.050

-.097

Wrong Word References

-.112

.070

-.016

.064

-.228

.190

-.120

-.118

-.073

Vague References
Confused References

Structural Unclarities
Total Communication Disturbances

Note. These domain summary scores were calculated by averaging across z scores converted
from raw scores for each of the neurocognitive measures that contributed to the particular
domain.
* p < .05.
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-.202

-.064

-.176

-.078
-.076

-.089

-.031

-.105

Verbal
Fluency

-.104

-.079

-.146

Higher
Cognitive

-.170

-.204

-.196

-.391*

-.051

General
Mental

prohibited without permission.

* p < .05. * * p < . 0 1 .

participants who lived with others, n = 27.

a Work Adjustment encompasses adjustment at work, education, and engaging in daily responsibilities, h This rating was made only for those

scores for each of the neurocognitive measures that contributed to the particular domain.

Note. SAS-II = Social Adjustment Scale - II. These domain summary scores were calculated by averaging across z scores converted from raw

-.258*

-.132

Social and Leisure Adjustment

Global Adjustment

-.192

-.133

External Family Adjustment
-.287*

-.164

-.104

.000

-.439**

Work Adjustment3

Attention

Household Member Adjustment

Verbal
Memory

SAS-II Rating

Neurocognitive Domain

Pearson Product Moment Correlations between Social Adjustment Scores and Neurocognitive Domain Summary Scores

Table 21
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Table 22
Summary of Hierarchical Regression Analysis for Variables Predicting the Quality of Life Interview
(QOLI) Rating of Global Life Satisfaction (N = 51)

Variable

B

SEB

beta

Depression-Anxiety

-.947

.187

-.581***

Depression-Anxiety

-.975

.179

-.599***

Ambiguous Word Meanings

.849

.339

.275*

Depressive-Anxiety

-.907

.171

-.557***

Ambiguous Word Meanings

.857

.321

.277**

-.470

.181

Model 1

Model 2

Model 3

Global Social Adjustment

-.272*

Note. R2 = .338 for Model 1. AR2 = .075 for Model 2. AR2 = .072 for Model 3.
* p < .05. ** p < .01 . *** p < .001
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